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Type 2 diabetes occurs when the body is unable to regulate blood glucose levels as a result 
of insulin resistance and impaired insulin secretion.  Type 2 diabetes mellitus exhibits 
significant heritability and the aim of my research is to examine the basis of this heritability.  
In the first study, we evaluate the effect of a family history of type 2 diabetes on risk of type 
2 diabetes and related metabolic traits.  We found that subjects with a positive family 
history had an increased risk of developing type 2 diabetes with an odds-ratio of 2.25 (95% 
CI: 1.85 – 2.75).  This increased risk appears to be mediated through increased obesity, 
insulin resistance and β-cell dysfunction.  
The year 2007 brought the advent of genome wide association studies, which lead to 
the identification of over a dozen novel type 2 diabetes susceptibility loci.  As these initial 
studies were carried out in populations of European ancestry, the relevance of these genetic 
variants in Asian populations remain less well-characterized.  To gain a greater appreciation 
of the genetic basis of type 2 diabetes in Asians, we have investigated the association 
between recently identified type 2 diabetes susceptibility loci with risk of diabetes in the 
Chinese, Malay and Asian-Indian populations in Singapore.  We also examined their 
associations with traits that appear to be involved in the pathogenesis of type 2 diabetes; 
namely obesity, insulin resistance and β-cell dysfunction. 
 In the second study, we examine the effect of genetic variants at the FTO locus in the 
Singapore Chinese and Malay populations.  We found statistically significant association 
between FTO variants with type 2 diabetes which appeared to be mediated through its 
effect on BMI (p=10-4–10-6).  
 In the third study, to characterize the effect of a newly identified susceptibility locus 
(KCNQ1), we investigate the association between polymorphisms at the locus with 
quantitative traits relevant to the pathogenesis of type 2 diabetes.  We found that the 
increased risk for type 2 diabetes associated with KCNQ1 is likely through a reduction in 
pancreatic β-cell function/insulin secretion (p=0.013). 
 In the fourth study, we examine the effects of genetic variants at eight type 2 
diabetes susceptibility loci (CDKAL1, CDKN2A/B, IGF2BP2, HHEX, SLC30A8, PKN2, 
LOC387761) and conduct a meta-analysis with studies in East Asians.  This study 
demonstrated that type 2 diabetes susceptibility loci identified through genome wide 
association studies in populations of European ancestry show similar effects in East Asian 
populations.  This suggest that failure to detect these effects across different populations 
are likely due to issues of power owing to limited sample size, lower minor allele frequency, 
or differences in genetic effect sizes.   
 Our studies examined several type 2 diabetes susceptibility loci and demonstrate a 
genetic basis/predisposition of type 2 diabetes in Asians.  As several groups worldwide are 
currently undertaking re-sequencing studies to identify causative variants at these loci, the 
examination of multiple ethnic groups may allow us to exploit differences in the patterns of 
linkage disequilibrium between ethnic groups, in order to refine the genomic region of 
interest and aid in this effort.  While many susceptibility loci continue to be identified, much 
of the disease variability still remains unaccounted for; further studies examining gene-
environment interaction as well as a more detailed interrogation of human genetic variation 
will provide further insight to the genetics of type 2 diabetes. 
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MODY  Maturity onset of diabetes in the young 
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NHS98  1998 Singapore National Health Survey 
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SDCS  Singapore Diabetes Cohort Study 
SiMES  Singapore Malay Eye Study 
SNP  Single nucleotide polymorphism 
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Type 2 diabetes mellitus (T2DM) affects more than 170 million individuals worldwide, and 
this has been projected to increase to over 360 million by 20301.  Although lifestyle factors 
such as diet and physical activity contribute to the development of T2DM, genetic factors 
are also important in the pathogenesis of T2DM.  Over the course of my studies, the ease of 
genotyping has increased while the cost has continued to decrease.  This is clearly illustrated 
(and indeed reflected by the studies in this thesis too) with the progression of studies 
examining a single polymorphism, to fine-mapping studies examining several 
polymorphisms within a gene, to studies examining polymorphisms across many different 
genes and genome wide association studies. 
However, as T2DM is a common, heterogeneous and polygenic disease, it would be 
erroneous to think that the genetic variance of this disease might be explained by a few 
genes.  Quite the opposite actually, as illustrated by the recent explosion of genetic 
association studies each touting new T2DM susceptibility loci.  Unfortunately, the gold 
standard for validation, replication in a separate study population, often falls short.  
Nonetheless, several novel T2DM susceptibility loci, identified by recent genome-wide 
association studies (GWAS), have shown consistent replication across different populations.  
However, as most of these initial studies were carried out in populations of European 
ancestry, the importance of these genetic variants in relation to T2DM susceptibility remains 
less well-characterized in Asian populations. 
Singapore, where my studies were carried out, is a highly developed country in 
Southeast Asia with a population of ~4.5 million.  Despite ethnic and cultural differences 
with Western countries, the prevalence rate of T2DM in Singapore (~9%) is comparable to 
those in the United States and Europe.  Singapore has a multi-ethnic population comprising 
7 
 
mainly Chinese, Malays and Asian-Indians.  These three ethnic groups represent the 
predominant portion of the population resident in Asia; where the prevalence of T2DM is 
expected to double in the next 20 years as a result of the rapid urbanization occurring in this 
region1.  The Malay ethnicity alone is the third largest ethnic group in Asia with a total 
population of over 200 million in Indonesia, Malaysia, Singapore and other Southeast Asian 
countries.  This ethnic group certainly represents a population with the propensity to 
develop T2DM and have a prevalence of T2DM of 8.5% in men and 10.1% in women in 
Singapore2.  However, to-date, the genetic susceptibility to T2DM in the Malays has not 
been examined. 
 In this thesis, we begin by examining the impact of a family history of diabetes; to 
further assess the genetic basis of type 2 diabetes, we next examine the contribution of 
recently identified novel T2DM susceptibility loci on the risk of T2DM in the Chinese, Malays 





7.1. PATHOGENESIS OF TYPE 2 DIABETES 
Diabetes is characterized by hyperglycaemia as a consequence of the body’s inability to 
regulate blood glucose levels.  The key hormone for blood glucose regulation is insulin, 
which is secreted by the β-cells in the pancreas, in response to the absorption of glucose 
from food.  Type 1 diabetes is characterized as an insulin deficiency syndrome, while T2DM, 
which accounts for ~90% of all diabetes cases, was considered a result of insulin resistance.  
However, it is now evident that the pathogenesis of T2DM comprises two components, 
insulin resistance and β-cell dysfunction3.   
Insulin resistance is present when the biological effect of insulin (i.e. suppression of 
glucose production in the liver and glucose disposal in muscles) is lessened.  Normally, as 
insulin sensitivity decreases, the β-cells are able to adapt and up-regulate insulin secretion, 
maintaining relatively normal blood glucose levels.  Consequently, β-cell dysfunction 
(through the inability to produce sufficient insulin) is critical in the pathogenesis of T2DM.  
At some stage during the pathogenesis of T2DM, the β-cell fails to compensate for insulin 
resistance and blood glucose levels rise (Figure 1).  This increase in blood glucose over time 
can cause glucose toxicity which in turn further damages the β-cells3.  Accordingly, factors 
which affect insulin resistance, β-cell function or glucose levels are considered risk factors 










                                                     Adapted from International Diabetes Center (IDC), Minneapolis, Minnesota. 
 
Figure 1.  Pathogenesis of type 2 diabetes, showing the progression from normal glucose tolerance 
to the pre-diabetic state of impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) 




7.2. HERITABILITY OF TYPE 2 DIABETES 
The heritability of T2DM is demonstrated by the high concordance among monozygotic 
twins (~70%) as compared to dizygotic twins (~30%)4, as well as the familial clustering of the 
disease. 
 
7.2.1. Family history of type 2 diabetes 
Several studies have shown that a positive family history of T2DM is associated with an 
increased risk of the disease, where individuals with a first degree relative with T2DM have 
a 15-25% chance of developing diabetes.  Interestingly, a positive family history of T2DM is 
not only associated with an increased risk of T2DM5-7 but also with the presence of other 
risk factors such as increased body mass index (BMI) and blood glucose8, 9, and decreased 
insulin secretion10.  Consistent with this, recent data from several GWAS have identified 
genetic variants associated with increased risk of T2DM, which encode obesity (e.g. FTO), 
insulin resistance (e.g. PPARγ) and impaired β-cell function (e.g. KCNJ11, TCF7L2, KCNQ1, 
CDKAL1, HHEX-IDE)11-14, the three key components in the pathogenesis of T2DM. 
 
7.2.2. Differential parental transmission of type 2 diabetes risk 
The heritability of T2DM and its related traits are complicated by an apparent excess 
maternal transmission5, 6, 15-18.  In the prospective study over 22.5 years by Bjornholt et al.6, 
compared to subjects with non-diabetic parents, subjects with a diabetic mother had a 
higher risk of developing T2DM (RR=2.51, p=0.0002), while subjects with a diabetic father 
had a non-statistically significant increase in risk (RR=1.41, p=0.376). 
One implication of a differential effect between maternal and paternal family history 
of T2DM is that, when conducting genetic association studies of T2DM or diabetes-related 
traits (e.g. obesity, dyslipidemia), it may be important to ascertain the maternal and 
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paternal transmission of the risk alleles.  Failing to do so could result in a reduction in the 
effect observed potentially leading to an underestimation of the risk associated with a 
particular allele, or failure to detect the association with the allele at all.   
 
7.2.3. Effect of a family history of type 2 diabetes in Asian populations 
While several studies in European populations have shown that a positive family history of 
T2DM increases risk of T2DM, the impact of a family history of T2DM, and the pattern of 
transmission in Asian populations has not been extensively studied. 
One study in Malaysia found that a parental history of T2DM was associated with 
higher WHR19.  However, this was a small study comprising 60 pre-pubertal Malay children 
and did not examine the role of paternal versus maternal transmission.  Another study 
carried out in Chinese living in Hong Kong18 found that patients with T2DM were more likely 
to have a diabetic mother than a diabetic father, suggesting that the excess maternal 
transmission observed in Caucasian populations may apply in Asian ethnic groups too.  
However, as the study included only subjects with T2DM, they were unable to determine 
the effect of a positive family history on the risk of developing T2DM.  Furthermore, these 
studies were unable to determine the impact of family history of T2DM on other diabetes 
related traits among normal glucose tolerant individuals.   
In complex disorders such as T2DM, it is often difficult to tease apart the genetic and 
environmental contributions to the familial clustering.  Studies have shown that levels of 
environmental risk factors for diseases such as obesity, physical activity and diet20, 21 are 
correlated among family members.  However, a simulation study by Khoury et al.22 
concluded that it is unlikely that simple familial clustering of common environmental factors 
alone could account entirely for familial aggregation of diseases.  Instead, genetic factors 
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(with possible interaction with environmental factors) are most likely the cause of familial 
aggregation of diseases.   
 
7.3. THE COMPLEXITY OF THE GENETICS OF TYPE 2 DIABETES 
Genetic studies of diseases have traditionally relied on two methods to discover the 
responsible genes: linkage mapping and candidate gene studies.  Genetic studies of T2DM 
initially employed the linkage mapping approach, however, when the limitations of linkage 
studies to identify common, low risk genetic determinants of T2DM became apparent, 
candidate gene studies superseded as the preferred study design.  Nonetheless, both 
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7.3.1 Linkage studies of type 2 diabetes 
Linkage mapping is conducted using related individuals (e.g. pedigrees, sibling pairs) and 
uses polymorphic genetic markers spaced across the genome (e.g. microsatellites) to detect 
regions of chromosomes that co-segregate with the disease phenotype (measured using log 
odds (LOD) score analysis).  Genomic regions that are present more frequently than 
expected among subjects with a particular phenotype are further interrogated in detail (e.g. 
sequencing, positional cloning) to isolate the causative gene. 
The use of linkage analysis in genetic studies of rare, monogenic forms of diabetes, 
such as maturity-onset diabetes of the young (MODY) have been relatively successful in 
identifying the aberrant genetic variants.  To date, six MODY genes (HNF4α, GCK, HNF1α, 
PDX1, HNF1β and NEUROD1) have been identified and account for ~85% of all MODY 
cases32.  In contrast, the linkage mapping approach has not proved as effective in identifying 
the genetic determinants of the more common and multifactorial type 2 diabetes.  One 
reason for this is that linkage analysis is better designed and powered for the study of 
diseases where one or a few highly penetrant genes are involved, and where multiple 
disease cases are present in the pedigree.  On the contrary, T2DM is a polygenic disease 
with many possible genes, each contributing a modest effect with additional gene-gene and 
gene-environment interactions adding further complexity to the analysis.  Nonetheless, a 
few diabetes susceptibility genes showing robust association have been identified using the 
linkage approach. 
Calpain-10 (CAPN10) was the first T2DM gene identified using linkage analysis23.  
CAPN10 is located on chromosome 2 and encodes a cysteine protease, subsequent studies 
have shown the association of several single nucleotide polymorphisms (SNPs) in CAPN10 
with increased risk of T2DM24, 33.  More recently, another T2DM susceptibility gene 
identified through linkage analysis is the transcription factor-7-like 2 gene (TCF7L2)25.  To-
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date, TCF7L2 has shown to confer the greatest effect on T2DM risk (meta-analysis OR of 
1.46, p<10-140)26.   
 
7.3.2. Candidate gene association studies of type 2 diabetes 
Following the limited success of family-based linkage approach in the detection of T2DM 
susceptibility loci, researchers realized that large-sample epidemiological association studies 
may be better designed to discover genetic susceptibility loci34.  One of the complicating 
factors is the clinical heterogeneity of T2DM.  The dichotomous diagnosis of T2DM is based 
on glucose levels, however this does not differentiate between the numerous possible 
underlying physiological or genetic alterations for the abnormal glucose levels.  In this 
respect, the use of genetic association studies would also allow the analysis of quantitative 
traits related to T2DM such as insulin resistance, β-cell function and obesity to facilitate the 
identification and characterization of T2DM susceptibility genes. 
Candidate genes are selected based on knowledge of their biological involvement in 
T2DM.  Initial candidate gene studies were largely constrained by the relatively inefficient 
and expensive genotyping methods available at the time, and the lack of public databases 
and depositories of genetic information (i.e. Human Genome Project, HapMap).  
Nonetheless, several T2DM susceptibility genes were discovered and showed consistent 
replication across different populations (Table 1).   Some of the more notable ones are the 
genes encoding the peroxisome proliferator-activated receptor γ (PPARγ), the potassium 
channel Kir6.2 (KCNJ11) and the wolframin protein (WSF1). 
PPARγ is a transcriptional factor that is activated by certain fatty acids, prostanoids, 
and more interestingly, is the molecular target of thiazolidinesdione medications.  A 
missense mutation results in a Proline  Alanine change at position 12 (P12A), and is 
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associated with decreased risk of T2DM (OR=0.79, p<10-4)35 likely through increased insulin 
sensitivity27. 
KCNJ11 encodes the ATP-sensitive potassium channel Kir6.2, together with the 
sulfonylurea receptor SUR1 (ABCC8), it regulates glucose-stimulated insulin secretion in 
pancreatic β-cells.  A missense mutation in KCNJ11 results in a glutamate  lysine change at 
position 23 (E23K), which has been shown to be significant association with increased risk of 
T2DM (OR=1.23, p=1.5x10−5)29.  Subsequent studies have also implicated the E23K variant 
with decreased insulin secretion36.  The association between ABCC8 polymorphisms with 
T2DM has been less consistent, with a large cohort study and meta-analysis finding no 
association with T2DM29. 
Genes known to be involved in MODY were also selected as T2DM candidate genes.  
Of the six known MODY genes, only one (HNF1β) showed a conclusive association with 
T2DM (OR=1.12, p=5x10-6)30.  In support of this finding, previous studies had shown that 
mutations in HNF1β lead to abnormal regulation of transcription in β-cells, causing a defect 
in metabolic signalling of insulin secretion and β-cell mass32. 
Rare mutations in the gene WSF1 causes defects in its encoded protein (Wolframin), 
which results in the Wolfram syndrome.  In particular, Wolfram syndrome is characterized 
by diabetes insipidus and juvenile diabetes, making it a plausible candidate gene for T2DM.  
A large candidate gene association study in the U.K. comprising 9,533 cases and 11,389 
controls subjects found significant association between common SNPs (minor allele 
frequency (MAF) >40%) at the WSF1 loci with risk of T2DM31.  This study also illustrated an 
important shortfall of the candidate gene-approach; with 1536 SNPs in 84 T2DM candidate 
genes selected based on their known role in β-cell development, growth and function, 
remarkably, only one showed significant association, underscoring a key limitation of 
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candidate gene studies; that they are restricted by our limited biological knowledge of the 
pathogenesis of the disease, precluding the discovery of novel disease markers/pathways. 
 
7.3.3. Genome-wide association studies 
Genome-wide association studies (GWAS) employ the unbiased interrogation of 
polymorphisms across the entire genome to identify statistical association between genetic 
variants and phenotypes.  In contrast to linkage studies, they are usually carried out in 
unrelated individuals, and unlike candidate gene studies, they do not require any prior 
supposition of the biological function of genes or pathogenesis of the disease.  Advances in 
genotyping technologies have been responsible for the feasibility of such studies. 
Commercially available genotyping arrays by Illumina® (San Diego, California, USA) and 
Affymetrix® (Santa Clara, California, USA) enable researchers to genotype up to one million 
SNPs per sample.  These technological advances coupled with: (1) the decreasing cost of 
genotyping (much less than 5% compared to a decade ago); (2) the construction of the 
International HapMap database to identify haplotype-tagging SNPs (increases genotyping 
efficiency by reducing the number SNPs required to account for genetic variation in regions 
of strong linkage disequilibrium (LD)); and (3) the development of methodologies to analyze 
and interpret the large datasets have been critical in driving the rapid publications of GWAS. 
In 2007, five large genome-wide association studies of the genetics of T2DM were 
carried out12, 37-40.  The findings from these GWAS corroborated the association with known 
genes (i.e. TCF7L2, KCNJ11 and PPARγ), as well as revealing several novel T2DM 
susceptibility genes (SLC30A8, HHEX, CDKAL1, IGF2BP2 and CDKN2A/B) (Table 2).  The 
GWAS by the Welcome Trust Case Control Consortium (WTCCC) also reported that genetic 
variants in the FTO gene were associated with T2DM, however this was found to be a 
consequence of its effect on BMI11.  More recently, two independent GWAS in Japan 
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identified a novel T2DM susceptibility locus (KCNQ1), this finding was corroborated by 
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 FTO rs9939609 1.19 (1.131.25), 
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 LOC387761 rs7480010 1.14 (1.01 - 1.27),  
p=2.9x10-4 
Hypothetical gene Unknown 38  
 PKN2 rs6698181 1.11 (1.05-1.16), 
p=5.3x10-5 
Protein kinase Regulation of  
β-cells 
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 JAZF1 rs864745 1.10 (1.07-1.13), 
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Transcriptional repressor Associated with β -
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44, 45  
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p=1.2x10-10 
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One particular advantage of GWAS in the study of complex disorders is that it allows 
the discovery of susceptibility loci without the need of prior knowledge of the putative gene 
function or location.  However, the modest effect sizes conferred by common variants, and 
the need for stringent statistical thresholds limit statistical power of studies, denote the 
need for larger sample sizes.  Power calculations of a meta-analysis of three early GWAS, 
comprising almost 10,000 subjects, showed that the power to discover variants with an 
effect size of OR<1.2 (which appears to be the norm for T2DM susceptibility loci, with the 
exception of TCF7L2) is relatively low (Figure 2), indicating that a large portion of 
susceptibility loci remains undetected46. 
  
 
Figure 2.  Power estimates of the DIAGRAM meta-analysis to detect genetic associations 





In an effort to boost study power to detect additional T2DM susceptibility loci with 
lower effects (OR<1.2), the Diabetes Genetics Replication and Meta-analysis (DIAGRAM)45 
consortium combined the results from three GWAS (FUSION group, WTCCC and Diabetes 
Genetics Initiative (DGI)).  Following meta-analysis, replication testing of promising loci 
identified (p<10-4) was carried out in about 50,000 independent subjects.   This exercise 
yielded an additional six loci (JAZF1, CDC123-CAMK1D, TSPAN8-LGR5, THADA, ADAMTS9, 
and NOTCH2-ADAM30) (Table 2), which showed association with T2DM at the genome-wide 
statistical significance threshold (p<10-8).   
Interestingly, most of these GWAS-identified loci appear to be associated with 
insulin secretion, rather than insulin resistance.  One explanation for this may be in the 
study design of the GWAS.  In the attempt to focus on genetic variants which predispose to 
T2DM independent of BMI, the GWAS by Sladek et al.38, limited T2DM cases to those with a 
BMI of <30kg/m2, while the GWAS by the Diabetes Genetics Initiative matched cases and 
controls by BMI40.  Thus by controlling for BMI, which in turn is highly correlated with insulin 
resistance, these studies were more likely to detect genetic variants associated with insulin 
secretion and β-cell function rather than insulin resistance related to adiposity.  Another 
possible reason is that measures of insulin secretion appear to be more heritable than 
insulin resistance47, 48, suggesting that insulin resistance may have a larger environmental 
component and may have fewer genetic determinants with more modest effects. 
 
7.4. DIRECT VERSUS INDIRECT ASSOCIATION 
With the exception of certain monogenic diseases (e.g. cystic fibrosis, thalassaemia), in 
which direct association with the function/causative mutation has been demonstrated, 
most of the known association between genetic variants and diseases are indirect.  Indirect 
association studies (e.g. GWAS) rely on LD between the genetic markers examined with the 
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causative variant or haplotype, allowing the detection of causal variants that have not been 
identified. Indirect association is not without its limitations, for example, incomplete LD 
between the marker and the causative loci reduces study power.  In addition, it is crucial 
that the SNPs genotyped account for most of the genetic variation at the locus in order for a 
negative association to be credible49.  Accordingly, much work has been done to optimize 
indirect association studies.  For example, the International HapMap Project was initiated to 
develop a haplotype map of the human genome, providing information on genomic 
variation and LD structure in different ethnicities.  This information facilitates the selection 
of haplotype-tagging SNPs for the efficient screening for disease association at putative loci.  
However, as information on genomic variation reaches saturation and with the increasing 
ease of sequencing, it will be feasible for association studies to examine all variation within 
and around the putative locus, including the causal variant.   
 
7.5. TYPE 2 DIABETES SUSCEPTIBILITY LOCI SELECTED FOR STUDY 
One of the main objectives of this thesis is to investigate and validate the effects of T2DM 
susceptibility loci in the Chinese, Malay and Asian-Indian populations in Singapore.  We have 
focused on T2DM susceptibility loci identified by the initial GWAS in 200712, 37-40 (FTO, 
SLC30A8, HHEX, CDKAL1, IGF2BP2, CDKN2A/B, PKN2 and LOC387761), in addition to KCNQ1, 






The “Fatso” gene (FTO) was first characterized by researchers when the deletion in a 
homologous region in mice resulted in fused toes (FT) and other (O) abnormalities50.  
Subsequently, the FTO gene has been referred to as the fat mass and obesity-related gene, 
after the GWAS by WTCCC11 identified the association between FTO with T2DM, through its 
effect on body mass.   
Obesity is an established risk factor for T2DM and accounts for some of the 
heritability of T2DM risk, it is also strongly associated with insulin resistance.  Adipose tissue 
modulates metabolism by releasing hormones (e.g. adiponectin), cytokines and non-
esterified fatty acids (NEFAs).  In obesity, NEFAs are increased and have been shown to 
induce insulin resistance and impair β-cell function, possibly due to interference with the 
insulin-signalling pathway51.  As such, genes associated with obesity are relevant for the 
study of the genetic basis of T2DM.  Several genes (e.g. PPARγ, Leptin, MC4R) have also 
been shown to be significantly associated with both T2DM and obesity51. 
Although robust replication of the association between variants at FTO locus with 
BMI has been observed in several populations of European ancestry52-56, this association is 
less consistent in populations of non-European ancestry.  In particular, the association of 
FTO variants with obesity was not observed in Chinese from Beijing and Shanghai57, 
although it was observed to be associated in the Japanese58.  One possible explanation for 
this discrepancy could be gene-environment interactions, with one study in Denmark 
reporting that physical activity attenuated the effects of the FTO variants on obesity52.  
Therefore, it is of interest to examine if this locus is associated with obesity and T2DM in the 
Chinese, Malay and Asian-Indian population resident in Singapore, and if the association 





More recently in 2008, two independent GWAS in Japan41, 42 identified SNPs (rs2237892, 
rs2237895, rs2237897 and rs2283228) within a novel T2DM susceptibility gene, KCNQ1, 
which were strongly associated with T2DM in the Japanese population.  This association was 
further corroborated in a Danish cohort and in the Singapore Chinese population.  KCNQ1 
encodes the pore-forming α-subunit of the IKSK
+ channel and is expressed in the pancreas 
where it is co-expressed with products of other regulators such as KCNE159.  As such, it is 
plausible that polymorphisms within the KCNQ1 gene alter the properties and role of IKSK
+ 
channel, affecting pancreatic β-cell function and insulin production.  Of the two initial 
studies, Unoki et al.41 did not examine the association with β-cell function or insulin 
resistance, while the study by Yasuda et al.42 reported an association with β-cell function in 
Japanese (p=0.021) and Finnish subjects (p=0.024).     
To further our understanding of the association between KCNQ1 with T2DM, it is 
important to examine the association between these genetic variants with quantitative 
traits involved in the pathogenesis of T2DM (e.g. blood glucose, β-cell function, insulin 
resistance).  The understanding of the pathophysiological effects of T2DM susceptibility loci 






7.5.3. T2DM GWAS identified susceptibility loci - CDKAL1, CDKN2A/B, IGF2BP2, HHEX, 
SLC30A8, PKN2, LOC387761 
T2DM susceptibility loci identified through GWAS (CDKAL, CDKN2B, IGF2BP2, HHEX, 
SLC30A8, PKN2, LOC387761)12, 37-40, have been well examined in populations of European 
descent as well as in independent Japanese studies58, 60.  However, the role of these loci in 
other Asian populations remains less clear.  For example, a study in China by Wu et al.61 did 
not find significant associations between SNPs in IGF2BP2 and SLC30A8 with T2DM, while an 
association between SNPs at the HHEX locus and T2DM was reported among Chinese living 
in Shanghai, but not among Chinese in Beijing.  Another study in Hong Kong Chinese62 also 
did not find an association with SNPs at the IGF2BP2 locus, however, they reported an 
association between T2DM with SNPs at the HHEX and SLC30A8 loci.  Consequently, it is 
important to fill this knowledge gap and establish a consensus as to the relevance and 
contribution of these recently identified T2DM susceptibility loci in Asian populations.  We 
also examined rs6698181 in PKN2 as it did showed some association in the GWAS by DGI 
and FUSION (p=10-3-10-5)37, 40, and rs7480010 in LOC387761 which showed an association in 
the GWAS by Sladek et al. (p=10-5)38.  As there have been fewer reports examining these 






The overall objective of this thesis is to examine the genetic basis of type 2 diabetes in the 
Chinese, Malay and Asian-Indian population living in Singapore.  To this end, we have 
examined several different facets of type 2 diabetes (i.e. Familial clustering, β-cell function 











The specific aims for each study are: 
 
Study I 
 To examine the effect of a family history of T2DM on the risk of abnormal glucose 
tolerance (impaired fasting glucose (IFG), impaired glucose tolerance (IGT) or T2DM) 
and related metabolic traits (blood glucose levels, insulin resistance, β-cell function). 
 To compare differences in the effect of a paternal versus a maternal history of T2DM 
 
Study II 
 To determine the associations between previously identified obesity associated SNPs 
at the FTO locus with obesity and T2DM in the Singapore Chinese, Malay and Asian-
Indians. 
 To examine if these associations were modulated by physical activity. 
 
Study III 
 To characterize the effect of polymorphisms at the KCNQ1 locus by examining their 
association with diabetes-related quantitative traits (e.g. insulin resistance and β-cell 
function, blood glucose levels) in the Singapore Chinese, Malay and Asian-Indians. 
 
Study IV 
 To ascertain the association and contribution of SNPs in GWAS identified diabetes 
susceptibility loci (CDKAL1, CDKN2A/B, IGF2BP2, HHEX, SLC30A8, PKN2, LOC387761) 
with the risk of T2DM in Chinese, Malays and Asian-Indians. 




9. STUDY POPULATIONS 
Study I-IV utilized data and materials from three studies conducted in Singapore, namely: 
(a) 1998 Singapore National Health Survey 
(b) Singapore Malay Eye Study 
(c) Singapore Diabetes Cohort Study 
The main outcomes of interest are glucose tolerance status (normal, IGT, IFG and T2DM), 
insulin resistance (HOMA-IR), β-cell function (HOMA-β, CIR120), and measures of obesity 
(BMI, WHR, waist circumference). 
 
9.1. THE 1998 SINGAPORE NATIONAL HEALTH SURVEY 
Study I-IV make use of clinical data and blood samples from the 1998 Singapore National 
Health Survey (NHS98).  The NHS98 was initiated to evaluate the impact of a National non-
communicable disease intervention programme on the prevalence of major cardiovascular 
disease risk factors in Singapore.  The research protocol for NHS98 was approved by the 
Singapore General Hospital Institutional Review Board. 
 
9.1.2. NHS98 sampling frame and sample size 
NHS98 is a cross-sectional study conducted between September to November 1998 through 
six survey centers across the Singapore Island.  A target sample size of 5000 subjects was 
determined in order to have 80% power to detect a 10-15% difference in the prevalence of 
common diseases and risk factors.  The sampling was divided into 2 phases (Figure 4).  In the 
first phase, to account for non-respondents, 11,200 households were selected from the 
National Database on Dwellings.  These households were selected based on their proximity  
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to the six survey centers as well as based on 
house-type (as a proxy for socio-economic 
status (SES)) to ensure a representative 
distribution of households in Singapore.  In 
the second phase, a random sample of 7500 
individuals (between ages 18-69 years) were 
selected from the 11,200 households, with 
an oversampling of Malays and Asian-
Indians to ensure that prevalence estimates 
for these ethnic groups were reliable.    
Participants were contacted first by mail, 
then by telephone. Interviewers 
subsequently also conducted a home visit.   
A response rate of 64.5% (4723/7500) was achieved comprising 3228 Chinese (64%), 849 
Malays (21%) and 646 Asian-Indians (15%). 
 
9.1.3. Biological measurements 
Fasting blood samples were drawn for measurement of glucose and insulin in all subjects 
after a 10 hour overnight fast.  All subjects who were not taking oral hypoglycemic agents or 
insulin were subjected to a 75g oral glucose tolerance test.  Subjects were diagnosed to 
have T2DM if they gave a history of T2DM or if their fasting glucose ≥7.0 mmol/l or 2 hour 
post challenge glucose (2HPG) ≥11.1 mmol/l.  IFG/IGT was diagnosed if their fasting glucose 
was >6.0 mmol/l & <7.0 mmol/l or if their 2HPG was >7.8 mmol/l & <11.1 mmol/l.   
Insulin resistance were estimated using the Homeostatic Model of Assessment 























corrected insulin response at 120 minutes (CIR120)
64 or HOMA-β.  These estimates have been 
demonstrated to correlate well with the ‘gold-standard’ measures for insulin resistance 
(euglycaemic clamp) and β-cell function (hyperglycaemic clamp).  The estimates were 
calculated using the formulae: 
(a) HOMA-IR = Fasting plasma glucose (mmol/L) x Fasting insulin (μU/ml) ÷ 22.5 
(b) CIR120 = 100 x Insulin120 ÷ [Glucose120 x (Glucose120 – 70)] 
(c) HOMA-β = *Fasting insulin (μU/ml) x 20+ ÷ *Fasting glucose (mmol/L) – 3.5] 
Serum glucose concentrations were measured using kits from Boehringer Mannheim 
Systems (Mannheim, Germany) and read on a BM/Hitachi 747 analyzer (Roche Diagnostics, 
Corp. Indianapolis, USA).  Insulin levels were measured using immunoassay (Abbott ASYM 
Abbott Laboratories, Chicago, IL).  DNA was isolated from blood samples using DNA blood 
Midi kits (Qiagen, Hilden, Germany) following the manufacturer’s recommended protocol.  
DNA samples for 2936 Chinese, 788 Malays and 598 Asian-Indians were available for 
analysis. 
Height, weight and blood pressure were measured for all subjects.  BMI was 
calculated as weight (in kilograms) divided by the square of height (in meters). Waist 
circumferences were measured at the narrowest part of the body below the costal margin, 
and hip circumference was measured at the widest part of the body below the waist. 
Overweight was defined as BMI 25.0-29.9 kg/m2 and obesity as BMI >30 kg/m2.  An 
interviewer-administered questionnaire was used to capture data on socio-demographic 
factors, dietary intake, physical activity, smoking and alcohol consumption.   
 
9.2. THE SINGAPORE DIABETES COHORT STUDY 
In Study IV, additional T2DM subjects were derived from the Singapore Diabetes Cohort 
Study (SDCS).   The research protocol for SDCS was approved by both the National University 
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of Singapore Institutional Review Board and the National Healthcare Group Domain-Specific 
Review Board. 
 
9.2.1. SDCS sampling strategy and measurements 
SDCS comprises Chinese, Malay and Asian-Indian individuals with T2DM.  Since 2004, all 
individuals diagnosed with T2DM at primary care facilities of the Singapore National 
Healthcare Group Polyclinics have been invited to participate in the SDCS.  Of the individuals 
approached, 91% agreed to participate in the study and formed our SDCS case group.  
Blood specimens were obtained for DNA extraction and measurement of HbA1c, at 
the National University Hospital Reference Laboratory.  At the time of this study, DNA 
samples from 1317 Chinese, 256 Malay and 130 Asian-Indian subjects were available for 
analysis.  Weight and height were measured in all participants; BMI was measured in all 
subjects in the same way as in NHS98.  Consenting subjects also completed a questionnaire 





9.3. THE SINGAPORE MALAY EYE STUDY 
In Study II and IV, subjects from the Singapore Malay Eye Study (SiMES) were also included.  
SiMES was started with the aim to quantify the prevalence of risk factors for visual 
impairment and major eye diseases in the general adult Malay population.  In addition, due 
to the interests of the co-investigators, measurement of risk factors for other common 
diseases (e.g. blood glucose, lipid levels) was also incorporated in the study design.  The 
research protocols for this study were approved by the Institutional Review Board of the 
Singapore Eye Research Institute. 
 
9.3.1. SiMES sampling frame and sample size 
SiMES is a population-based, cross-sectional 
epidemiological study of Malay adults residing 
in Singapore, aged between 40 and 79 years 
and has been previously described in detail65.  
Briefly, the Ministry of Home Affairs provided a 
list of 16,069 Malays, aged between 40-79 
years, randomly selected from 15 districts in 
south-western Singapore. The target 
population was selected from these districts as 
they were close to the public trains, which 
allowed easy access to the study clinic, they 
were representative of the distribution of age, 
house-type and socio-economic status in 
Singapore (Figure 5).  Using age-stratified sampling, 5600 names (1400 from each decade 

























eligible (i.e. alive, currently residing selected address for at least six months and no terminal 
illness).  A response rate of 78.7% was attained, with the number of study participants 
totaling 3280.  There were no significant differences observed (sex, location, telephone 
ownership) between participants and non-participants. 
 
9.3.2. Biological measurements 
A 40-mL sample of non-fasting venous blood was collected and levels of plasma glucose, 
serum lipids and HbA1c were measured on the same day, at the National University Hospital 
Reference Laboratory, using enzymatic methods implemented in the Advia 2400 Chemistry 
System (Siemens Medical Solutions Diagnostics, Deerfield, IL, USA).  T2DM was diagnosed if 
the subject reported a history of T2DM, or if the random (non-fasting) plasma glucose ≥11.1 
mmol/l.   DNA was extracted from serum using an automated DNA extraction technique at 
the Singapore Tissue Network.  DNA samples for 2997 subjects were available for analysis.  
BMI was measured in all subjects in the same way as in NHS98.    
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10. STUDY DESIGN AND METHODS 
10.1. STUDY I 
The aims of Study I are to investigate the effect of a positive family history of T2DM on 
glucose intolerance (IFG/IGT and T2DM) and obesity related traits, and to examine for 
parental effects in risk transmission.   
To do this, we employed a case-control approach utilizing data from NHS98, 
comprising 4717 subjects (3225 Chinese, 848 Malays and 644 Asian-Indians).  We defined 
cases as subjects with abnormal glucose tolerance (IFG/IGT and T2DM, which were analyzed 
separately), while controls were subjects with normal glucose tolerance (NGT).  Details of 
NHS98 are described in section 8.1 above.  We also conducted quantitative trait association 
analysis among NGT subjects to compare the effect of a positive family history of T2DM on 
related traits, such as obesity, insulin resistance and β-cell function. 
 
10.1.2. Classification of family history of T2DM 
Data on the family history of T2DM of study participants were collected using an 
interviewer-administered questionnaire.  Positive family history was defined as having at 
least one diabetic first degree relative.  We further divided those with a positive family 
history of T2DM into four groups, according to the relationship between the affected family 
members with the subject.  Specifically, those that had: (1) a sibling with diabetes but no 
parental history; (2) a maternal history of diabetes; (3) a paternal history of diabetes; and (4) 
those with both parents having diabetes.  These groups were mutually exclusive.   
To examine the effect of a maternal versus a paternal history of T2DM, we included 
only subjects with one parent having T2DM.  Subjects with a sibling with T2DM (no parental 




10.1.3. Statistical analysis 
Initial analysis did not reveal statistically significant heterogeneity between the ethnic 
groups or genders (p>0.1).  As such, subsequent analyses were performed with the ethnic 
groups and genders combined with summary indices adjusted for these variables.  We used 
logistic regression to determine the risk of IFG/IGT and T2DM associated with the different 
categories of T2DM family history.  Comparisons and adjusted means for continuous 
variables between groups were carried out using ANOVA.  HOMA-β was log transformed to 
improve normality.  To assess β-cell function in the presence of increased insulin resistance, 
analysis of HOMA-β was adjusted for HOMA-IR to avoid overestimating β-cell function.  
Where stated, we also adjusted for age, gender, ethnicity and education.  Education level 
was determined from the NHS98 interviewer administered questionnaire.  Subjects were 
divided into three categories based on the number of years of formal education (<6 years, 6-
10 years, >10 years).  Statistical analyses were performed using SPSS (version 15 for 
Windows). 
To examine the risk factors that may contribute to the effect of a family history of 
T2DM, obesity, insulin resistance and β-cell function were added to the logistic regression 
models one at a time.  A reduction in the standardised β coefficient of the family history 
independent variable was interpreted as indicating that the effect of a family history of 






10.2. STUDY II 
The aim of this study is to examine the association of FTO variants with obesity and risk of 
T2DM in South-East Asian populations. 
 We conducted a genetic association study with measures of obesity (BMI, waist 
circumference, WHR) as the outcomes of interest, utilizing data from NHS98 and SiMES.  A 
case-control approach was employed to examine the effect of FTO variants on risk of T2DM, 
as defined in section 8.1 and 8.3 above. 
 
10.2.1.  Genotyping 
Genotype data were available for 4298 NHS98 subjects, comprising 2919 Chinese, 785 
Malays and 594 Asian-Indians.  In SiMES, genotype data were available for 2996 subjects.  
Nine SNPs at the FTO locus that were previously described11, 52-56 were selected for this 
study (rs9939609, rs8050136, rs1421085, rs17817449, rs7193144, rs1121980, rs9940128, 
rs9939973, rs9926289).  Genotyping of the nine SNPs was carried out using the Sequenom 
MassARRAY platform (Sequenom, San Diego, CA, USA).  Thirty samples were analyzed in 
duplicate; genotyping was 100% concordant for these samples. 
 
10.2.2.  Statistical analysis 
A general inheritance model was fitted and an additive model was used based on the 
observed effects.   Individuals were assigned as 0/1/2 according to their number of risk 
alleles, for each SNP, which correspond to the risk alleles identified to be associated with 
obesity in European populations. Multiple linear regression analyses were performed to 
study the associations between SNPs with measures of obesity and related-traits.  Initial 
analysis did not reveal statistically significant heterogeneity between the genders (p>0.1).  
35 
 
Hence subsequent analyses were performed with the genders combined with summary 
indices adjusted for gender.  All analyses were stratified by ethnic group.  Logistic regression 
was used to examine the association between SNPs with risk of T2DM.  Where stated, 
adjustment for age, gender, BMI and physical activity was carried out by adding these 
variables to the model.   
To test the hypothesis that physical activity may modify the effect of FTO variants, 
the interaction variable (SNP*physical activity) was included into the regression models.  
The test of linear hypothesis was used to estimate the p-values of the interaction, by 
comparing the regression models with and without the interaction variable.  The level of 
physical activity was categorized into three groups, based on guidelines from the American 
College of Sports Medicine (www.acsm.org): (1) those who regularly exercised, defined as 
participation in any form of sports for at least 20 minutes ≥3 days per week; (2) those who 
occasionally exercised <3 days per week; and (3) those who did not exercise.   
Minor allele frequency, deviation from HWE and LD were estimated for the nine 
SNPs using Haploview66.  Meta-analysis using the inverse variance weighted method was 
performed to determine the pooled effects across the ethnic groups.  The test of 
heterogeneity of effects between groups was carried out using Cochran’s test of 






10.3. STUDY III 
The aim of this study is to elucidate the mechanisms through which KCNQ1 mediates its 
effect on T2DM risk. 
We conducted a genetic association study with diabetes related traits (β-cell 
function, insulin resistance, blood glucose levels, BMI) as the outcomes of interest, utilizing 
the NHS98 study subjects, excluding those on diabetic medication. 
 
10.3.1.  Genotyping 
Genotype data were available for 3734 subjects, comprising of 2520 Chinese, 693 Malay, 
and 521 Asian-Indians.  Genotyping of four SNPs in intron 15 of KCNQ1 rs2237897(C>T), 
rs2237895(A>C), rs2237892(C>T), and rs2283228(A>C) was performed using the TaqMan® 
SNP genotyping assay (Applied Biosystems, Foster City, CA, USA).  Genotyping success rate 
for the SNPs were 92%, 99%, 92% and 87% respectively.  To assess reproducibility, 1% of 
samples were analyzed in duplicate; genotyping was 100% concordant for these samples. 
 
10.3.2.  Statistical analysis 
An additive model was used based on observed effects; for each SNP, subjects were 
assigned as 0/1/2 according to their number of risk alleles, which correspond to the risk 
alleles defined in Japanese and European populations.  Linear regression was performed to 
study the associations between KCNQ1 SNPs with diabetes related metabolic traits.  The 
distribution of glucose and insulin measures were skewed and therefore normalized by 
natural logarithmic transformation.  Means were subsequently back-transformed for 
presentation.  There was no significant heterogeneity between the genders (p>0.05) and 
subsequent analyses were performed with the genders combined with adjustment for 
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gender.  Linear regression with adjustment for ethnicity was used to estimate the summary 
effect size of the SNPs in the combined sample from the three ethnic groups. 
Logistic regression was used to estimate the association between KCNQ1 SNPs and 
T2DM.  All analyses were stratified by ethnic group and adjusted for age, gender and BMI 
(where appropriate).  β-cell function was assessed CIR120 and insulin resistance was 
estimated using HOMA-IR.  Analysis of association with β-cell function was further adjusted 
for insulin resistance.  Minor allele frequency, HWE and LD (reported using r2), for the four 






10.4. STUDY IV 
The aim of this study is to replicate the association between T2DM susceptibility loci, 
identified through GWAS in the Singapore Chinese, Malays and Asian-Indians.  A meta-
analysis of similar studies in other East Asian populations was performed in order to clarify 
the importance and relevance of these loci in Asia. 
We employed a case-control approach, using subjects from NHS98 (n=4322), SDCS 
(n=1703) and SiMES (n=2997).  Controls from NHS98 comprised NGT subjects (2196 Chinese, 
472 Malays and 364 Asian-Indians).  Cases included subjects with the diagnosis of T2DM 
from NHS98 (224 Chinese, 113 Malays and 116 Asian-Indians) as well as all subjects from 
SDCS (1317 Chinese, 256 Malays and 130 Asian-Indians).  Subjects with IFG/IGT (n=837) 
were excluded from analysis.  The definitions for NHS98 are described in detail in section 
8.1.    In SiMES, controls (n=1785) were selected on the basis of having an HbA1C <6.1% (2 
standard deviations above the mean for the non-diabetic population), while cases (n=707) 
were defined as subjects that reported a history of T2DM, or if the non-fasting plasma 
glucose ≥11.1 mmol/l.  For the meta-analysis, we combined our results from the Chinese 
and Malays with published studies in East Asian, including Chinese populations from China 
and Hong Kong, as well as Korean and Japanese populations.  Asian-Indians, who are 
considered South-Asians, were not included in our meta-analysis. 
 
10.4.1.  Genotyping 
We genotyped SNPs in eight diabetes susceptibility loci identified by recent GWAS studies.   
These include rs7756992 in CDKAL1, rs10811661 in CDKN2A/B, rs4402960 in IGF2BP2, 
rs1111875 in HHEX, rs13266634 in SLC30A8, rs2237897 in KCNQ1, rs6698181 in PKN2 and 
rs7480010 in LOC387761.  Genotyping of the SNPs was carried out using the Sequenom 
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MassARRAY platform (Sequenom, San Diego, CA, USA), with the exception of rs2237897, 
which was genotyped using the TaqMan® SNP genotyping assay (Applied Biosystems, 
Foster City, CA, USA).  Thirty samples were analyzed in duplicate; genotyping was 100% 
concordant for these samples. 
 
10.4.2.  Statistical analysis 
An additive model was used based on observed effects; for each SNP, subjects were 
assigned as 0/1/2 according to their number of risk alleles, which correspond with the risk 
alleles identified in the original GWAS.  Minor allele frequency and HWE were calculated 
using Haploview66.   
We stratified the analysis by the three ethnic groups with adjustment for study.  
Logistic regression was performed to study the association between the SNPs with T2DM.  
The primary analysis considered only the genetic variants in the model.  These analyses 
were subsequently adjusted for gender and BMI by adding these variables to the model.   
As a supplementary analysis, we also assessed the joint effect of the SNPs using 
logistic regression to calculate the OR with respect to the total number of risk alleles carried 
by each subject at the eight loci.  We grouped individuals into categories based on the 
number of risk alleles, with each category treated as an independent variable in the logistic 
regression model.  Adjacent categories were combined if they had a frequency of <5%.   
For meta-analysis, Cochran’s Q test and I2 were used to assess heterogeneity 
between the studies.  Based on the range of I2 values observed (31– 49%), meta-analysis 
was performed using a random effects model.  A comparison of the estimates from fixed 
effects versus random effects model are shown in Section 11.3.  The statistical analyses 




11.1 CLINICAL CHARACTERISTICS OF STUDY PARTICIPANTS 
Data collected from three studies (NHS98, SiMES and SDCS) were used in this thesis.  Study 
I-IV utilized data collected from subjects in NHS98.  In addition, subjects from SiMES and 
SDCS were also included in Studies II and IV.       
Table 3a shows the general clinical characteristics of NHS98 study participants, while 
Table 3b lists the characteristics for SDCS and SIMES study participants.  The prevalence of 
T2DM is observed to be highest among Asian-Indians (19.9%), followed by Malays (14.4%) 
and Chinese (7.6%).  Correspondingly, the Chinese had lower levels for diabetes related 
metabolic traits/risk factors (i.e. obesity measures, blood glucose levels, insulin-resistance), 
compared to the Malays and Asian-Indians. Similarly, in SDCS, HbA1c levels were highest 
among Asian-Indians, followed by Malays and the Chinese (p<0.001).  Age and gender 
distribution did not differ significantly between the three ethnic groups within NHS98.  
SiMES participants were older, compared to NHS98 participants (p<0.001), although their 
BMI was comparable to the NHS98 Malays (p=0.30).  SDCS participants also tended to be 
older as compared to NHS98 participants; however there were no significant differences in 





  Chinese Malays Indians 
 
 
n 3225 848 644 
 
 
Age (years) 37.9 ± 12.2 38.8 ± 12.7 40.5 ± 12 
 
 
% Male 0.46 0.48 0.48 
 
 
BMI (kg/m2)* 22.7 ± 3.7 25.6 ± 5 25.2 ± 4.8 
 
 
Waist Circumference (cm)* 78.1 ± 10.6 82.6 ± 12.0 85.2 ± 11.8 
 
 
Waist-Hip Ratio 0.82 ± 0.07 0.83 ± 0.08 0.86 ± 0.08 
 
 
Fasting glucose (mmol/L)*† 5.5 (0 - 17.9) 5.9 (3.5 - 30) 6.0 (4.1 - 21.5) 
 
 
2 hour glucose (mmol/L)*† 6.2 (2 - 33.3) 6.9 (2.8 - 34.2) 6.9 (2.6 - 32.9) 
 
 
Fasting insulin (μU/mL)*† 6.1 (0.2 - 576) 7.4 (0.7 - 83.4) 8.8 (1 - 119) 
 
 
2 hour insulin (μU/mL)*† 42.7 (1 - 816) 53.2 (1 - 663) 63.4 (2.4 - 833) 
 
 
HOMA-IR*† 1.47 (0.05 - 19.68) 1.86 (0.11 - 22.24) 2.20 (0.23 - 31.2) 
 
 
HOMA-β*† 63.0 (2.1 - 5485.7) 66.6 (2.8 - 667.2) 75.9 (5.3 - 991.6) 
 
 
CIR120*† 0.79 (0.001 – 9.2) 0.76 (0.002 – 10.9) 0.84 (0.003 – 11.1) 
 
 
Glucose Tolerance (n, %)* 
   
 
 
NGT 2425 (75.2) 509 (60.0) 391 (60.7) 
 
 
IFG/IGT 556 (17.2) 217 (25.6) 128 (19.9) 
 
 
T2DM 244 (7.6) 122 (14.4) 125 (19.4) 
 
 
Note: Mean ± SD, unless otherwise stated. 
* Significant differences of trait (p<0.02) between ethnic groups  
† Geometric mean (range) shown, due to skewed nature of data 
 
Table 3a.  Clinical characteristics of NHS98 study participants. 
 

















Age (years) 63.9 ± 9.7 60.5 ± 9.5 60 ± 10.5 
 
58.7 ± 11 
 
 





BMI (kg/m2) 25.3 ± 3.9 28.5 ± 5 26.9 ± 4.6 
 
26.4 ± 5.1 
 
 
HbA1c (%)* 7.3 (4.5 - 16.2) 7.5 (5.5 - 14) 7.6 (5.8 - 13.9) 
 
6.3 (3.8 - 15.1) 
 
 
Non-fasting glucose (mmol/L)* -- -- -- 
 
6.2 (2.2 - 32.1) 
 
 
Glucose Tolerance (n, %) 
     
 
 










* Geometric mean (range) shown, due to skewed nature of data. 
† NGT subjects (n=590) with HbA1c >6.1 were excluded as controls in Study V.  
 






11.2. STUDY I:  Effects and importance of a family history of T2DM 
The prevalence of a family history of T2DM according to glucose tolerance status is shown in 
Table 4.  Of the NHS98 study population, 29.2% had at least one first degree relative with 
T2DM.  A positive family history of T2DM was associated with a statistically significant 
increase in the risk of both IFG/IGT and T2DM.  A maternal history of T2DM was associated 
with greater risk of T2DM, than a paternal history.  However, this difference was abolished 











Unadjusted OR  
(95% CI) 




Family history of 
T2DM 
% of study 
population 
NGT IFG/IGT T2DM NGT IFG/IGT T2DM IFG/IGT T2DM 
 
 
At least 1 affected 
first-degree family 
member 
29.2 25.6 35.8 42.8 1 
1.63  
(1.39 – 1.91) 
2.25  
(1.85 – 2.75) 
1.67  
(1.42 – 1.97) 
2.95  
(2.36 – 3.70) 
 
 
At least 1 affected 
sibling (no parental 
history) 
1.9 2.7 5.1 9.8 1 
2.27  
(1.39 – 3.71) 
3.49  
(2.05 – 5.93) 
1.55  
(0.93 – 2.60) 
1.77  
(0.97 – 3.22) 
 
 
At least 1 affected 
parent : 
27.3 24.3 33 38.5 1 
1.53  
(1.31 – 1.80) 
2.01  
(1.64 – 2.46) 
1.61  
(1.36 – 1.90) 
2.61  
(2.06 – 3.30) 
 
 
 Diabetic  
father only 
10.6 12.4 15 17.3 1 
1.15  
(0.91 – 1.45) 
1.12  
(0.83 – 1.52) 
1.39  
(1.09 – 1.78) 
1.74  
(1.24 – 2.44) 
 
 
 Diabetic  
mother only 
14.0 14.0 21.3 27.3 1 
1.63  
(1.32 – 1.97) 
2.01  
(1.58 – 2.56) 
1.48  
(1.21 – 1.83) 
2.02  
(1.55 – 2.65) 
 
 
 Both parents 
diabetic 
2.7 2.0 3.3 6.1 1 
1.65  
(1.07 – 2.55) 
3.19  
(2.05 – 4.96) 
1.49  
(0.95 – 2.33) 
2.81  
(1.71 – 4.60) 
 
 
* Adjusted for age, gender, ethnicity and education. 
 
Table 4.  Prevalence of a positive family history of T2DM and the associated risk of developing T2DM 






We next determined the effect of a family history of T2DM on obesity and other 
diabetes-related traits, among NGT subjects (Table 5).  Compared to subjects with no family 
history of T2DM, subjects with a positive family history had higher BMI (p<0.001), WHR 
(p<0.001), fasting plasma glucose (p=0.001), 2-hour glucose (p=0.001), HOMA-IR (p<0.001) 












To examine the components which contributed to the risk associated with a positive 
family history of T2DM, we constructed a series of logistic regression models with T2DM as 
the outcome and family history (yes/no) as an independent variable (Table 6).  We first 
estimated the standardised coefficient and p-value for family history of T2DM.  We then 
added other variables (i.e. WHR, HOMA-IR and HOMA-β) to the model one at a time to 
determine the effect of these variables on the coefficient and significance of the family 
history variable.  A reduction in the standardised coefficient was interpreted as being 
indicative that the effect of family history may be explained by the risk factor added to the 
 




  Yes No 
 
 




BMI (kg/m²) 24.0 ± 0.15 23.4 ± 0.12 <0.001 
 
 
Waist circumference (cm) 78.0 ± 0.31 76.5 ± 0.20 <0.001 
 
 
Waist-Hip ratio 0.83 ± 0.002 0.82 ± 0.002 <0.001 
 
 
Fasting glucose (mmol/l) 5.33 ± 0.02 5.27 ± 0.01 <0.001 
 
 
2-hour glucose (mmol/l) 5.82 ± 0.04 5.67 ± 0.03 0.001 
 
 
HOMA-IR 1.93 ± 0.05 1.78 ± 0.04 <0.001 
 
 
HOMA-β † 67.3 ± 1.01 69.2 ± 1.01 0.006 
 
 
HDL cholesterol (mmol/l) 1.30 ± 0.01 1.33 ± 0.01 0.006 
 
 
LDL cholesterol (mmol/l) 3.49 ± 0.04 3.45 ± 0.03 0.221 
 
 
Triglyceride (mmol/l) 1.40 ± 0.03 1.34 ± 0.02 0.006 
 
 
* Adjusted for age, gender, ethnicity and education. 
† Additionally adjusted for HOMA-IR. 
 




model.  Reductions were observed when WHR, HOMA-IR and HOMA-β were added to the 
model.  After including all these variables in the model, the risk of T2DM associated with a 















- - - 0.188 7x10-15 0.02 
 
 
Age, Sex, Ethnicity 0.171 1.4x10-14 0.27 
 
 





Age, Sex, Ethnicity, WHR, HOMA-IR 0.057 0.024 0.44 
 
 
Age, Sex, Ethnicity, WHR, HOMA-IR, HOMA-β -0.004 0.883 0.74 
 
 
Age, Sex, Ethnicity, WHR, HOMA-IR, HOMA-β, TG, HDL -0.006 0.786 0.75 
 
 
Note: HOMA-IR, HOMA-β and triglyceride (TG) levels were log-transformed to improve normality. 
 
Table 6.  Effect of diabetes-related traits on the risk associated with a family history of T2DM. 
  
Lastly, we compared the effect of a maternal versus a paternal history of T2DM on 
diabetes-related metabolic traits among NGT subjects (Table 7).  For this analysis, only 
subjects with one parent having T2DM were included.  In both men and women, compared 
to individuals with no family history of T2DM, a maternal history of T2DM was associated 
with an increase in obesity measures (i.e. BMI, WHR, waist circumference).  A maternal 
history of T2DM, compared to a paternal history, was observed to be associated with higher 
levels of obesity, blood glucose, HOMA-IR and HOMA-β.  However, this parental effect only 

























Males n=1138 n=146 n=164 
   
 
 
BMI (kg/m²) 23.0 ± 3.64 23.4 ± 3.4 24.0 ± 3.91 0.132 0.014 0.25 
 
 
Waist-hip ratio 0.860 ± 0.059 0.862 ± 0.048 0.878 ± 0.053 0.225 0.042 0.252 
 
 
Waist circumference (cm) 82.5 ± 9.6 83.1 ± 8.2 85.5 ± 10.3 0.269 0.018 0.106 
 
 
Fasting glucose (mmol/l)† 5.36 ± 0.36 5.38 ± 0.34 5.41 ± 0.40 0.458 0.449 0.83 
 
 
2-hr glucose (mmol/l)† 5.6 ± 1.16 5.7 ± 1.1 5.8 ± 1.15 0.083 0.064 0.763 
 
 
HOMA-IR† 1.7 ± 1.34 1.7 ± 1.03 1.8 ± 1.24 0.818 0.702 0.926 
 
 
HOMA-β †‡ 75.7 ± 56.51 78 ± 43.65 78.9 ± 57.95 0.448 0.413 0.886 
 
 




BMI (kg/m²) 22.0 ± 3.87 22.5 ± 3.84 23.0 ± 4.35 0.106 0.070 0.709 
 
 
Waist-hip ratio 0.770 ± 0.05 0.773 ± 0.05 0.784 ± 0.05 0.105 0.002 0.453 
 
 
Waist circumference (cm) 72.4 ± 8.4 73.4 ± 8.5 74.9 ± 11.0 0.030 0.005 0.946 
 
 
Fasting glucose (mmol/l)† 5.17 ± 0.40 5.26 ± 0.36 5.27 ± 0.41 0.002 0.021 0.471 
 
 
2-hr glucose (mmol/l)† 5.8 ± 1.01 5.7 ± 1.02 6.1 ± 0.92 0.986 0.001 0.007 
 
 
HOMA-IR† 1.5 ± 0.94 1.8 ± 1.72 1.9 ± 1.26 0.012 <0.001 0.670 
 
 
HOMA-β †‡ 79.2 ± 46.39 87.2 ± 62.46 89.8 ± 58.53 0.021 0.176 0.332 
 
 
* Adjusted for age, ethnicity and education. 
† For analysis, these variables were log-transformed to improve normality. 
 ‡ Additionally adjusted for HOMA-IR. 
 





11.3. STUDY II:  Association between FTO with obesity in the Singapore population 
Allele frequencies for the nine genotyped SNPs and test for HWE deviation are listed in 
Table 10.  The minor allele frequencies for all nine SNPs were higher in Asian-Indians (0.33-
0.43) than in Malays (0.28-0.33) or Chinese (0.12-0.18).  None of the SNPs showed 
significant deviation from HWE.  Figure 6 illustrates the LD between the nine FTO SNPs in 
the different ethnic populations.  A high degree of LD was observed between the SNPs, with 
similar patterns in all three ethnic groups in our population.  In addition, the LD structure of 





on Chr 16 
HWE p-value 
 
Minor Allele Frequency 
 Genotyping 
success rate 

























rs9939973 52358069 0.572 0.826 0.128 0.882  0.18 0.31 0.43 0.33  97.9 99.7 
 
 
rs9940128 52358255 0.527 0.785 0.121 0.882  0.18 0.32 0.43 0.33  98.1 99.5 
 
 
rs1421085 52358455 0.653 0.303 0.27 0.962  0.12 0.28 0.35 0.29  97.5 99.5 
 
 
rs1121980 52366748 0.328 0.443 0.044 0.951  0.17 0.31 0.42 0.33  98.9 99.2 
 
 
rs7193144 52368187 0.525 0.709 0.204 0.634  0.12 0.29 0.34 0.31  97.6 99.5 
 
 
rs17817449 52370868 0.648 0.786 0.362 0.990  0.12 0.28 0.34 0.30  96.0 99.4 
 
 
rs8050136 52373776 0.718 0.868 0.283 0.990  0.12 0.28 0.33 0.30  97.7 99.6 
 
 
rs9926289 52378004 0.625 0.893 0.275 0.999  0.12 0.28 0.34 0.30  97.9 99.5 
 
 
rs9939609 52378028 0.652 0.586 0.2324 0.780  0.12 0.28 0.33 0.30  97.7 99.5 
 
 
Note: Minor allele in NHS98 and SiMES corresponds with the minor allele in populations of European descent. 
 



























Table 11 shows associations between the nine SNPs with BMI, IFG/IGT and T2DM.  
All nine FTO SNPs were associated with increased BMI with an effect size (per risk allele) of 
0.42-0.68kg/m2 (p<0.0001) in NHS98 Chinese, 0.65-0.91kg/m2 (p<0.02) in NHS98 Malays, 
and 0.52-0.64kg/m2 (p<0.0001) among SiMES Malays.   Meta-analysis of the association 
between rs9939609 and BMI for all ethnic groups in NHS98 and SiMES was also performed.  
No significant heterogeneity was observed and the pooled effect size was 0.62 kg/m2 (95% 
CI: 0.45-0.80; p=2x10-12).  FTO variants were also associated with an increased risk of T2DM 
in the NHS98 Chinese (rs9939609: OR=1.32-1.42, p≤0.049), NHS98 Malays (rs9939609: 
OR=1.52-1.63, p≤0.028) and SiMES Malays (rs9939609: OR=1.20-1.24, p≤0.007).  However, 
these associations were abolished after adjustment for BMI, except in the SiMES Malays 
(rs9939609: OR=1.17-1.22, p≤0.026).  No statistically significant associations were observed 
in Asian-Indians.    
Figure 6.  LD (in r2) between nine FTO SNPs genotyped in NHS98 and SiMES population.  LD of CEU population 





FTO SNP rs9939973 rs9940128 rs1421085 rs1121980 rs7193144 rs17817449 rs8050136 rs9926289 rs9939609 
 
 
NHS98 Chinese (N=2919) 
          
 
∆BMI (kg/m2) per risk-allele 0.43 0.42 0.68 0.43 0.63 0.67 0.68 0.68 0.66 
 
 
p-value* 4.7x10-4 5.2x10-4 1.6x10-6 2.1x10-4 9.2x10-6 3.7x10-6 2.1x10-6 2.2x10-6 3.5x10-6 
 
 
Risk of T2DM [OR (95%CI)] 1.33 (1.01-1.74) 1.32 (1.00-1.72) 1.42 (1.04-1.93) 1.19 (0.91-1.53) 1.42 (1.04-1.92) 1.39 (1.01-1.90) 1.40 (1.02-1.90) 1.40 (1.02-1.90) 1.37 (1.00-1.86) 
 
 
p-value*/p-value† 0.036/0.132 0.043/0.15 0.024/0.128 0.187/0.434 0.025/0.102 0.039/0.178 0.036/0.168 0.035/0.163 0.049/0.212 
 
 
NHS98 Malay (N=785) 
          
 
∆BMI (kg/m2) per risk-allele 0.83 0.82 0.9 0.65 0.82 0.91 0.86 0.88 0.89 
 
 
p-value* 0.001 0.002 0.001 0.011 0.002 0.001 0.001 0.001 0.001 
 
 
Risk of T2DM [OR (95%CI)] 1.61 (1.10-2.33) 1.60 (1.09-2.32) 1.59 (1.09-2.32) 1.57 (1.08-2.25) 1.52 (1.04-2.21) 1.63 (1.11-2.38) 1.53 (1.04-2.24) 1.60 (1.09-2.32) 1.57 (1.08-2.29) 
 
 
p-value*/p-value† 0.013/0.082 0.014/0.084 0.016/0.095 0.016/0.071 0.027/0.12 0.011/0.074 0.028/0.129 0.015/0.092 0.018/0.104 
 
 
NHS98 Asian-Indians (N=594) 
         
 
∆BMI (kg/m2) per risk-allele 0.24 0.23 0.03 0.28 0.12 0.1 0.04 0.11 0.1 
 
 
p-value* 0.352/0.333 0.36/0.347 0.913/0.781 0.267/0.247 0.658/0.458 0.715/0.527 0.877/0.719 0.674/0.487 0.7/0.532 
 
 
Risk of T2DM [OR (95%CI)] 0.84 (0.59-1.19) 0.85 (0.59-1.20) 0.87 (0.60-1.25) 0.94 (0.66-1.31) 0.93 (0.64-1.32) 0.85 (0.58-1.23) 0.87 (0.60-1.24) 0.88 (0.61-1.27) 0.96 (0.67-1.37) 
 
 
p-value*/p-value† 0.341/0.356 0.349/0.365 0.467/0.564 0.711/0.74 0.677/0.766 0.393/0.438 0.445/0.53 0.51/0.543 0.84/0.914 
 
 
SiMES Malay (N=2996) 
          
 
∆BMI (kg/m2) per risk-allele 0.55 0.55 0.64 0.52 0.62 0.64 0.63 0.61 0.64 
 
 
p-value* 1.2x10-4 1.2x10-4 7.3x10-6 2.1x10-4 1.2x10-5 8.0x10-6 9.8x10-6 2.0x10-5 8.3x10-6 
 
 
Risk of T2DM [OR (95%CI)] 1.23 (1.08-1.40) 1.24 (1.08-1.40) 1.20 (1.05-1.37) 1.24 (1.08-1.40) 1.21 (1.05-1.37) 1.20 (1.05-1.37) 1.20 (1.05-1.37) 1.20 (1.05-1.37) 1.21 (1.05-1.38) 
 
 
p-value*/p-value† 0.001/0.004 0.001/0.004 0.007/0.025 0.001/0.003 0.005/0.019 0.007/0.026 0.007/0.023 0.006/0.021 0.005/0.019 
 
 
*Adjusted for age and sex. 
† Adjusted for age, sex and BMI. 
 






We next examined the association between FTO SNPs with other measures of 
obesity (waist circumference and WHR) (Table 12).  We chose rs9939609 as the 
representative SNP as it had one of the strongest associations with BMI in our study, and is 
the index SNP in the original study11.  In our study, rs9939609 also showed highly significant 
association with waist circumference in both NHS98 Chinese (p<0.0001) and NHS98 Malay 











0 1 2 0 1 2 
 
 
NHS98 Chinese 77.84 79.09 80.35 <0.0001 0.82 0.83 0.83 0.184 
 
 
NHS98 Malays 81.7 83.56 85.42 0.001 0.83 0.83 0.84 0.198 
 
 
NHS98 Indians 84.97 85.17 85.38 0.74 0.86 0.85 0.85 0.584 
 
 
* Adjusted for age and sex. 
 
Table 12.  Association between FTO SNP rs9939609 with other measures of 
obesity in the NHS98 study population. 
   
As a supplementary analysis, we conducted haplotype-based analyses, which 
recapitulated findings from the single-SNP analyses, these results are shown in Table 13.  
We also examined the interaction between rs9939609 and physical activity in relation to 
BMI.  Although it appeared that rs9939609 had a smaller effect on BMI in those who 
exercised regularly, the interaction did not attain statistical significance in any of the ethnic 





 Figure 7.  Effect of interaction between rs9939609 with physical activity on BMI in NHS98 Chinese. 
 
 




Haplotype frequency 0.81 0.05 
  
0.12   
 
 
∆BMI (kg/m2) Reference -0.11 0.602 - - 0.69 1 x 10-6 - - 
 
 
∆Waist Circumference (cm) Reference -0.12 0.8 - - 1.31 6 x 10
-5
 - - 
 
 




Haplotype frequency 0.66 0.03 
  
0.28   
 
 
∆BMI (kg/m2) Reference 0.39 0.58 - - 0.77 0.004 - - 
 
 
∆Waist Circumference (cm) Reference 0.78 1 x 10
-6
 - - 1.48 0.008 - - 
 
 




Haplotype frequency 0.56 0.08 
  
0.34   
 
 
∆BMI (kg/m2) Reference 0.79 0.093 - - 0.2 0.47 - - 
 
 
∆Waist Circumference (cm) Reference 1.66 0.112 - - 0.36 0.544 - - 
 
 




Haplotype frequency 0.66 0.03 
  





) Reference -0.24 0.432 - - 0.64 2 x 10
-6
 - - 
 
 
T2DM vs NGT (Odds-ratio) 1 1.50 (1.06 - 2.13) 0.04 0.021 1.19 (1.04 - 1.37) 0.003 0.012 
 
 
Note: Only haplotypes with a frequency of more than 0.02 are shown.  SNPs arranged from 5’ to 3’ (rs9939973, rs9940128, 
rs1421085, rs1121980, rs7193144, rs17817449, rs8050136, rs9926289, rs9939609).  Haplotype 1: 1-1-1-1-1-1-1-1-1; Haplotype 2: 
2-2-1-2-1-1-1-1-1; Haplotype 3:2-2-2-2-2-2-2-2-2-2 (where 1=common allele, 2=minor allele) 
*Adjusted for age and sex. 
† Adjusted for age, sex, BMI. 
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11.4. STUDY III:  Effect of KCNQ1 variants on diabetes-related traits 
Allele frequency for rs2237897, rs2237895, rs2237892 
and rs2283228 were similar between the Chinese and 
Malays but different in Asian-Indians (Table 14).  
rs2237895 was in weak LD with rs2237897, rs2237892 
and rs2283228 (r2<0.25), while moderate LD was 
observed between rs2237897, rs2237892 and 
rs2283228 (Chinese: r2=0.56-0.79 Malay: r2=0.74-0.86, 
Asian-Indian: r2=0.39-0.62) (Figure 8).  Data from all 
SNPs in the Chinese and Malays were consistent with 
HWE (p>0.05).  In the Asian-Indians, three of the SNPs 
which had low MAF (rs2237897, rs2237892 and 
rs2283228) were not in HWE. Accordingly, the results 
for the Asian-Indians should be interpreted with 
caution.   
Table 14 also shows the association between KCNQ1 SNPs with T2DM in the Chinese, 
Malay and Asian-Indian populations in Singapore.  Significant associations were observed in 
the Chinese, with rs2237897 showing the strongest effect (OR=1.50, p=0.003).  In the 
combined analysis, the risk alleles of rs2237897(C), rs2237892(C) and rs2283228(A) were 
also associated with T2DM in our study, consistent with previous reports41, 42.  Of these, 
rs2237897 showed the strongest association (OR=1.45, p=0.001).   







Risk Allele  
Frequency 




    
 
 
Chinese 0.07 0.65 1.50 (1.15 - 1.96) 0.003 
 
 
Malay 0.15 0.67 1.32 (0.88 - 1.98) 0.183 
 
 









    
 
 
Chinese 0.65 0.35 1.09 (0.85 - 1.39) 0.496 
 
 
Malay 0.13 0.32 1.39 (0.90 - 2.14) 0.14 
 
 









    
 
 
Chinese 0.32 0.67 1.39 (1.08 - 1.79) 0.011 
 
 
Malay 0.17 0.68 1.28 (0.85 - 1.93) 0.245 
 
 









    
 
 
Chinese 0.55 0.63 1.22 (0.94 - 1.58) 0.135 
 
 
Malay 0.15 0.66 1.39 (0.91 - 2.11) 0.124 
 
 





1.26 (1.02 - 1.57) 0.038 
 
 
* Adjusted for age, gender, BMI and ethnicity (for combined analysis). 
† Combined analysis including Chinese and Malays only. 
 
Table 14.  Association between KCNQ1 variants with risk of T2DM 
  
The association between KCNQ1 SNPs with diabetes-related traits are shown in 
Table 15.  The risk alleles for rs2237897, rs2237892 and rs2283228 showed statistically 
significant association with higher fasting glucose levels (p=0.014, 0.011 & 0.034 
respectively) and reduced β-cell function (CIR120: p=0.007, 0.013 & 0.014 respectively) in the 
Chinese population.  Even after restricting to subjects without diabetes, the association 
remained significant with CIR120 (p=0.011, 0.020 & 0.015 respectively).  A similar trend was 
observed among the Malays and Asian-Indians, though the associations did not reach 
statistical significance, possibly due to the limited sample sizes for these minority ethnic 
groups.  In the combined analysis among Chinese and Malay subjects, SNPs rs2237897, 
rs2237892 and rs2283228 were significantly associated with increased fasting glucose levels 
(p=0.023, 0.017 & 0.041 respectively) and CIR120 (p=0.009, 0.017 & 0.011 respectively).  
These SNPs also showed associations with BMI in the Malay population and WHR in Asian-
Indians.  However these associations were no longer statistically significant in the combined 
analysis.  Based on a risk allele frequency of between 0.3-0.6, power calculations estimate 














 Number of Risk Alleles: 0 1 2 0 1 2 0 1 2 Δ Trait 
 rs2237897 (C>T) N=2291  N=638  N=489     
 BMI (kg/m2) 23.5 23.5 23.4 0.566 26.4 25.4 24.5 0.001 23.4 23.9 24.3 0.477 -0.066 0.573  
 WHR 0.87 0.87 0.87 0.382 0.88 0.88 0.87 0.227 0.86 0.88 0.90 0.036 0.001 0.383  
 Fasting Glucose (mmol/L)†  5.58 5.63 5.68 0.014 5.76 5.80 5.83 0.252 5.37 5.57 5.78 0.209 0.052 0.023  
 Fasting Insulin (mmol/L)†  6.45 6.44 6.43 0.517 7.25 6.83 6.43 0.846 6.49 7.44 8.52 0.290 -0.33 0.558  
 HOMA-IR† 1.60 1.61 1.62 0.236 1.87 1.77 1.67 0.623 1.55 1.84 2.17 0.211 0.015 0.669  
 CIR120†‡ 0.83 0.76 0.70 0.007 0.80 0.76 0.71 0.322 1.18 1.08 0.99 0.820 -0.076 0.009  
 rs2237895 (A>C) N=2520  N=693  N=521     
 BMI (kg/m2) 23.4 23.5 23.6 0.269 25.4 25.0 24.5 0.128 24.7 24.6 24.5 0.786 0.108 0.359  
 WHR 0.87 0.87 0.87 0.137 0.88 0.87 0.87 0.123 0.90 0.90 0.90 0.562 0.002 0.146  
 Fasting Glucose (mmol/L)†  5.61 5.64 5.67 0.237 5.78 5.80 5.82 0.528 5.63 5.71 5.80 0.160 0.034 0.271  
 Fasting Insulin (mmol/L)†  6.45 6.40 6.34 0.241 6.86 6.76 6.66 0.687 8.56 8.72 8.87 0.474 -0.046 0.259  
 HOMA-IR† 1.61 1.60 1.59 0.375 1.77 1.75 1.74 0.571 2.14 2.20 2.27 0.297 -0.005 0.400  
 CIR120†‡ 0.76 0.73 0.70 0.187 0.84 0.76 0.69 0.240 1.22 1.07 0.94 0.071 -0.053 0.218  
 rs2237892 (C>T) N=2327  N=642  N=474     
 BMI (kg/m
2
) 23.6 23.5 23.4 0.707 26.2 25.4 24.6 0.003 23.9 24.1 24.3 0.619 -0.040 0.735  
 WHR 0.87 0.87 0.87 0.584 0.88 0.87 0.87 0.401 0.87 0.88 0.89 0.064 0.002 0.623  
 Fasting Glucose (mmol/L)†  5.55 5.60 5.66 0.011 5.72 5.74 5.76 0.163 5.49 5.61 5.73 0.460 0.044 0.017  
 Fasting Insulin (mmol/L)†  6.42 6.42 6.42 0.460 7.42 6.92 6.45 0.585 6.81 7.58 8.44 0.342 -0.082 0.498  
 HOMA-IR† 1.58 1.60 1.61 0.207 1.90 1.77 1.66 0.893 1.59 1.84 2.13 0.310 0.039 0.529  
 CIR120†‡ 0.85 0.78 0.72 0.013 0.88 0.84 0.80 0.311 1.13 1.09 1.05 0.937 -0.067 0.017  
 rs2283228 (A>C) N=2215  N=586  N=450     
 BMI (kg/m2) 23.4 23.4 23.4 0.669 25.8 25.2 24.6 0.011 23.2 24.1 24.9 0.078 -0.037 0.757  
 WHR 0.87 0.87 0.87 0.774 0.88 0.88 0.87 0.399 0.87 0.88 0.90 0.011 -0.0003 0.848  
 Fasting Glucose (mmol/L)†  5.57 5.61 5.65 0.034 5.66 5.73 5.80 0.072 5.60 5.69 5.79 0.672 0.006 0.041  
 Fasting Insulin (mmol/L)†  6.26 6.35 6.45 0.172 7.31 6.83 6.38 0.437 6.79 7.78 8.93 0.257 -0.001 0.951  
 HOMA-IR† 1.55 1.58 1.62 0.071 1.86 1.75 1.65 0.844 1.69 1.96 2.28 0.284 0.001 0.799  
 CIR120†‡ 0.83 0.77 0.71 0.014 0.90 0.82 0.76 0.109 1.13 1.06 0.99 0.809 -0.008 0.011  
 Note: Risk allele in Bold.  Asian-Indians excluded from combined analysis, except for rs2237895, as SNPs were not in HWE.  
CIR120: Corrected insulin response at 120 minutes. 
* P-values adjusted for age and gender. 
† Subjects taking diabetic medication were excluded (59 Chinese, 35 Malays, 44 Indians). 
   Values were log-transformed to improve normality in regression analysis, adjusted means were subsequently back transformed. 
‡ Additionally adjusted for HOMA-IR. 
 
 






11.5. STUDY IV:  Relevance of T2DM susceptibility loci identified through GWAS in Asia 
The allele frequencies, test for HWE deviation and genotype call rates for the eight 
genotyped SNPs are listed in Table 16.  HWE was calculated based on the allele frequencies 
in controls only. Significant deviation from HWE was observed for rs2237897 in the Indians 



























































A>G 0.98 0.22 0.72 0.28 0.008* 0.44 0.2 
 
 
*Significant deviation from HWE (p<0.01), excluded from subsequent analysis. 
 
Table 16.  MAF and HWE test for the 8 SNPs in Non-diabetic subjects from NHS98 and SiMES. 
 
  
The association between genotyped SNPs with risk of T2DM are shown in Table 17.  
In Chinese, SNPs in CDKAL1 (OR=1.19, p=2x10-4), HHEX (OR=1.15, p=0.013) and KCNQ1 
(OR=1.21, p=3x10-4) were significantly associated with T2DM.  Among Malays, SNPs in 
CDKN2A/B (OR=1.22, p=3.7x10-4), HHEX (OR=1.12, p=0.044), SLC30A8 (OR=1.12, p=0.037) 
and KCNQ1 (OR=1.19, p=0.003) showed significant association with T2DM.  In Asian-Indians, 
SNPs at the CDKAL1 locus (OR=1.39, p=0.011) and KCNQ1 locus (OR=2.48, p=0.019) were 





The combined analysis of the three ethnic groups revealed significant associations 
between SNPs in CDKAL1 (OR=1.13, p=3x10-4), CDKN2A/B (OR=1.16, p=9x10-5), HHEX 
(OR=1.14, p=6x10-4) and KCNQ1 (OR=1.16-1.20, p=3x10-4-3x10-6) with T2DM.  Subsequent 
adjustment for gender and BMI largely recapitulated the findings of the unadjusted 
analyses, with the exception of SLC30A8 (OR=1.06, p=0.039) which only showed association 
after adjustment for gender and BMI in the combined analysis.  No statistically significant 











Risk allele frequency 
95% CI p-value p-value* 
 
 
  Controls Cases 
 
 
CDKAL1 (rs7756992 A>G) 
      
 
Chinese     0.45 0.50 1.19 (1.09 - 1.31) 2x10-4 8x10-5 
 
 
Malay     0.44 0.44 1.03 (0.93-1.14) 0.612 0.24 
 
 
Indian     0.22 0.28 1.39 (1.06 - 1.81) 0.015 0.011 
 
 
Combined†     1.13 (1.06 - 1.21) 3x10-4 1x10-5 
 
 
CDKN2A/B (rs10811661 T>C) 
  
   
 
 
Chinese 0.58 0.61 1.10 (0.99 - 1.23) 0.074 0.304 
 
 







Indian     0.81 0.83 1.19 (0.87 - 1.63) 0.282 0.482 
 
 
Combined†     1.16 (1.08 - 1.25) 9x10-5 3x10-5 
 
 
HHEX (rs1111875 T>C) 
  
   
 
 
Chinese     0.29 0.33 1.15 (1.03 - 1.29) 0.013 0.028 
 
 
Malay     0.31 0.33 1.12 (0.99-1.26) 0.044 0.013 
 
 
Indian     0.33 0.37 1.20 (0.93 - 1.57) 0.167 0.248 
 
 
Combined†     1.14 (1.06 - 1.24) 6x10-4 2x10-4 
 
 
IGF2BP2 (rs4402960 G>T) 
  
   
 
 
Chinese     0.23 0.25 1.11 (0.98 - 1.26) 0.103 0.263 
 
 
Malay     0.31 0.31 1.00 (0.89-1.12) 0.97 0.741 
 
 
Indian     0.44 0.45 1.02 (0.81 - 1.3) 0.849 0.941 
 
 
Combined†     1.05 (0.97 - 1.13) 0.26 0.226 
 
 
SLC30A8 (rs13266634 C>T) 
  
   
 
 
Chinese     0.53 0.53 0.98 (0.88 - 1.09) 0.734 0.512 
 
 
Malay     0.57 0.59 1.12 (1.01-1.25) 0.037 0.023 
 
 
Indian     0.74 0.77 1.18 (0.88 - 1.58) 0.269 0.316 
 
 
Combined†     1.06 (0.98 - 1.13) 0.145 0.039 
 
 
KCNQ1 (rs2237987 C>T) 
      
 
Chinese     0.65 0.69 1.21 (1.09 - 1.34) 3x10-4 2x10-4 
 
 





Indian‡ 0.94 0.98 2.48 (1.22 - 5.04) 0.012 0.019 
 
 
Combined†     1.20 (1.11 - 1.30) 3x10-6 1x10-7 
 
 
PKN2 (rs6698181 C>T) 
  
   
 
 
Chinese     0.34 0.35 1.06 (0.96 - 1.17) 0.221 0.387 
 
 
Malay     0.21 0.22 1.04 (0.92-1.18) 0.552 0.900 
 
 
Indian     0.18 0.18 1.02 (0.76 - 1.38) 0.873 0.815 
 
 
Combined†     1.05 (0.98 - 1.13) 0.183 0.535 
 
 
LOC387761 (rs7480010 A>G) 
  
   
 
 
Chinese     0.22 0.21 0.94 (0.84 - 1.05) 0.266 0.224 
 
 
Malay‡     0.28 0.27 0.98 (0.88-1.10) 0.763 0.455 
 
 
Indian     0.44 0.45 1.04 (0.83 - 1.30) 0.734 0.995 
 
 
Combined†     0.97 (0.90- 1.04) 0.405 0.186 
 
 
Number of subjects (control/case): Chinese (2196/1541), Malay (2257/1076) and Asian-Indian (364/246). 
*Adjusted for gender and BMI 
†Combined odds-ratio adjusted for ethnicity 
‡SNP not in HWE (p<0.01), excluded from combined & meta-analysis 
 
Table 17.  Association of SNPs in eight susceptibility loci with risk of T2DM in the 








The joint effect analysis of SNPs at six loci (CDKAL1, CDKN2A/B, HHEX, IGF2BP2, SLC30A8 
and KCNQ1) showed a significant increase in the risk of T2DM with an increase in the number 
of risk alleles for the combined sample of Chinese, Malay and Asian-Indian from Singapore.  
Compared to subjects carrying zero to three risk alleles (8.3% of study population), each 




Note: Column bars depict Odds-ratio and 95% CI for type 2 diabetes.  Solid line shows the 
percentage of subjects in each category.  Analysis comprised SNPs from CDKAL1, CDKN2A/B, HHEX, 
IGF2BP2, SLC30A8 and KCNQ1.  Adjusted for ethnicity, BMI and gender.   
 
Figure 9.  Risk of T2DM with increasing number of risk alleles at six T2DM susceptibility loci in the 
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Figure 10 illustrates the meta-analysis of risk estimates for six of the loci (CDKAL1, 
CDKN2A/B, HHEX, IGF2BP2, SLC30A8, KCNQ1), using data from published studies in East 
Asia, including Chinese populations China61, 67-70 and Hong Kong62, as well as Korean62, 71 and 
Japanese populations 41, 58, 72.  In essence, the meta-analysis showed that these six diabetes 
susceptibility loci identified through GWAS are associated with T2DM in populations across 
Asia.  The reference studies used in the meta-analysis are: 1) Chinese A (Beijing + Shanghai), 
424 cases & 1908 controls61, 69;  2) Chinese B 1912 cases & 2041 controls67, 70;  3) Chinese C 
1769 cases & 1734 controls68; 4) Hong Kong (1481 cases & 1530 controls), Korea SNUH (761 
cases & 632 controls), Korea KHGS (799 cases, 1516 controls) 62;  5) Korean (908 cases & 502 
controls)71;  6) Japanese A (1630 cases & 1064 controls)58;  7) Japanese B (864 cases & 864 






















































































































Japanese A 1.16 (1.01, 1.34)
1.21 (1.09, 1.34)
1.25 (1.08, 1.45)Japanese A
Japanese A 1.37 (1.17, 1.60)
1.18 (1.00, 1.39)
Japanese A 1.24 (1.06, 1.45)
Japanese A 1.23 (1.06, 1.42)




12.1. METHODOLOGICAL CONSIDERATIONS 
In this thesis we used data collected from two population-based cross-sectional studies 
(NHS98 and SiMES) to conduct association studies to examine the relationship between 
genetic polymorphisms with diabetes-related traits and risk factors.  In addition, we also 
included a case series study (SDCS) to supplement the number of T2DM subjects to examine 
the association between genetic polymorphisms with risk of T2DM. 
While case-control studies are useful when the disease is infrequent or has a long 
induction/latent period, they are more prone to bias such as selection bias (as it is often 
difficult to define the source population) and recall bias (as exposure information is 
collected retrospectively).  In comparison, in population-based studies like ours, the study 
base is defined prior to the selection of cases and controls, this ensures that the controls 
accurately represent the population that gave rise to the cases.  Also, as participants were 
not selected on the basis of exposure or disease status, an unbiased estimate of disease 
prevalence can be determined.  An advantage of genetic association studies is that the 
exposure (genotype) is usually unknown to both the investigators and the participants, thus 
reducing the likelihood of selection bias.  In addition, as genotype is unlikely to be related to 
other environmental risk factors (age, exercise diet, socio-economic status), confounding is 
less likely to occur.  T2DM has an age-standardized prevalence of 8-12% across the three 
ethnic groups in Singapore2, as such, the usage of population-based cross-sectional studies 
was suitable for our genetic association studies.  In addition, the inclusion of additional 






In epidemiology, bias is defined as “any systematic error in an epidemiologic study that 
results in an incorrect estimate of the association between exposure and risk of disease”.  
This is distinguished from chance findings, which arise from random error/variation.  Bias in 
turn diminishes the internal validity of a study (in contrast to external validity which refers 
to the generalizability of the study findings in other populations).  However, potential 
sources of bias can be minimized or eliminated through the rigorous design and conduct of 
the study.  While there are many classifications of bias, the three most commonly 
acknowledged ones are: selection bias, information bias and confounding bias. 
 
12.2.1.  Selection Bias 
Selection bias is the systematic error introduced when the inclusion criteria differ between 
groups in the study population.  Occurring primarily in case-control studies, selection bias 
occurs when the probability of being selected as a case or control is related to exposure 
status.   
 The types of selection bias that can occur in cross-sectional studies include 
ascertainment bias, non-random sampling bias and non-response bias: 
 Ascertainment bias:  produced when the participants selected do not accurately 
represent the population from which they originated.  Ascertainment bias may arise 
from a variety of factors such as healthcare access bias, where individuals with 
different economic, cultural or geographical backgrounds have dissimilar access to 
the institution.  In both NHS98 and SiMES, participants were selected from a National 
database, with an even distribution across different house-types (as a proxy for 
socio-economic status).  In addition, NHS98 participants were also selected for their 
62 
 
proximity to one of the six survey centres across Singapore, while in SiMES, which 
only had one survey centre, selected participants from 15 districts situated close to 
the public trains to ensure easy access to the study clinic.  SDCS recruited T2DM 
patients  that were being treated at nine outpatient primary care facilities, located 
across Singapore, with the majority of patients (91%) agreeing to participate.  
 Non-random sampling bias:  results from a selection procedure that yields a non-
representative sample.  For example, in telephone sampling, households without a 
telephone would be excluded from the sample.  However, in developed countries 
such as Singapore, this difference is not believed to be significant73.  In NHS98 and 
SiMES, telephone calling was one method used to invite individuals to participate in 
the study; invitations were also sent out to the selected households by post. 
 Non-response bias:  when participants differ from non-participants.  This can result 
from the healthy volunteer effect, where participants are healthier than the general 
population.  This is particularly relevant in population-based studies, where such a 
bias may result in a misrepresentation of the population’s health/risk-profile.  In 
NHS98, non-participants were contacted to obtain information regarding their 
demographic and socio-economic profile, diabetes and hypertension status.  
Characteristics of the non-participants were similar to the survey participants.  
Similarly, in SiMES, no significant differences (sex, location, telephone ownership) 





12.2.2.  Information bias 
Information bias or observation bias is the error that occurs when the accuracy of data 
collection differs between groups to be compared.  This can occur in cohort studies, where 
different techniques, with differing accuracy, are used to ascertain the outcome in the 
exposed and unexposed group; or in case-control studies where the methods used to assess 
the exposure differ between the cases and controls. 
Inaccuracy in the measurement or collection of study variables leads to 
misclassification bias.  There are two types of misclassification bias, non-differential and 
differential: 
 Non-differential misclassification bias:  where the misclassification is equal between 
the groups (i.e. cases and controls).  For dichotomous outcomes, the estimates will 
be biased towards the null. 
 Differential misclassification bias:  when the degree of misclassification is different 
between the groups.  Differential misclassification may bias the estimates towards or 
away from the null. 
 
One type of information bias is recall bias, where the likelihood for cases and 
controls to recall and report prior exposures differ.  In this thesis, with the exception of 
Study I and III, recall bias is not likely to have a substantial effect to the studies.  In genetic 
association studies, the exposure is genotype information, of which participants could not 
have had knowledge.  As such, it is impossible that recall bias in exposure could occur.  In 
Study I, the recall of a family history of T2DM could be different between diabetic versus 
non-diabetic participants, which would lead to the differential misclassification of the 
exposure, we chose to only use the information of first-degree relatives as we felt that 
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awareness of a parent/sibling diabetes status would be much higher, and did not consider 
the family history beyond first-degree relatives.  In addition, more than half of the diabetic 
participants in NHS98 had undiagnosed T2DM74, thus most participants would have been 
unaware of their diabetes status at the point of the interviewer-administered questionnaire.  
In Study III, we examined the interaction between physical activity with FTO genotype on 
BMI.  Recall of the level of physical activity may have been different among the obese, 
overweight and normal subjects.  However, as participants were not aware of their 
exposure (FTO genotype) information, exposure status and physical activity remained 
independent.  This, at worse, would have resulted in non-differential misclassification bias 
of physical activity, which would have biased the estimates towards the null. 
 
12.2.2.1. Misclassification of the outcome 
Misclassification of the outcome (e.g. T2DM status, BMI, glucose levels) could have occurred 
in our studies.  Error in data collection is almost unavoidable; this can be caused by random 
error, such as in the rounding of values or missing data, or in the variability of laboratory 
methods.  However, the misclassification is not likely to be related to the exposure as the 
administrators or laboratories would not have had knowledge of the individual’s genetic 
profile.  As we utilized and combined data from three different studies, the data would have 
been collected/measured at different survey sites and laboratories.  However, it is not likely 
that any inter-survey or inter-laboratory differences are related to the genotype frequencies 






12.2.2.2. Misclassification of the exposure  
In genetic association studies, misclassification of the exposure is related to the accuracy 
and success of the genotyping methods used.  As genetic effects in complex disorders tend 
to be small (<5% of disease variance), it is crucial that genotyping methods are robust and 
reliable.  Genotyping errors can be due to several factors including: non-optimized 
genotyping assay, low quality or quantity of DNA (where only one of the two alleles are 
amplified), contamination by other DNA molecules, human error (sample mix-up, use of 
incorrect reagents), and sporadic mutations (mutation at primer/probe binding site).  In 
order to circumvent these problems, several precautionary measures were taken.  Firstly, 
DNA samples of all participants are randomly assigned to the DNA plates to prevent any 
genotyping error from being differential between cases and controls.  In addition, all 
genotyping was carried out by the author personally to ensure the highest standard of care 
and attention in the genotyping.  Secondly, information on the case-control status of the 
samples is not known at the time of genotyping preventing any bias in the ascertainment of 
genotype calls.  Thirdly, positive and negative controls are included in each genotyping plate 
to assess contamination and concordance of the genotyping.  Accordingly, any 
misclassification of the exposure in our samples is likely to be non-differential, resulting in a 
more conservative risk estimate, biased towards the null.  In our studies, genotype success 
call rates were >90% with a concordance of >99%.  The Sequenom® and Taqman® methods 
used in our studies are highly robust (error rates ~0.5% 75, 76) with automated methods in 





12.2.3.  Confounding 
Confounding occurs when an independent predictor of the outcome is distributed unevenly 
between comparison groups (e.g. exposed vs unexposed), and is not an intermediate in the 
causal pathway between the exposure and outcome.  All epidemiologic study designs are 
susceptible to confounding, and if unaccounted for, can mask true effects or yield spurious 
associations.  Nevertheless, confounding can be neutralized at the design stage (e.g. 
randomization, matching) or at the analysis stage (e.g. adjustment, stratification), provided 
the confounder has been measured properly. 
 More recently, Hernan et al.77 defined confounding as the presence of common 
causes to the exposure and outcome, whereby the confounder does not have to be a direct 
cause of the exposure or outcome, but may act indirectly through a surrogate marker.  
Fortunately, in genetic association studies, it is unlikely that any lifestyle factors influence 
the genetics of participants.  In fact, we were cautious not to over-adjust or over-stratify as 
this can result in the creation of ‘backdoors’ (in the context of directed acyclic graphs) 
resulting in spurious associations between genetic factors and the disease78.  A notable 
example of this is in the study of the association between TCF7L2 variants with diabetes 
related traits.  Several studies reported an association between the risk allele in TCF7L2 with 
lower BMI 79-81.  However, the analyses in these studies were stratified by case/control 
status; by controlling for diabetes status, this may result in the spurious association 
between BMI and TCF7L2, reflecting instead the joint independent risk of BMI and TCF7L2 
on T2DM.  One explanation for this is that if the risk allele of TCF7L2 impairs insulin 
secretion, then individuals with the risk allele would tend to develop diabetes at a lower 
BMI than otherwise.   
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 Our studies comprised participants of three different ethnic groups, namely the 
Chinese, Malays and Asian-Indians.  Ethnic differences in risk allele frequency and disease 
prevalence can result in population stratification, which is also a type of confounding.  One 
way to deal with population stratification is to adjust for ethnicity in multivariate analysis.  
This method is valid as long as the relationship between the exposure and outcome is in the 
same direction between ethnic groups (i.e. no effect modification by ethnicity).  To examine 
for effect modification by ethnicity, we included the interaction term (ethnicity x SNP) into 
the regression model to determine the presence of significant differences in effect between 
the ethnic groups.  However, such interactions can often be difficult to detect as study 
power is reduced, and the observed effects are dependent on the measure of association 
(i.e. multiplicative scale vs additive scale).  In particular, the results of indirect genetic 
association analyses are affected by the genetic architecture (allele frequency, haplotype 
distribution, LD pattern) of the study population.  Accordingly, for the genetic association 
studies carried out in this thesis, we have stratified the analysis by ethnic group.  This also 
facilitates comparisons with other studies in different or similar ethnic groups. 
 
12.2.4.  Precision and power 
In spite of all efforts to eliminate bias, chance and random error in measuring the exposure 
or outcome can lead to a non-representative study population.  Increasing the sample size 
of a study and making repeated measurements can reduce random error and increase 
precision.  For the studies in this thesis, we were fortunate to have access to well-designed 
studies with fairly large sample sizes (~10,000 subjects in total); biological measurements 
were made using robust laboratory and genotyping methods.   
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Another important aspect in managing random error and chance occurrences is 
statistical power.  Power refers to the ability for a study to correctly reject the null 
hypothesis when the alternative is true.  Several factors affect study power including: 
sample size, prevalence and variance of the outcome, and the risk allele frequency in the 
population.  Also as the genetic associations that we are measuring are likely indirect 
associations (i.e. SNPs examined are not the causative polymorphism but in LD with it), 
differences in LD structure (measured by r2) in our sample population will affect the power 
to detect association observed in other studies.  However, as the causative polymorphism is 
not often known, we are unable to take into account any differences in the r2 between the 
genotyped SNP with the causative variant in our population.  In general, our studies were 
sufficiently powered (>80%) to detect effect sizes similar to those reported in previous 
studies.  Nevertheless, the smaller sample size available among Asian-Indian subjects and 
lower risk allele frequencies at certain loci in our population may have reduced study power, 
hampering our ability to detect an association.  Consequently, those results should be 
interpreted with some caution. 
 Besides study power, multiple testing is another factor that can hinder a study’s 
ability to draw meaningful conclusions from the data.  The commonly accepted p-value 
significance threshold of 0.05 implies that based on the observed data, there is a 5% chance 
of incorrectly rejecting the null hypothesis.  However, if several statistical test are conducted 
simultaneously, then the probability of a false positive finding will increase (as specified by 
the formula [1-(1-α)k, where test are independent], where α is the significance threshold 
and k is the number of test performed).  Accordingly, in the context of genetic association 
studies, the more SNPs tested against the outcome, the more likely at least one would yield 
an association (by chance) with a p-value<0.05.  Thus in order to maintain an overall rate of 
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false positive of 0.05, the significance threshold has to be more stringent.  One method of 
multiple testing correction is the Bonferroni correction, where a revised significant 
threshold is calculated by the formula α/k.  However, the Bonferroni method is often 
considered to be too conservative, and does not take into account the dependency between 
the statistical tests performed, LD between SNPs, correlation between phenotypes, or the a 
priori probability of association.  Bayesian methods have been used to account for the a 
priori probability of association.  However, these methods require knowledge of the prior 
probability as well as the distribution of the effect sizes that will be encountered.  In 
genome-wide or gene-expression studies, so many tests are performed that these 
parameters can be estimated within the experiment, however, these are more difficult to 
estimate in candidate gene studies.  
As the objective of correcting for multiple testing is to reduce the likelihood of false 
positive findings, it has been suggested that it is not the number of test performed that is 
crucial, but the a priori probability of finding an association.  Consequently, we have 
continued to use a significance threshold of α=0.05 as one of the key aims of our studies is 
to replicate and extend the findings (with regard to T2DM susceptibility loci) from 
populations largely of European descent, in Asian populations.  However, we have followed 
the guidelines as suggested by the NCI-NHGRI Working Group on Replication in Association 
Studies82.  We have used phenotypes with widely-accepted criteria, comparable to the initial 
studies (i.e. T2DM defined using WHO criteria) and we used the same genetic model as in 
the initial study.  In addition, rather than employing a gene-based approach or fine-
mapping, we chose to use a SNP-based approach to the replication in order to achieve the 
gold-standard for replication (i.e. repeating the association with precisely the same genetic 
variant in an independent sample)83; avoiding the problems of gene-based approaches such 
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as, multiple comparisons and having to rationalize differences in LD structure between the 
populations.  In study III, we were the first study, following the initial GWAS in Japan, to 
report on the association between KCNQ1 with diabetes-related traits, specifically β-cell 
function and blood glucose levels.  Some of the p-values in this study would not have 
remained significant after multiple testing corrections, due to the number of traits 
examined.  Nonetheless, we feel that this is of limited concern as one of the initial studies 
had reported an association with β-cell function, and it was our a priori hypothesis that 
KCNQ1 variants would be associated with β-cell function due to its biological role and 
expression in pancreatic β-cells. 
 
12.3. FIXED EFFECTS VERSUS RANDOM EFFECTS MODEL FOR META-ANALYSIS 
In Study IV, we conducted a meta-analysis to clarify the importance of GWAS identified 
T2DM susceptibility loci.  The test of heterogeneity is often used to decide between the 
fixed effects versus random effect model for meta-analysis.  One measure is Cochran’s Q 
test statistic; however, this test has been shown to be poor at detecting true heterogeneity 
when the number of studies is small.  Conversely, when there are many studies, it has been 
suggested that this test is “over-powered”.  More recently, another approach has been 
developed to quantify heterogeneity (I2)84.  The value of I2 describes the percentage of total 
variation across studies due to heterogeneity rather than chance.  Based on the range of I2 
values observed in Study IV (31-49%), which suggests the presence of moderate 
heterogeneity, we chose to present the combined effects derived from a random effects 
model.  A comparison of the combined effects estimates using the two different methods 
are shown in Table 18, with minimal discrepancy in the estimates observed.  It has been 
shown that fixed effect models typically have a greater Type I bias, with narrower 
71 
 
confidence intervals, as compared to random effect models, which may lead to the 
overstating of the significance/precision of the effect estimates obtained85.  Nonetheless, in 












CDKAL1 (rs7756992) 48.90% 0.048 1.20 (1.13 - 1.27) 1.19 (1.14 - 1.23) 
 
 
CDKN2A/B (rs10811661) 49.60% 0.044 1.26 (1.18 - 1.34) 1.24 (1.18 - 1.29) 
 
 
HHEX (rs1111875) 31.30% 0.158 1.18 (1.11 - 1.25) 1.17 (1.12 - 1.23) 
 
 
IGF2BP2 (rs4402960) 35.10% 0.127 1.11 (1.05 - 1.17) 1.10 (1.05 - 1.15) 
 
 
SLC30A8 (rs13266634) 39.00% 0.108 1.12 (1.06 - 1.18) 1.11 (1.06 - 1.16) 
 
 
KCNQ1 (rs2237897) 43.40% 0.116 1.30 (1.22 - 1.38) 1.29 (1.23 - 1.35) 
 
 






13. FINDINGS AND IMPLICATIONS 
13.1. STUDY I 
In Study I, we showed that in South East Asian populations, a positive family history in a first 
degree relative is an important risk factor for the development of T2DM, similar to that 
observed in Caucasian populations5-7, 86.  In addition, we showed that a positive family 
history of T2DM is associated with several diabetes related traits, even amongst those with 
apparently normal glucose tolerance.  This is also in line with studies from other 
populations8, 15, 17, 18, 87-90. 
Through our regression analyses, based on our data, it appears that the components 
of family history that contribute to the risk of T2DM are obesity, insulin resistance and 
impaired β-cell function.  When these variables were added to the model, obesity, IR and β-
cell function significantly attenuated the risk of T2DM associated with a positive family 
history.  While it is often difficult to separate the genetic and environmental contributions 
to the familial clustering of diseases, the simulation study by Khoury et al.22 showed that it is 
unlikely that environmental factors alone could account entirely for familial aggregation of 
common diseases.  Indeed, the susceptibility loci identified from recent GWAS have been 
shown to exert their effect through obesity, insulin resistance and impaired β-cell function, 
the three variables that appear to account for familial risk of T2DM in our study. 
Study I also provided some evidence of an excess maternal transmission of the risk 
of T2DM and its related metabolic traits.  We observed a larger effect of a maternal history 
of diabetes on the risk of IFG/IGT and T2DM, compared to a paternal history.  However, the 
increased risk associated with a maternal history, was evident only in the crude, not the 
adjusted, estimates of risk.  Our data also suggest that there is excess maternal transmission 
of risk for certain T2DM related traits amongst subjects with normal glucose tolerance and 
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that this was particularly obvious in females.  It is interesting to note that these traits that 
show excess maternal transmission relate more to obesity measures rather than β-cell 
function.  However, the differences in effect between maternal and paternal FH are small, 
and achieve statistical significance only in the 2 hour plasma glucose in females.  
Nevertheless, these findings are supported by data from previous studies.  The prospective 
study by Bjornholt et al.6 found that over a 22.5 year period, NGT men with a maternal 
family history had a higher risk (RR=2.51) of developing T2DM compared to men with a 
paternal family history of diabetes (RR=1.41).  In a longitudinal study examining if parental 
history of T2DM influenced diabetes-related traits in their offspring during adolescent 
growth, Kelly et al.91 reported that fasting blood glucose and β-cell function was significantly 
influence by a maternal history of T2DM. 
While the existence of excess maternal transmission of T2DM risk still remains under 
discussion, several mechanisms have been suggested to explain the disparity in parental 
effects on the transmission of metabolic disease risk, namely: (1) genomic imprinting, 
whereby the penetrance of the susceptibility genes inherited are different depending if they 
are maternally versus paternally derived; and (2) mutations in mitochondrial DNA (mtDNA), 
which are maternally inherited and may contribute to the observed excess maternal 
transmission.  Several mutations have been described affecting proteins which are encoded 
in mitochondrial DNA which participate in protein synthesis, the maintenance of mtDNA or 
the respiratory chain. The specific genes and mutations involved have been described in a 
recent review92.  Studies have also shown that intrauterine exposure to diabetes is 
associated with reduced β-cell mass and hyperinsulinemia in offspring93, 94, which 
subsequently leads to abnormal glucose tolerance during adulthood, increasing their 
susceptibility to T2DM and metabolic dysfunction.  Boney et al.93 demonstrated that 
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intrauterine exposure to T2DM is associated with a higher prevalence of components of the 
metabolic syndrome in children.  Pettitt et al.95, 96 reported that offspring of mothers with 
diabetes during pregnancy, had a higher prevalence of obesity and higher glucose 
concentrations, suggesting that prenatal environment may affect subsequent growth and 
glucose metabolism of offspring in childhood and early adulthood. 
One implication of a differential effect between maternal and paternal family history 
of diabetes is that, for traits related to obesity, IR and dyslipidemia, it may be important to 
ascertain the maternal and paternal transmission of the risk alleles, when conducting 
genetic association studies.  This could result in a reduction in the effect associated with an 
allele potentially leading to an underestimate of the risk associated with a particular allele, 
or failure to detect the association with the allele at all.  Conventional case-control 
association studies using unrelated individuals have shown tremendous recent success in 
the identification of novel genetic loci associated with obesity, T2DM and other related 
metabolic traits.  However, these study designs do not allow us to investigate parent-of-
origin effects.  Instead, family based association studies, such as parent-offspring trios, 
would need to be employed to dissect the differential effects of maternal and paternal 
transmission97.  In addition, despite the recent success of T2DM GWAS, we should also 
consider mitochondrial DNA mutations and the impact of intrauterine exposures as a basis 





13.2. STUDY II 
In Study II, we provided evidence that genetic variants at the FTO locus are associated with 
obesity and T2DM in Chinese and Malays living in Singapore.  In Asian-Indian subjects, the 
risk alleles appeared to be associated with a modest increase in BMI (Δ0.1–0.2kg/m2), 
however this was not statistically significant.  Given the relatively small sample size (n=594) 
for this ethnic group, we had only 40% power to detect changes in BMI of 0.5kg/m2 for this 
population. Furthermore, meta-analysis showed no significant heterogeneity of effect 
between populations.   
The findings of Study II are in line with findings from a Japanese study58 but in 
contrast to a previous study by Li et al.57, which reported the lack of association between 
FTO variants and obesity among Han Chinese resident in Shanghai and Beijing.  Our study 
had a similarly large sample size (n=2919 NHS98 Chinese vs n=3210 in Li et al. 2008) and, as 
described in the methods, was more than adequately powered (~90%) to detect an effect 
size on BMI similar to that observed in populations of European ancestry.   Li et al. 
suggested that the lower frequencies of minor alleles and differences in genetic architecture 
at this locus between Chinese and Europeans may have contributed to the lack of 
association.  It has been suggested that population differences in the patterns of 
association, such as these, may occur due to an evolutionary divergence that might reflect a 
history of negative selection against the FTO risk alleles in African and Chinese populations, 
as has been suggested in relation to variants at the TCF7L2 locus98.  However, it seems 
unlikely that any of these hypotheses provide an explanation for these different findings.  
Firstly, the MAFs of FTO SNPs examined were very similar between the Chinese in our 
population and the Han Chinese from Beijing and Shanghai, yet we observed a strong and 
significant association with obesity.  Secondly, we studied two of the three SNPs tested by Li 
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et al. (rs8050136 and rs9939609) with both showing strong association with obesity traits.   
Lastly, comparisons of LD patterns between our study populations and Europeans (CEU) 
populations from HapMap revealed no major differences in this region.  The nine SNPs 
tested were in strong LD with each other in our Chinese (r2=0.60-0.99), Malay (r2= 0.77-0.99) 
and Indian (r2=0.64-0.99) samples as they were in the CEU population from HapMap 
(r2=0.83-0.96, see Figure 6).   
The common form of obesity is a multi-factorial condition, thought to develop from 
an intricate interplay of genes and environmental factors such as dietary habits and levels of 
physical activity.  The occurrence of gene-gene and gene-environment interactions would 
therefore, make it difficult to clearly elucidate the role of specific genetic variants in obesity 
risk99.  Recent studies have already recognized the significance of environmental modulation 
in variants of LIPC, APOA5 and PPARγ with metabolic traits100.  Likewise, possible 
explanations for the differences in associations seen in our population as compared to the 
study by Li et al. could lie in different exposures to environmental or lifestyle factors 
between the populations.  For example, Andreasen et al.52 reported that physical activity 
attenuated the effects of the FTO variants on obesity. This may be relevant given that 
studies of Chinese living in Shanghai101, 102, show that an average of 35% of subjects 
participated in regular exercise compared to only 15.8% in the Singapore Chinese 
population of NHS9874.  Similarly in our study, we observed that the effect of FTO on obesity 
was lower among subjects who exercised regularly, however this interaction was not 
statistically significant, though our study was underpowered to detect these interactions 
(with an MAF of 12% we only had 40% power at α-level 0.05).  Another possible explanation 
for the disparate findings could be due to age-gene interactions, as demonstrated by the 
age-dependent association observed between ROBO1 variants and obesity103.  As such, 
77 
 
differences in the average age between NHS98 Chinese (37.9 ± 12.2 years) and the Chinese 
in the study by Li et al. (58.6±6.0 years) may have contributed to the discrepancies.  
However, it should also be noted that FTO associations with BMI did not show 
heterogeneity across European populations with varying mean ages 11. 
Interestingly, the adjustment for BMI diminished, but did not abolish, the association 
with T2DM among SiMES Malays.  Perhaps, this indicates a direct effect of FTO with T2DM, 
which, to the best of our knowledge, has not been observed in other studies.  Another 
possibility could relate to residual confounding by obesity. It is well known that compared to 
Caucasians of similar BMI, Asians have different levels of adiposity and thus, risks of 
T2DM104.  Consequently, adjusting for BMI may not have fully accounted for the effects of 





13.3. STUDY III  
In Study III, we expand on the findings of previous studies which showed that genetic 
variants within the KCNQ1 locus are strongly associated with an increased risk of T2DM in 
the East Asian and European populations41, 42.  Of the three polymorphisms within KCNQ1 
previously described, rs2237897 appeared to have the strongest association with T2DM in 
one study41, whilst another study reported the strongest association with rs223789242.  
Consistent with these findings, we found that both these SNPs were significantly associated 
with T2DM in the combined analysis of the three ethnic groups in our study.  
Study III also provided further insight into the possible role of KCNQ1 in the 
pathophysiology of T2DM.  We found that the risk allele for KCNQ1 variants rs2237897, 
rs2237892 and rs2283228 were associated with increased fasting glucose level and 
decreased β-cell function in the Chinese population and combined sample.  This is in 
agreement with the study by Yasuda et al.42, which reported an association of these KCNQ1 
variants with β-cell function.  Together, these findings corroborate the hypothesis that the 
risk associated with KCNQ1 is likely mediated through effects on the pancreatic β-cell.  In 
contrast, there was no association between rs2237895 with any diabetes related traits, 
specifically highlighting the importance of these polymorphisms rs2237897, rs2237892 and 
rs2283228 (which are in moderate LD), in increasing the risk of developing T2DM.  Further 
fine mapping of SNPs in KCNQ1, especially within the LD block containing rs2237897 and 
rs2237892 may allow the identification of the causal variant.  
While we do appreciate that the association with T2DM observed in the Chinese do 
not represent an independent replication since the controls used are largely the same as 
those in the initial study by Unoki et al.41, Study III also provided new and important data on 
Malays and Indians.  It was reassuring that similar trends in the effect of the three KCNQ1 
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SNPs on association with T2DM, fasting glucose and β-cell function were also observed in 
the Malay and Asian-Indian subjects, even though their limited numbers certainly resulted 
in a reduction of study power. Although associations with BMI in Malays and WHR in Asian-
Indians were observed, the smaller sample sizes for these ethnic groups, together with the 
fact that these observations were not found in other ethnic groups, inevitably led us to be 
cautious in interpreting these findings.   
One limitation of this study was in the use of CIR120, as an approximate measure of β-
cell function, which may be better assessed using the CIR30.  Thus, if CIR30 measurements 
were available, the positive associations that had been observed in our study may be further 
strengthened.  It has also been suggested that CIR120 may capture information on additional 
aspects of glucose intolerance instead of insulin secretion alone64.  Interestingly, following 
the publication of Study III, two separate studies in Han Chinese populations also reported 
an association between KCNQ1 variants with HOMA-β/insulin secretion68, 69, adding weight 






13.4. STUDY IV 
In Study IV, we report on the contribution and importance of diabetes-susceptibility loci, 
identified through GWAS, in the three major ethnic groups in Asia.  This is also the first study 
to examine these loci in ethnic Malays.  In Study II, we found that variants in the FTO gene 
were associated with BMI and contributed towards risk of T2DM in the Singapore 
population.  To expand on this, in Study IV we examined eight other diabetes-susceptibility 
loci in Chinese, Malays and Asian-Indians living in Singapore.  In the combined analysis of 
the three ethnic groups, we found statistically significant associations with SNPs at five loci 
(CDKAL1, CDKN2A/B, HHEX, SLC30A8 and KCNQ1), demonstrating that these loci are also 
relevant in Asian populations, despite differences in allele frequencies from those observed 
in populations of European ancestry.  In addition, we also provide evidence demonstrating 
the cumulative effect of diabetes-risk alleles on the risk of T2DM, with subjects who carry 
nine or more risk alleles having 2.45 times the risk of T2DM as compared to subjects with 
zero to three risk alleles (see Figure 9).   
One caveat of this study is the smaller sample sizes for the Asian-Indians, which 
certainly decreased study power.  Based on a risk allele frequency of 0.3, power calculations 
estimate that the Indian samples provided only 35-45% power to detect an OR of 1.2.  In 
contrast, the larger sample sizes available in the Chinese and Malays provided 85-90% 
power.  However, despite having sufficient power in our Chinese and Malay samples to 
detect the effect sizes as previously reported37, 40, we did not detect significant association 
between SNPs in PKN2 and LOC387761 with T2DM.  With the exception of the initial GWAS, 
the association with these SNPs have largely been negative12, 105, 106; this could suggest that 
the effects at these loci may be population specific or possibly false-positives.  
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We also failed to detect significant association between IGF2BP2 with T2DM risk, 
among the Singapore Chinese, Malay and Indian subjects; although the effect estimates 
were in the same direction as previous reports12, 37, 40, 62.  However, meta-analysis with other 
East Asian populations revealed a statistically significant association, similar to those 
observed in populations of European ancestry.  Indeed the failure to replicate the 
association with T2DM for all the susceptibility SNPs seems to be commonplace among 
replication studies carried out in different populations and ethnic groups.  It has been 
suggested that differences in the patterns of linkage disequilibrium between the examined 
SNPs and unknown functional variants at these loci could underlie these disparate findings.  
Alternatively, gene-environment interactions may operate in the pathogenesis of T2DM and 
that differences in the level of environmental risk factors in different populations may alter 
the impact of susceptibility genes on the risk of T2DM.  For example, Andreasen et al.52 
reported that physical activity attenuated the effects of the FTO variants on obesity.  
However, when we combined our data with those in other Asian populations, adding 4817 
controls and 2863 cases to the existing literature, our meta-analysis suggests that the 
effects of the polymorphisms are similar to those in populations of European descent, in line 
with findings from a recent Japanese meta-analysis107.  These findings demonstrate that the 
importance of these polymorphisms is similar in Asians as it is in populations of European 
descent, and that limitation in statistical power to detect variants which confer a modest 
risk for T2DM, may underlie previous failure of replication studies.  This does not preclude 
the possibility that heterogeneity of effect exist between populations.  In fact, significant 
heterogeneity of effect was observed between populations with I2 of up to 49.6%.  
However, our findings suggest that this heterogeneity, whether due to differences in the 
pattern of linkage disequilibrium or to gene-environment interactions, may be subtle 




In this thesis, we have studied a multi-ethnic population in Singapore, comprising Chinese, 
Malays and Asian-Indians, the three most populous ethnic groups in Asia.   
 
 A positive family history is associated with increased risk of T2DM in Asian 
populations, as they are in Caucasian populations.  We demonstrate that the effect 
of a family history of T2DM operates through obesity, IR and impaired β-cell 
function.  In addition, obesity shows some evidence of excess maternal transmission 
among those with normal glucose tolerance.  Should future studies establish a 
parental effect, family based designs would allow consideration of the parent of 
origin of the risk allele. It is also possible that heritability occurs through 
mitochondrial DNA mutations or intrauterine exposure to hyperinsulinemia. 
 
 By examining common variants in T2DM susceptibility loci, identified in populations 
of European ancestry, and performing a meta-analysis with other Asian populations, 
we have found that these loci are generally predisposing in East Asian.  Thus, failure 
to detect these effects across different populations may be due to issue of power 
owing to limited sample size, lower minor allele frequency, or to differences in 
genetic effect sizes.  Our findings suggest that the examination of multiple ethnic 
groups may allow us to exploit differences in the patterns of linkage disequilibrium, 
between ethnic groups, in order to refine the genomic regions of interest to aid in 




 We have verified that variants at the FTO locus are associated with obesity in ethnic 
Chinese and Malays.  Our findings make it unlikely that differences in allele 
frequency or genetic architecture underlie the lack of association between FTO 
variants and obesity related traits, as previously reported in Han Chinese in 
Shanghai57.  Given these findings, it reiterates the importance to explore interactions 
between these genetic variants with lifestyle factors (e.g. physical activity, diet) to 
better elucidate possible gene-environmental interactions that may underlie 
population differences. 
 
 Our analysis of quantitative traits related to a recently identified T2DM susceptibility 
locus, KCNQ1, showed that the risk alleles at this locus are associated with decreased 
pancreatic β-cell function and fasting glucose levels, providing important insight to 




15. FUTURE STUDIES 
Our understanding of the genetics of T2DM has advanced greatly in just the past few years.  
With the continual identification of putative T2DM susceptibility loci (e.g. G6PD2, KLF11, 
MTNR1B)108-110, replication in independent populations and different ethnic groups are 
important to confirm these novel loci.  Interestingly, the risk variants that have been 
identified collectively only account for a small proportion of the heritability (~10%), which 
leads us to the enduring question: where are the unidentified genetic variants that account 
for the remaining heritability?  To answer this, several issues need to be addressed: 
 
 Most, if not all, of the SNPs identified through GWAS are likely to be merely 
surrogate markers in strong LD with the actual disease-causing variants.  Accordingly, 
several groups worldwide are currently undertaking re-sequencing studies to identify 
causative variants at these T2DM susceptibility loci.   
 One limitation of the current GWAS is the poor coverage by the current genotyping 
arrays for rare variants. While it is unclear how much heritability would be explained 
by uncommon or rare variants (<1%), the importance of investigating rare variants in 
relation to complex diseases has become evident, as demonstrated by the 
identification of multiple rare variants in relation to schizophrenia111, high-density 
lipoprotein cholesterol level112, 113 and type-1 diabetes114.   
 Deep re-sequencing has proven to be a well-founded approach to identify new and 
rare variants, as demonstrated recently in the identification of rare variants at the 
type 1 diabetes susceptibility loci IFIH1114. 
 While whole genome sequencing will likely replace whole genome genotyping in the 
near future, in the interim, targeted sequencing of the regions identified by GWAS 
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and linkage studies, exome sequencing and sequencing of biological plausible 
candidate genes would be feasible alternatives.   
 The examination of other ‘non-SNP’ variants (e.g. copy number variations (CNVs), 
translocations, short indels) could potentially account for some of the heritability of 
T2D and provide a more complete understanding of its genetic basis.  In fact, 
evidence is now available linking CNVs with complex diseases such as autoimmune 
disorders, HIV infection, schizophrenia, and autism111, 115-117.  
 The possible presence of parental effects in the heritability of T2DM risk, as 
suggested by Study I, indicate that epigenetic studies might be an important aspect 
to examine. The FTO locus, which has shown to be associated with T2DM through its 
effect on obesity, encodes a methylase, which could have a role in regulating gene 
expression.  The study of the effect of this gene (and others alike) on birth-weight 
and weight gain may provide further insights into the pathogenesis of T2DM.  
However, studying epigenetic effects such as DNA methylation and histone 
modification is also challenging, as these processes are tissue-specific, reversible and 
change according to the cellular environment.  Pancreatic tissue or β-cells are a 
logical area to be studied for T2D, but such studies are probably most feasible in 
animal models. 
 
Other potential aspects to be examined in future genetic studies of T2D are gene-gene 
(GxG) and gene-environment (GxE) interactions.  However, a comprehensive genome-wide 
scale  GxG or GxE interaction study may not be feasible at the moment, due to the need for 
large sample sizes to ensure sufficient statistical power (e.g. the simplest pairwise GxG 
interaction model would have over 500,0002 pairwise SNP combinations).  GxG interaction 
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analysis is further complicated by multi-marker interaction and interaction between SNPs 
and other types of genetic variations. Similar challenges plague GxE interaction studies 
because of the numerous environment exposures that one can measure, and the difficulty 
in accurately measuring such exposures (e.g. dietary intake and physical activity) for 
diabetes studies.  Environmental exposures change throughout an individual’s life, making it 
difficult to develop a standardized measure when dealing with large cohorts. As such, 
prospective studies which accurately collect and measure environmental data will be 
essential in order for GxE interaction to be accurately assessed.   
Despite the tremendous wealth of information garnered from GWAS, much work still 
remains, including the detailed interrogation of putative loci and examining the effect 
modification of genes.  While the current list of bona fide T2DM susceptibility loci only 
modestly improves risk prediction (over traditional T2DM risk factors), these loci may 
provide us a better understanding of the pathophysiology of T2DM, and offers new 
potential avenues for therapeutic treatment.  The correlation of genetic studies with 
expression data and functional and physiological studies will be crucial in driving the 
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a b s t r a c t
Aim: To evaluate family history (FH) of type 2 diabetes (T2DM) as a risk factor for impaired
fasting glucose (IFG), impaired glucose tolerance (IGT), T2DM and related metabolic traits in
South East Asia and to compare the effects of a paternal versus maternal history.
Methods: We studied 4717 men and women (68% Chinese, 18% Malays and 14% Asian
Indians) living in Singapore. FH was considered positive if at least one first degree relative
had T2DM. Obesity, fasting lipids, glucose and insulin levels were measured for all subjects.
Insulin resistance (IR) was estimated by homeostasis model assessment (HOMA). An oral
glucose tolerance test was carried for all subjects except those on diabetes medication.
Results: Apositive FHwas associatedwith increased risk of IFG/IGT (OR = 1.67, 95%CI = 1.42–
1.97) and T2DM (OR = 2.95, 95% CI = 2.36–3.70) as well as higher levels of obesity, HOMA-IR,
fasting triglyceride (TG), and lower levels of high density lipoprotein (HDL) cholesterol and
HOMA-b. A maternal history of T2DM appeared to have a greater impact on obesity-related
traits than a paternal history of T2DM. Compared to individuals with no FH of T2DM, a
maternal history was associated with (i) greater body mass index (BMI) (24.15 kg/m2 vs.
23.42 kg/m2, p = 0.016) andwaist-to-hip ratio (WHR) (0.874 vs. 0.865, p = 0.037) inmen; and (ii)
greater WHR (0.788 vs. 0.779, p = 0.004), fasting triglyceride (1.23 mmol/L vs. 1.09 mmol/L,
p < 0.001), HOMA-IR (2.02 vs. 1.75, p < 0.001), fasting plasma glucose (5.25 mmol/L vs.
5.18 mmol/L, p = 0.005) and 2-h plasma glucose (6.01 mmol/L vs. 5.78 mmol/L, p = 0.001)
and lower HDL-C (1.41 mmol/L vs. 1.47 mmol/L, p = 0.031) in women.
Conclusion: T2DM appears to be heritable in South East Asians with excess maternal
transmission of obesity, IR and dyslipidemia.
# 2008 Elsevier Ireland Ltd. All rights reserved.
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Type 2 diabetes mellitus (T2DM) is a complex disorder with a
considerable genetic component, as evidenced by the familial
clustering of the disease and the high concordance in
monozygotic twin studies [1]. Its mode of inheritance is likely
polygenic with its penetrance influenced by environmental
factors such as diet and exercise [2].
Many studies in normal glucose tolerant (NGT) Caucasian
populations have shown that a positive family history of T2DM
is associated not only with an increased risk of T2DM [3–5] but
also with the presence of other cardiovascular risk factors,
such as increased body mass index (BMI) [6,7] and dyslipide-
mia [6,8,9] (manifested as high triglyceride (TG) and low HDL-
cholesterol concentration). The heritability of T2DM and
associated cardiovascular risk factors is complicated by an
apparent excessmaternal transmission of diabetes [3,5,10–13].
However, the influence of parental diabetes and the pattern
of transmission in Asian populations have been less well
characterized. One study in Malaysia found that a parental
history of T2DMwas associated with higher waist-to-hip ratio
(WHR) and lower HDL cholesterol [14] in 60 pre-pubertal Malay
children. This was a small study and did not examine the role
of paternal versus maternal transmission. Another study
carried out in Chinese living in Hong Kong [13] found that
patientswith T2DMweremore likely to have a diabeticmother
than a diabetic father, suggesting that the excess maternal
transmission observed in Caucasian populationsmay apply in
Asian ethnic groups too. However, as the study included only
subjects with T2DM, they were unable to document the effect
of a family history of T2DM on the risk of T2DM in their
offspring. Furthermore, this study was not able to determine
the impact of a family history of T2DM on other CVD risk
factors in individuals without T2DM. An understanding of the
factors underlying T2DM are particularly relevant in Asia
because this is the region that is likely to see the greatest
growth in the burden of T2DM and cardiovascular disease
(CVD) in the next 30 years [15]. These findings may have
relevance to the design of studies to identify genetic variants
associated with the risk of T2DM and other CVD risk factors.
The aim of this study was to study a South East Asian
population and (1) determine the risk of glucose intolerance
(impaired fasting glucose (IFG), impaired glucose tolerance
(IGT) and T2DM) associated with a family history of T2DM in a
South East Asian population; (2) to determine the association
between a family history of T2DM and other related CVD risk
factors in NGT individuals; (3) to test the hypothesis that a
maternal history of T2DM has a greater effect on glucose
tolerance andCVD risk factors than a paternal history of T2DM.2. Materials and methods
2.1. Subjects
We studied 2180men (1469 Chinese, 403Malays and 307 Asian
Indians) and 2537 women (1756 Chinese, 445 Malays and 337
Asian Indians) from the 1998 Singapore National Health
Survey (NHS98). The methodology for this study has been
described in detail previously [16]. Essentially, the surveyprotocol was based on theWHO-recommendedmodel for field
surveys of diabetes and other non-communicable diseases
and the WHO MONICA protocol for population surveys. An
initial sampling frame of 11,200 individuals aged 18–69 was
generated based on data from the Department of Statistics.
Subsequently, a process of disproportionate stratified and
systematic sampling was used to select individuals from this
initial sampling frame, with over sampling of the minority
groups to ensure that prevalence estimates for the minority
groups were reliable and to allow statistical comparison
between ethnic groups.
Data on family history of diabetes was collected using an
interviewer-administered questionnaire. Positive family his-
tory was defined as having at least one diabetic first degree
relative. We further divided those with a positive family
history of T2DM into four groups, according to the relationship
between the affected family members with the subject.
Specifically, those that had a sibling with diabetes but no
parental history, a maternal history of diabetes, a paternal
history of diabetes and those with both parents having
diabetes. These groups were mutually exclusive. Education
level was used as a marker for socio-economic status and
determined by interviewer administered questionnaire. Sub-
jects were divided into three categories based on the number
of years of formal education (<6 years, 6–10 years, >10 years).
Ethnicity was self-reported.
2.2. Biological measurements
Fasting blood was drawn for measurement of glucose, insulin
and serum lipids in all subjects in the morning after a 10 h
overnight fast. Subjects not on oral hypoglycemic agents or
insulin underwent a 75-g oral glucose tolerance test (OGTT).
After 2 h, a second blood sample was obtained, and 2-h post-
challenge glucose (2HPG) and insulin (2-h insulin) were
measured. Glucose concentrations and serum lipids were
measured using kits from Boehringer Mannheim Systems
(Boehringer Manheim, Mannheim, Germany) and read on a
BM/Hitachi 747 analyzer (Roche Diagnostics, Corp. Indiana-
polis, IN, USA). Insulin concentrations were measured by
immunoassay using an Abbot AxSYM; Abbott Laboratories,
Chicago, IL). Total cholesterol (TC) (intra-assay CV 0.8%, inter-
assay CV 1.7%) and triglyceride (intra-assay CV 1.5%, inter-
assay CV 1.8%) were measured using enzymatic colorimetric
assays. HDL cholesterol (intra-assay CV 2.9%, inter-assay CV
3.6%) was measured using a homogenous colorimetric assay
whereas LDL cholesterol (intra-assay CV 0.9%, inter-assay CV
2.0%) wasmeasured using a homogenous turbidimetric assay.
Waist circumference was measured at the narrowest part
of the body below the costal margin, and hip circumference
was measured at the widest part of the body below the waist.
At least two readings of blood pressure were taken from
respondents, after they had rested adequately, using a
standard mercury sphygmomanometer. If the two readings
differed bymore than diastolic 15 mmHg or systolic 25 mmHg,
a third reading was performed and the mean values of the
closest two readings were calculated.
Subjects were divided in three categories of glucose
tolerance according to the recommendations of the WHO
[17]. T2DMwas diagnosed if the subject gave amedical history
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2HPG  11.1 mmol/L. Individuals with FPG  6.0 mmol/L and
2HPG  7.8 mmol/L with no history of T2DM were categorized
as NGT. IFG was diagnosed if FPG > 6.0 and 2HPG  7.8.
Impaired glucose tolerance was diagnose if FPG < 7.0 mmol/
L and 7.8 mmol/L  2HPG < 11.1 mmol/L. In this study, IFG and
IGT were grouped together as an intermediate category of
glucose tolerance between NGT and T2DM. HOMA-IR and
HOMA-b were used to quantify insulin resistance and b-cell
function, as described in [18].
2.3. Statistical analysis
Statistical analyses were performed using SPSS (version 15




n 4717 3325 901





BMI (kg/m2) 23.6  4.3 22.6  3.9 25.2  4.1
Waist-to-hip
ratio




5.8  1.7 5.3  0.4 5.9  0.5




















3.5  1.0 3.3  0.9 3.9  1.0
Triglyceride
(mmol/L)*





Chinese 68.3 72.9 61.7
Malay 18.0 15.3 24.1
Indian 13.7 11.8 14.2
Education level
<6 years 14.1 9.2 19.2
6–10 years 71.9 74.0 72.6
>10 years 14.0 16.9 8.2
Data are means  S.D., or (*) median (range).normality. Comparisons and adjusted means for continuous
variables between groups were carried out using ANOVA. We
used logistic regression to determine the risk of IFG/IGT and
T2DM associated with a family history of T2DM. Categorical
variables were compared using the x2-test. Where stated,
adjustment for age, gender, ethnic group and years of educa-
tion was carried out by adding these variables to the model.
To test the hypothesis that the effect of family history of
T2DMmight be mediated through other traits such as obesity,
insulin resistance and b-cell function, these variables were
added to the logistic regression models one at a time. The log
likelihood ratio was calculated for the models, with and
without the variable for family history of T2DM. The p-values
were estimated assuming a x2 distribution with one degree of












) 51 (19–69) < 0.001 < 0.001 <0.001
8.1  7.0
26.7  4.9 <0.001 <0.001 <0.001
7 0.90  0.07 <0.001 <0.001 <0.001
9.2  3.5 <0.001 <0.001 <0.001
8.4  2.1
7.7 137.7  21.6 <0.001 <0.001 <0.001
.2 82.0  12.0 <0.001 <0.001 <0.001
6.1  1.2 <0.001 <0.001 0.001
1.2  0.3 <0.001 <0.001 <0.001
4.1  1.1 <0.001 <0.001 <0.001
–22.18) 1.79 (0.51–30.82) <0.001 <0.001 <0.001
47.5 0.001 NS NS
49.7 <0.001 <0.001 <0.001
24.8 <0.001 <0.001 NS
25.5 0.026 <0.001 <0.001
37.7 <0.001 <0.001 <0.001
56.6 NS <0.001 <0.001
5.7 <0.001 <0.001 0.044








T2DM Crude odds ratio (95% CI) Adjusted odds ratioa (95% CI)
















28.2 24.3 33.0 38.5 1 1.53 (1.31–1.80) 2.01 (1.64–2.46) 1.61 (1.36–1.90) 2.61 (2.06–3.30)
With diabetic
father
11.0 12.4 15.0 17.3 1 1.15 (0.91–1.45) 1.12 (0.83–1.52) 1.39 (1.09–1.78) 1.74 (1.24–2.44)
With diabetic
mother
14.4 14.0 21.3 27.3 1 1.63 (1.32–1.97) 2.01 (1.58–2.56) 1.48 (1.21–1.83) 2.02 (1.55–2.65)
With diabetic
parents
2.8 2.0 3.3 6.1 1 1.65 (1.07–2.55) 3.19 (2.05–4.96) 1.49 (0.95–2.33) 2.81 (1.71–4.60)
a Adjusted for age, sex, ethnic group and education.
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The ethnic composition and clinical characteristics of the
study sample are shown in Table 1. Table 2 shows the
prevalence of a family history of diabetes according to glucose
tolerance. Of the entire population, 30.1% had at least one first
degree relative with T2DM. Of these, 28.2% had at least one
parent with T2DM (11% father only, 14.4% mother only, 2.8%
had two diabetic parents) and 2% had a sibling with T2DM but
no parental history of T2DM. A positive family history of
diabetes was associated with a statistically significant
increase in the risk of both IFG/IGT and T2DM. In unadjustedTable 3 – Association of diabetes related risk factors and cardio




BMI (kg/m2) 23.97  0.15
Waist-to-hip ratio 0.828  0.002
Systolic blood pressure (mmHg) 118.42  0.53
Diastolic blood pressure (mmHg) 71.94  0.40
Total cholesterol (mmol/L) 5.42  0.04
HDL cholesterol (mmol/L) 1.30  0.01
LDL cholesterol (mmol/L) 3.49  0.04
Triglyceride (mmol/L) 1.40  0.03
Fasting plasma glucose (mmol/L) 5.33  0.02
2-hr plasma glucose (mmol/L) 5.82  0.04
Insulin resistance (HOMA-IR) 1.93  0.05
b-cell function (HOMA-b)b 67.30  1.01
Data are adjusted means  S.E.
a Family History is defined as any first-degree relative who has reported
b Log-transformation of HOMA-b and adjusted for HOMA-IR.models, it did appear that a maternal history of T2DM was
associated with greater risk of T2DM in the study subjects,
than a paternal history. However, this difference was not seen
after adjustment for age, gender, ethnicity and education. In
fact, it was adjustment for age that had the greatest impact on
the difference between a maternal or paternal history (data
not shown).
Wenextdetermined theeffectofa familyhistoryofT2DMon
obesity and related CVD risk factors in individuals with NGT
(Table 3). As compared to subjects with no family history of
diabetes, subjectswith a positive family history had higher BMI
(23.97 vs. 23.40, p < 0.001), WHR (0.83 vs. 0.82, p < 0.001), lowervascular risk factors with a positive family history of T2DM,
historya p-values
No Adj. for age, gender,
ethnic group, education
2473
23.40  0.12 <0.001
0.821  0.002 <0.001
118.61  0.40 NS
71.56  0.30 NS
5.41  0.03 NS
1.33  0.01 0.006
3.45  0.03 NS
1.34  0.02 NS
5.27  0.01 <0.001
5.67  0.03 0.001
1.78  0.04 0.001
69.18  1.01 0.006
having T2DM (i.e. Parents/siblings).
Table 4 – Parental effect on diabetes related metabolic traits and cardiovascular risk factors in normal glucose tolerant
subjects













BMI (kg/m2) 23.42  0.18 23.76  0.33 24.15  0.31 0.289 0.016 0.341
Waist-to-hip ratio 0.865  0.003 0.869  0.005 0.874  0.004 0.360 0.037 0.407
Systolic blood pressure (mmHG) 121.32  0.65 122.06  1.20 119.75  1.12 0.526 0.151 0.118
Diastolic blood pressure (mmHG) 74.50  0.49 75.87  0.90 74.46  0.83 0.115 0.968 0.206
Total cholesterol (mmol/L) 5.55  0.05 5.64  0.09 5.62  0.09 0.326 0.391 0.893
HDL cholesterol (mmol/L) 1.20  0.02 1.20  0.03 1.17  0.03 0.989 0.231 0.380
LDL cholesterol (mmol/L) 3.65  0.05 3.73  0.08 3.73  0.08 0.309 0.265 0.978
Triglyceride (mmol/L) 1.63  0.05 1.58  0.09 1.66  0.08 0.596 0.667 0.463
Insulin resistance (HOMA-IR) 1.82  0.07 1.79  0.12 1.83  0.11 0.785 0.904 0.761
Fasting plasma glucose (mmol/L) 5.38  0.02 5.39  0.03 5.40  0.03 0.555 0.423 0.896
2-hr plasma glucose (mmol/L) 5.62  0.06 5.75  0.11 5.76  0.10 0.209 0.157 0.945
b-cell function (HOMA-b)b 65.31  1.01 64.27  1.02 64.12  1.02 0.481 0.393 0.935













BMI (kg/m2) 23.38  0.17 23.84  0.29 23.87  0.27 0.107 0.062 0.923
Waist-to-hip ratio 0.779  0.002 0.784  0.004 0.788  0.003 0.147 0.004 0.317
Systolic blood pressure (mmHG) 115.32  0.58 116.26  0.98 115.29  0.91 0.327 0.974 0.418
Diastolic blood pressure (mmHG) 68.82  0.44 68.78  0.75 69.31  0.69 0.954 0.470 0.559
Total cholesterol (mmol/L) 5.26  0.04 5.23  0.07 5.25  0.06 0.593 0.817 0.797
HDL cholesterol (mmol/L) 1.47  0.02 1.46  0.03 1.41  0.03 0.690 0.031 0.198
LDL cholesterol (mmol/L) 3.26  0.04 3.23  0.06 3.29  0.06 0.619 0.572 0.413
Triglyceride (mmol/L) 1.09  0.03 1.09  0.04 1.23  0.04 0.868 <0.001 0.012
Insulin resistance (HOMA-IR) 1.75  0.05 1.99  0.09 2.02  0.08 0.003 <0.001 0.796
Fasting plasma glucose (mmol/L) 5.18  0.02 5.27  0.03 5.25  0.03 0.001 0.005 0.591
2-hr plasma glucose (mmol/L) 5.78  0.05 5.78  0.08 6.01  0.07 0.950 0.001 0.012
b-cell function (HOMA-b)b 73.62  1.01 69.82  1.02 71.29  1.02 0.012 0.098 0.436
Subjects with either a paternal or maternal or no family history of T2DM are included. Subjects with siblings or both parents with a family
history of T2DM are not included in this analysis.
a Adjusted for age, ethnic group, education.
b Log-transformation of HOMA-b and adjusted for HOMA-IR.
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p = 0.009), increased TG level (1.40 mmol/L vs. 1.34 mmol/L,
p = 0.003), higher fasting plasma glucose (5.33 mmol/L vs.
5.27 mmol/L, p = 0.001) and 2HPG (5.82 mmol/L vs. 5.67mmol/
L, p = 0.001). A family history of T2DMwas also associated with
increasedHOMA-IR (1.93 vs. 1.78, p < 0.001) and impaired b-cell
function (67.30 vs. 69.18, p = 0.006). To determine whether the
effect of a family history of diabetes on the risk of IFG/IGT and
T2DM was mediated through these other risk factors, we
constructed a series of logistic regressionmodelswith T2DMas
the outcome (data not shown). We first estimated the log-
likelihood ratio for a positive family history of T2DM after
adjustment for age, sex and ethnic group. We then added the
other variables to the model one at a time (in the order WHR,
BMI, TG, HDL, HOMA-IR, HOMA-b), to determine the effect of
adding these variables on the log-likelihood ratio associated
with a positive family history of T2DM. A reduction in the log-
likelihood ratiowas interpreted as indicating that the effect of a
familyhistory ofT2DMmaybemediated through the risk factor
added to the model. The greatest reductions in the log-
likelihood ratio were observed when BMI, WHR, IR and b-cellfunction were added to the model. After including all these
variables in themodel, theassociationbetweena familyhistory
of T2DM and the risk of T2DM was no longer statistically
significant.
Lastly, we examined the effect of a maternal versus a
paternal history of T2DM on metabolic traits, in NGT subjects
(Table 4). For this analysis, we included only those with only
one parent having T2DM. Individuals with a siblingwith T2DM
(no parental history) and those with both parents having
T2DM were excluded. In both men and women, compared to
individualswith no family history of T2DM, amaternal history
of T2DM was associated with a greater BMI and WHR than a
paternal history of T2DM. In women, a greater effect of a
maternal history of T2DM, compared to a paternal history of
T2DM was additionally observed in relation to lower HDL-C,
higher TG, greater IR and b-cell function, higher FPG and 2HPG.
However, these differences between paternal and maternal
histories reached statistical significance for two variables, TG
( p = 0.012) and 2HPG levels (p = 0.012). These associations
were also examined separately in IFG/IGT subjects with a
similar pattern as observed in NGT subjects, with greater
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not shown).4. Discussion
Singapore has a multiethnic population including Chinese,
Asians Indians and Malays. The former two ethnic groups
represent a large portion of the population resident in Asia, the
region that is likely to see the greatest growth in the burden of
T2DM and cardiovascular disease in the next 30 years [15]. As
such, it is of importance to identify high-risk individuals, to
allow theearly implementationof preventativemeasures, such
as lifestyle modification, which has shown significant success
[19]. Furthermore, the prevalence of diabetes has risen rapidly
in Singapore over the past 20 years, from 4.8% in 1984 to 8.6% in
1998, largely as a consequence of rapid urbanization [20].
Consequently, findings fromour populationmay have implica-
tions for other populations in developing countries in Asia.
Wehave shown, that in a South East Asian population, as in
Caucasian populations [3–5,21], that a positive family history
in a first degree relative is an important risk factor for the
development of T2DM. In addition, a positive family history of
T2DMwas also associated with several diabetes related traits,
even amongst those with apparently normal glucose toler-
ance. This is also in line with studies from other population
[6,7,9–11,13,22,23].
It would appear, based on our data, that most of the risk of
T2DM associated with a positive family history is mediated by
obesity, insulin resistance and impaired b-cell function.When
these variables were added to themodel, obesity, IR and b-cell
function significantly attenuated the risk of T2DM associated
with a positive family history.
Familial clustering has been observed for many diseases,
although it is often difficult to determine the genetic and
environmental contributions to the clustering. Studies have
shown that levels of environmental risk factors for diseases
such as obesity, physical activity and diet [24,25] are correlated
among family members. However, a simulation study by
Khoury et al. [26] concluded that it is unlikely that simple
familial clustering of environmental factors alone could
account entirely for familial aggregation of disease. Based
on these data, it has been suggested that genetic factors (with
possible interaction with environmental factors) are most
likely to cause familial aggregation of diseases. Indeed, recent
data from several genome-wide association studies have
identified genetic variants associated with increased risk of
T2DM, which encode obesity (e.g. FTO) [27,28], insulin
resistance (e.g. PPARG) [28] and impaired b-cell function (e.g.
TCF7L2, CDKAL1,HHEX-IDE, KCJN11) [29,30], the three variables
that appear to mediate the familial risk of T2DM in our study.
It has been suggested that T2DM and its associated
metabolic traits show excess maternal transmission [3,5,10–
13]. Bjornholt et al. [3] found that, over a 22.5 period, NGTmen
with a maternal family history had a higher risk (RR = 2.51) of
developing T2DM compared to men with a paternal family
history of diabetes (RR = 1.41). In contrast, Lee et al. [13]
observed that male subjects with diabetic fathers had higher
BMI than male subjects with diabetic mothers. Huxtable et al.
[31] also found an excess of paternally inherited risk alleles, ofthe insulin gene, in T2DM subjects.We observed a larger effect
of a maternal history of diabetes on the risk of IFG/IGT and
T2DM, compared to a paternal history. However, this
increased risk, associated with a maternal history, was
evident only in the crude, but not the adjusted estimates of
risk. The difference in risk between a paternal history versus a
maternal history of T2DM was diminished when the risk
estimates were adjusted for age.
Despite similar risk of T2DM association with a maternal
and paternal history, our data suggests that there is excess
maternal transmission of risk for some of the T2DM related
traits amongst those with normal glucose tolerance and that
this was particularly obvious in females. It is interesting to
note that these traits that show excessmaternal transmission
relatemore to obesity (BMI,WHR, IR, TG, HDL-C) rather than b-
cell function. It should, however, be noted that the differences
in effect between maternal and paternal FH are small, and
achieve statistical significance only in the instance of
triglyceride and 2 h plasma glucose in females. Nevertheless,
these findings are supported by data from previous studies.
Groop et al. [11] reported that females with a diabetic mother
had lower HDL cholesterol levels than females with a diabetic
father. Kasperska et al. [10] reported that male subjects with
diabetic mothers had higher TG levels than males with
diabetic fathers. Lee et al. [13] also observed that females
with a diabeticmother had higher cholesterol levels compared
to females with a diabetic father.
It has been suggested that the disparity in parental effects
on the transmission of metabolic disease risk may be a result
of (1) genomic imprinting, whereby the penetrance of the
susceptibility genes inherited is different depending if it is
maternally versus paternally derived; (2) mutations in
mitochondrial DNA (mtDNA), which are maternally inherited
and may contribute to the observed excess maternal trans-
mission. Several mutations have been described affecting
proteins which are encoded in mitochondrial DNA which
participate in protein synthesis, themaintenance ofmtDNAor
the respiratory chain. The specific genes and mutations
involved have been described in a recent review [32]. Of
these, the 3243A>Gmutation affecting the gene for tRNA (LEU,
UUR) is the most common and is present in 0.2–2% of diabetic
patients with high penetrance. However, it should be noted
that the presence of this mutation is associated with reduced
obesity in Japanese and French populations, and as such, is
unlikely to underlie our observation of excess maternal
transmission for obesity [33]; or (3) metabolic programming,
such as intrauterine exposure to maternal diabetes/hyper-
insulinemia. Studies have shown that intrauterine exposure
to diabetes is associated with reduced b-cell mass and
hyperinsulinemia in offspring [34,35], which subsequently
lead to abnormal glucose tolerance in adult offspring,
increasing the susceptibility to T2DM and metabolic dysfunc-
tion. Boney et al. [35] demonstrated that intrauterine exposure
to T2DM is associatedwith a higher prevalence of components
of the metabolic syndrome in children. Pettitt et al. [36]
reported that offspring, of mothers with diabetes during
pregnancy, had a higher prevalence of obesity. Subsequently,
in a follow-up study, Pettitt et al. [37] further observed that
offspring of women who had diabetes during pregnancy, had
higher glucose concentrations. Consequently, the authors
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subsequent growth and glucose metabolism of offspring in
childhood and early adulthood.
One implication of a differential effect between maternal
and paternal family history of diabetes is that, for traits related
to obesity, IR and dyslipidemia, it may be important ascertain
the maternal and paternal transmission of the risk alleles,
when conducting genetic association studies. This could result
in a reduction in the effect associatedwith an allele potentially
leading to an underestimate of the risk associated with a
particular allele, or failure to detect the association with the
allele at all. Conventional case–control association studies
using unrelated individuals have shown tremendous recent
success in the identification of novel genetic loci associated
with obesity, T2DM and other related metabolic traits.
However, these study designs to do not allow us to investigate
parent-of-origin effects. Instead, family-based association
studies, such as parent–offspring trios, would need to be
employed to dissect the differential effects of maternal and
paternal transmission [38]. Our data suggest that such family
based study designs may allow us to better delineate the
effects of genetic variants associated with obesity-related
traits such as IR and dyslipidemia, and less important for
T2DM. In addition, despite the recent success of genome-wide
association studies for T2DM, we should also consider
mitochondrial DNA mutations and the impact of intrauterine
exposures as a basis for the heritability of these traits.
In summary, a positive family history is associated with
increased risk of T2DM in populations in South East Asia, as
they are in Caucasian populations. The effect of a family
history of T2DM operates through obesity, IR and impaired
b-cell function. No excess maternal transmission was
observed for IFG/IGT or T2DM, after adjustment for age.
However, obesity, IR and dyslipidemia show some evidence
of excess maternal transmission among those with normal
glucose tolerance. In designing studies to investigate the
basis of heritability for these traits, investigators should
consider the use of family based designs that allow
consideration of the parent of origin of the risk allele, and
also the possibility that heritability occurs through mito-
chondrial DNA mutations or intrauterine exposure to
hyperinsulinemia.5. Conflict of interest
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OBJECTIVE—Association between genetic variants at the FTO
locus and obesity has been consistently observed in populations
of European ancestry and inconsistently in non-Europeans. The
aim of this study was to examine the effects of FTO variants on
obesity and type 2 diabetes in Southeast Asian populations.
RESEARCH DESIGN AND METHODS—We examined associ-
ations between nine previously reported FTO single nucleotide
polymorphisms (SNPs) with obesity, type 2 diabetes, and related
traits in 4,298 participants (2,919 Chinese, 785 Malays, and 594
Asian Indians) from the 1998 Singapore National Health Survey
(NHS98) and 2,996 Malays from the Singapore Malay Eye Study
(SiMES).
RESULTS—All nine SNPs exhibited strong linkage disequilib-
rium (r2  0.6–0.99), and minor alleles were associated with
obesity in the same direction as previous studies with effect sizes
ranging from 0.42 to 0.68 kg/m2 (P  0.0001) in NHS98 Chinese,
0.65 to 0.91 kg/m2 (P  0.02) in NHS98 Malays, and 0.52 to 0.64
kg/m2 (P  0.0001) in SiMES Malays after adjustment for age,
sex, smoking, alcohol consumption, and exercise. The variants
were also associated with type 2 diabetes, though not after
adjustment for BMI (with the exception of the SiMES Malays:
odds ratio 1.17–1.22; P  0.026).
CONCLUSIONS—FTO variants common among European pop-
ulations are associated with obesity in ethnic Chinese and Malays
in Singapore. Our data do not support the hypothesis that
differences in allele frequency or genetic architecture underlie
the lack of association observed in some populations of Asian
ancestry. Examination of gene-environment interactions involv-
ing variants at this locus may provide further insights into the
role of FTO in the pathogenesis of human obesity and diabetes.
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A recent genome-wide association study for type2 diabetes using a U.K.-based population re-vealed a novel locus associated with BMI: thefat mass– and obesity-related gene (FTO) on
chromosome 16 (1). The representative single-nucleotide
polymorphism (SNP), rs9939609, was confirmed to be
associated with elevated BMI after replication in more
than 38,000 study participants of European ancestry. Fur-
ther replication of this association has been observed in
several populations of distinctly European ancestry (2–6).
However, this association is inconsistent in populations of
non-European ancestry. A study in Japanese showed an
association between variants at this locus and obesity (7)
that was not observed in African Americans (6) or Han
Chinese (8). The aims of this study were 1) to determine
the associations between previously identified obesity-
associated SNPs at the FTO locus with obesity and type 2
diabetes in Chinese, Malays, and Asian-Indians and 2) to
examine whether any associations were modulated by
exercise.
RESEARCH DESIGN AND METHODS
This study utilized data from two cross-sectional studies: the 1998 Singapore
National Health Survey (NHS98) (4,723 subjects) and the Singapore Malay Eye
Study (SiMES) (3,280 subjects). NHS98 is a population-based, cross-sectional
study of Chinese, Malays, and Asian Indians, aged between 18 and 69 years,
that has previously been described (9,10). An interviewer-administered ques-
tionnaire was used to capture data on sociodemographic factors, smoking,
and alcohol consumption. The level of physical activity was categorized into
three groups: those who regularly exercised, defined as participation in any
form of sports for at least 20 min for 3 or more days per week; those who
occasionally exercised (3 days per week); and those who did not exercise.
BMI and blood pressure were measured for all subjects. Waist circumferences
were measured at the narrowest part of the body below the costal margin, and
hip circumference was measured at the widest part of the body below the
waist. Fasting blood samples were drawn for measurement of serum lipids,
glucose, and insulin after a 10-h overnight fast. Type 2 diabetes was defined as
fasting glucose 7.0 mmol/l, 2 h postchallenge glucose (2HPG) 11.1 mmol/l,
or self-reported type 2 diabetes. Impaired fasting glucose/impaired glucose
tolerance was diagnosed if 6.0 mmol/l  fasting glucose 7.0 mmol/l or 7.8
mmol/l  2HPG 11.1 mmol/l.
SiMES is a population-based, cross-sectional epidemiological study of
Malay adults, aged between 40 and 79 years, that has previously been
described (11–14). Serum lipids and glucose were measured in nonfasting
venous samples. Type 2 diabetes was defined as random glucose11.1 mmol/l
or self-reported type 2 diabetes (additional information regarding the methods
of NHS98 and SiMES can be found in an online appendix, available at
http://dx.doi.org/10.2337/db08-0214).
Genotyping. Genotype data were available for 4,298 NHS98 subjects, com-
prising 2,919 Chinese (1,331 male and 1,588 female), 785 Malays (377 male and
408 female), and 594 Asian Indians (284 male and 310 female). In SiMES,
genotype data were available for 2,996 subjects (1,442 male and 1,554 female).
10 FTO SNPs that have previously been described (1–6,8) were selected for
this study (rs9939609, rs8050136, rs1421085, rs17817449, rs7193144, rs1121980,
rs9940128, rs9939973, rs9926289, and rs9930506). However, rs9930506 failed
assay design and was not genotyped.
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Genotyping of the remaining nine SNPs was carried out using the Seque-
nom MassARRAY platform (Sequenom, San Diego, CA). All nine SNPs passed
the genotyping call-rate threshold (95%) with an average call rate of 97.7% in
NHS98 samples and 99.5% in SiMES samples. Genotyping success rates for
individual SNPs are listed in Table 1 of the online appendix.
Statistical analysis. Minor allele frequency (MAF), deviation from Hardy-
Weinberg equilibrium (HWE), and linkage disequilibrium (reported as r 2)
were estimated for the nine SNPs using Haploview (15).
All measurement variables that were skewed were normalized by natural
logarithmic transformation. Estimated means were subsequently backtrans-
formed for presentation in the tables. Power calculations were carried out
using QUANTO software (http://hydra.usc.edu/gxe). Based on an MAF of 0.12,
as found in Chinese from Beijing and Shanghai (8), our study had 89% power
( level 0.05) to detect an effect size between 0.4 and 0.5 kg/m2 in BMI from
NHS98 Chinese and SiMES Malays, similar to effect sizes observed in
populations of European ancestry (0.4–0.66 kg/m2) (16).
Multiple linear regression analyses were performed to study the associa-
tions between individual SNPs with obesity, blood pressure, and lipid levels.
A general inheritance model was fitted and an additive model used based on
observed effects. Individuals were assigned as 0, 1, or 2 according to their
number of minor/risk alleles, which correspond to the risk alleles associated
with obesity in European populations. Initial analysis did not reveal statisti-
cally significant heterogeneity between the sexes (P 0.1); hence, subsequent
analyses were performed with the data from sexes combined with summary
indexes adjusted for sex. All analyses were stratified by ethnic group. Logistic
regression was used to examine the association between SNPs and categorical
outcomes. To test the hypothesis that exercise may modify the effect of FTO
variants, the interaction variable (SNP/exercise) was included into the regres-
sion models. The likelihood ratio test was used to estimate the P values for
interaction by comparing the regression models with and without the inter-
action term. Where stated, adjustment for age, sex, BMI, current smoking,
alcohol intake, and regular exercise was carried out by adding these variables
to the model. Meta-analysis was performed to determine the pooled effects
across all four populations studied using the inverse variance–weighted
method. A test of heterogeneity of effects between populations was carried
out using Cochran’s test of heterogeneity. These statistical analyses were
performed using STATA (version 9.1 for Windows). We also carried out
haplotype-based analyses, the methods for which are described in the online
appendix.
RESULTS
Table 1 shows the clinical characteristics of the two study
populations. Allele frequencies for the nine genotyped
SNPs and test for HWE deviation are listed in online
appendix Table 1. The MAFs for all nine SNPs were higher
in Asian Indians (0.33–0.43) than in Malays (0.28–0.33) or
Chinese (0.12–0.18). None of the SNPs showed significant
deviation from HWE. Figure 1 illustrates the linkage
disequilibrium between the nine FTO SNPs in the different
ethnic populations. A high degree of linkage disequilib-
rium was observed between the SNPs, with similar pat-
terns in all three ethnic groups in our population. In
addition, the linkage disequilibrium structure of our pop-
ulation showed similarity to that of the European popula-
tion (CEU population of HapMap [online appendix Fig. 1]).
Table 2 shows associations between the nine SNPs with
obesity, impaired fasting glucose/impaired glucose toler-
ance, and type 2 diabetes. All nine FTO SNPs were
associated with increased BMI with an effect size, per risk
allele, of 0.42–0.68 kg/m2 (P  0.0001) in NHS98 Chinese,
0.65–0.91 kg/m2 (P 0.02) in NHS98 Malays, and 0.52–0.64
kg/m2 (P  0.0001) in SiMES Malays. FTO variants were
also associated with an increased risk of type 2 diabetes in
the NHS98 Chinese (odds ratio 1.32–1.42; P  0.049),
NHS98 Malays (1.52–1.63; P  0.028) and SiMES Malays
(1.20–1.24; P  0.007). However, these associations were
abolished after adjustment for BMI, except in the SiMES
Malays (1.17–1.22; P  0.026). No statistically significant
associations were observed in Asian Indians.
We next examined the association between FTO SNPs
with obesity-related traits. Table 3 summarizes the associ-
ation between rs9939609 and these traits. We chose
rs9939609 as the representative SNP in our study because
it was the index SNP in the original study (1) and had one
TABLE 1
Clinical characteristics of the NHS98 and SiMES study populations
NHS 98 SiMES
Chinese Malay Indian Malay
n 2,919 785 594 2,996
Male (%) 45.6 47.9 47.8 48.1
Age (years) 37.9 12.2 38.9 12.5 40.6 11.9 58.6 11.0
BMI (kg/m2) 22.7 3.71 25.5 4.96 25.1 4.60 26.3 5.11
Waist-to-hip ratio 0.82 0.07 0.83 0.07 0.85 0.07 NA
Waist circumference (cm) 78.1 10.6 82.6 11.9 85.1 11.5 NA
HDL cholesterol (mmol/l) 1.42 0.37 1.30 0.33 1.14 0.30 1.35 0.33
LDL cholesterol (mmol/l) 3.38 0.95 3.86 1.08 3.69 1.03 3.54 1.00
Triglycerides (mmol/l) 1.40 1.19 1.67 1.28 1.68 1.36 1.60 1.32
Total cholesterol (mmol/l) 5.41 1.04 5.81 1.15 5.51 1.10 5.62 1.16
Fasting plasma glucose (mmol/l) 5.62 1.30 6.09 2.23 6.23 2.17 NA
2HPG (mmol/l) 6.65 2.76 7.37 3.55 7.63 4.07 NA
Systolic blood pressure (mmHg) 120. 16.3 124. 19.3 121. 17.1 147. 23.7
Diastolic blood pressure (mmHg) 73.7 11.2 76.0 12.0 73.6 12.0 79.7 11.2
Hypertension 18.6 25.9 20.2 68.5
Glucose tolerance (%)
Normal 2,179 (74.7) 473 (60.2) 362 (60.9) 2,288 (76.4)*
IFG/IGT 515 (17.6) 201 (25.6) 118 (19.8) NA
Type 2 diabetes 224 (7.7) 111 (14.1) 114 (19.2) 708 (23.6)
Currently smoking (%) 12.4 22.9 14.6 20.2
Regularly exercise (%)† 14.7 17.6 22.8 NA
Consume alcohol (%)‡ 45.1 7.3 33.3 1.6
Data are means  SD or n (%) unless otherwise indicated. *SiMES participants with no diabetes; †regular exercise defined as participation
in any form of sports for at least 20 min for 3 or more days per week; ‡individuals who consume at least 1 alcoholic beverage per month.
IFG/IGT, impaired fasting glucose/impaired glucose tolerance; NA, not applicable.
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of the strongest associations with BMI. In our study,
rs9939609 also showed highly significant association with
waist circumference in both NHS98 Chinese (P  0.0001)
and NHS98 Malay (P  0.001); waist circumference data
were not available for SiMES Malays. Borderline associa-
tion was also observed with LDL cholesterol and triglyc-
eride, the latter only after adjustment for BMI, in NHS98
Chinese samples. Details of the associations for the other
SNPs are listed in online appendix Table 2. Meta-analysis
of the association between this SNP and BMI for all four
populations in our study was also performed. No signifi-
cant heterogeneity was observed between the four popu-
lations, and the pooled effect size was BMI 0.62 kg/m2 (95%
CI 0.45–0.80; P  2  1012). Haplotype-based analyses
recapitulated findings from individual SNP analyses; these
results are shown in online appendix Table 3.
We also examined the interaction between rs9939609
and physical activity in relation to BMI (online appendix
Fig. 2). Although it appeared that rs9939609 had a smaller
effect on BMI in those who exercised regularly, the inter-
action was not statistically significant (P  0.248).
DISCUSSION
In our study, FTO variants showed associations with
obesity and type 2 diabetes in Chinese and Malays living in
Singapore. Similar effects were not observed in Asian
Indian samples from the NHS98 cohort. However, it should
be noted that given the relatively small sample size (n 
594) for this ethnic group, we had only 40% power to
detect changes in BMI of 0.5 kg/m2 for this population.
Furthermore, meta-analysis showed no heterogeneity of
effect between populations. We also examined the associ-
ation between these SNPs and other obesity-related traits.
Other than a strong association with waist circumference,
only borderline associations were observed with LDL
cholesterol and triglycerides. A recent study by Freathy et
al. (17) showed associations with LDL cholesterol in the
same direction as that observed in our study. Their study
also suggested that much larger sample sizes than are
currently available are required to detect the effect of
these genetic variants on secondary traits related to obe-
sity. Given the multiple associations tested, we also cannot
exclude the possibility that these could represent false-
positive findings.
Results from our NHS98 Chinese subjects are in line
with findings in a Japanese study (7) but in contrast to
those of a recent study by Li et al. (8) describing the lack
of association between FTO variants and obesity in Han
Chinese resident in China. Our study had a similarly large
sample size (n 2,919 for NHS98 Chinese vs. n 3,210 for
A NHS98 Chinese
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FIG. 1. Linkage disequilibrium (r 2) between the nine FTO SNPs in the NHS98 and SiMES populations.
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Han Chinese) and, as described in RESEARCH DESIGN AND
METHODS, was more than adequately powered to detect an
effect size on BMI similar to that observed in populations
of European ancestry. The authors suggested that the
lower MAFs and differences in genetic architecture at this
locus between Europeans and Chinese may have contrib-
uted to the lack of association in other ethnic groups. It
has been suggested that population differences in the
patterns of association such as these may occur as a result
of an evolutionary divergence that might reflect a history
of negative selection against the FTO risk alleles in African
and Chinese populations, as has been suggested in relation
to variants at the TCF7L2 locus (18). However, it seems
unlikely that any of these hypotheses provide an explana-
tion for these different findings. The MAFs of FTO SNPs
examined were very similar between the Chinese in our
population and the Han Chinese from Beijing and Shang-
hai, yet we observed a strong association with obesity.
Importantly, we studied two of the three SNPs tested by Li
et al. in Chinese Hans (rs8050136 and rs9939609), both of
which were strongly associated with obesity traits. Fur-
thermore, comparisons of linkage disequilibrium patterns
between our study populations and European (CEU) pop-
ulations from HapMap (excluding rs9926289, where no
data were available based on NCBI Build36) revealed no
major differences in this region. The nine SNPs tested
were correspondingly in strong linkage disequilibrium
with each other in our Chinese (r2  0.60–0.99), Malay
(r2  0.77–0.99 in NHS98 and r2  0.80–0.99 in SiMES),
and Asian Indian (r2 0.64–0.99) samples, as they were in
the CEU population from HapMap (r2  0.83–0.96 [online
appendix Fig. 1]).
The common form of obesity is a multifactorial condi-
tion thought to develop from an intricate interplay of
genes and environmental factors such as dietary habits
and levels of physical activity. The occurrence of gene-
gene and gene-environment factors would, therefore,
make it difficult to clearly elucidate the role of specific
TABLE 2
Association between nine FTO SNPs with obesity, risk of type 2 diabetes, and impaired fasting glucose/impaired glucose tolerance
(IFG/IGT) in the NHS98 and SiMES populations
SNP rs9939973 rs9940128 rs1421085 rs1121980
NHS98 Chinese (n  2,919)
BMI per risk allele present
(kg/m2) 0.43 0.42 0.68 0.43
P*/P† 0.0001/0.0001 0.001/0.0001 0.0001/0.0001 0.0001/0.0001
Glucose tolerance
OR (95% CI)* for type 2
diabetes vs. NGT 1.33 (1.01–1.74) 1.32 (1.00–1.72) 1.42 (1.04–1.93) 1.19 (0.91–1.53)
P*/P† 0.036/0.132 0.043/0.15 0.024/0.128 0.187/0.434
OR (95% CI) for IFG/IGT
vs. NGT* 1.10 (0.91–1.32) 1.09 (0.90–1.31) 1.15 (0.92–1.42) 1.08 (0.90–1.29)
P*/P† 0.323/0.527 0.338/0.546 0.197/0.503 0.368/0.702
NHS98 Malay (n  785)
BMI per risk allele present
(kg/m2) 0.83 0.82 0.90 0.65
P*/P† 0.001/0.002 0.002/0.002 0.001/0.001 0.011/0.015
Glucose tolerance
OR (95% CI)* for type 2
diabetes vs. NGT 1.61 (1.10–2.33) 1.60 (1.09–2.32) 1.59 (1.09–2.32) 1.57 (1.08–2.25)
P*/P† 0.013/0.082 0.014/0.084 0.016/0.095 0.016/0.071
OR (95% CI) for IFG/IGT
vs. NGT* 1.34 (1.03–1.74) 1.35 (1.03–1.74) 1.22 (0.93–1.58) 1.37 (1.06–1.77)
P*/P† 0.028/0.075 0.025/0.067 0.144/0.331 0.015/0.033
NHS98 Asian-Indians (n  594)
BMI per risk allele present
(kg/m2) 0.24 0.23 0.03 0.28
P*/P† 0.352/0.333 0.36/0.347 0.913/0.781 0.267/0.247
Glucose tolerance
OR (95% CI)* for type 2
diabetes vs. NGT 0.84 (0.59–1.19) 0.85 (0.59–1.20) 0.87 (0.60–1.25) 0.94 (0.66–1.31)
P*/P† 0.341/0.356 0.349/0.365 0.467/0.564 0.711/0.74
OR (95% CI) for IFG/IGT
vs. NGT* 0.95 (0.69–1.29) 0.96 (0.70–1.30) 0.90 (0.65–1.24) 1.05 (0.77–1.41)
P*/P† 0.754/0.707 0.775/0.732 0.515/0.509 0.774/0.895
SiMES Malay
BMI per risk allele present
(kg/m2) 0.55 0.55 0.64 0.52
P*/P† 0.0001/0.0001 0.001/0.0001 0.0001/0.0001 0.0001/0.0001
Glucose tolerance
OR (95% CI)* for type 2
diabetes vs. NGT 1.23 (1.08–1.40) 1.24 (1.08–1.40) 1.20 (1.05–1.37) 1.24 (1.08–1.40)
P*/P† 0.001/0.004 0.001/0.004 0.007/0.025 0.001/0.003
Continued on following page
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genetic variants in obesity risk (19). Recent studies have
already recognized the significance of environmental mod-
ulation in variants of LIPC, APOA5, and PPARG with
metabolic traits (20). Likewise, possible explanations for
the differences in associations seen in our population
compared with the findings of Li et al. (8) could lie in
different exposures to environmental or lifestyle factors
between the populations. For example, Andreason et al.
(4) reported that physical activity attenuated the effects of
the FTO variants on obesity. This may be relevant given
that studies in Shanghai Chinese by Lee et al. (21) and Jurj
et al. (22) have reported that an average of 35% of subjects
participated in regular exercise compared with 14.7% of
the NHS98 Singapore Chinese population. While our study
found no significant interaction with physical activity, our
study may have been underpowered to detect these inter-
actions (assuming an MAF of 12%, we only had 40% power
at an  level of 0.05). Furthermore, recent findings related
to the association between ROBO1 variants and obesity
have emphasized the importance of age-gene interactions
that may result in nonreplication (23). The differences in
average age between the two Chinese populations (37.9 
12.2 years in NHS98 Chinese vs. 58.6  6.0 years in Han
Chinese) may have contributed to the discrepancies. Al-
though this is an interesting hypothesis, it should be noted
that the FTO associations with BMI showed no heteroge-
neity across populations of European ancestry with
greatly varying mean ages (1).
Interestingly, adjustment for BMI diminished but did not
abolish the association with type 2 diabetes among SiMES
Malays. Perhaps this indicates a direct effect of FTO with
type 2 diabetes, which, to the best of our knowledge, has
not been observed in other studies. Another possibility
could relate to residual confounding by obesity. It is well
known that compared with Caucasians of similar BMI,
Asians have different levels of adiposity and, thus, risks of
TABLE 2
Continued
rs7193144 rs17817449 rs8050136 rs9926289 rs9939609
0.63 0.67 0.68 0.68 0.66
0.0001/0.0001 0.0001/0.0001 0.0001/0.0001 0.0001/0.0001 0.0001/0.0001
1.42 (1.04–1.92) 1.39 (1.01–1.90) 1.40 (1.02–1.90) 1.40 (1.02–1.90) 1.37 (1.00–1.86)
0.025/0.102 0.039/0.178 0.036/0.168 0.035/0.163 0.049/0.212
1.10 (0.89–1.37) 1.14 (0.91–1.41) 1.14 (0.91–1.40) 1.14 (0.92–1.41) 1.12 (0.89–1.38)
0.366/0.729 0.241/0.578 0.25/0.611 0.223/0.568 0.313/0.684
0.82 0.91 0.86 0.88 0.89
0.002/0.002 0.001/0.001 0.001/0.002 0.001/0.001 0.001/0.001
1.52 (1.04–2.21) 1.63 (1.11–2.38) 1.53 (1.04–2.24) 1.60 (1.09–2.32) 1.57 (1.08–2.29)
0.027/0.12 0.011/0.074 0.028/0.129 0.015/0.092 0.018/0.104
1.21 (0.93–1.57) 1.25 (0.95–1.63) 1.20 (0.91–1.56) 1.24 (0.95–1.61) 1.22 (0.93–1.59)
0.154/0.331 0.103/0.243 0.186/0.392 0.113/0.267 0.136/0.318
0.12 0.10 0.04 0.11 0.10
0.658/0.458 0.715/0.527 0.877/0.719 0.674/0.487 0.7/0.532
0.93 (0.64–1.32) 0.85 (0.58–1.23) 0.87 (0.60–1.24) 0.88 (0.61–1.27) 0.96 (0.67–1.37)
0.677/0.766 0.393/0.438 0.445/0.53 0.51/0.543 0.84/0.914
0.88 (0.63–1.21) 0.85 (0.60–1.17) 0.91 (0.66–1.25) 0.87 (0.62–1.20) 0.87 (0.63–1.20)
0.432/0.404 0.327/0.294 0.576/0.565 0.411/0.378 0.419/0.369
0.62 0.64 0.63 0.61 0.64
0.0001/0.0001 0.0001/0.0001 0.0001/0.0001 0.0001/0.0001 0.0001/0.0001
1.21 (1.05–1.37) 1.20 (1.05–1.37) 1.20 (1.05–1.37) 1.20 (1.05–1.37) 1.21 (1.05–1.38)
0.005/0.019 0.007/0.026 0.007/0.023 0.006/0.021 0.005/0.019
*Adjusted for age and sex; †adjusted for age, sex, current smoking, exercise (except in the SiMES population), BMI (for risk of type 2
diabetes), education, and alcohol consumption. NGT, normal glucose tolerance.
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type 2 diabetes (24). Consequently, adjusting for BMI may
not fully account for the confounding effects of adiposity
on the risk of type 2 diabetes in the SiMES Malays.
In conclusion, we have found that variants at the FTO
locus are associated with obesity in ethnic Chinese and
Malays living in Singapore. In addition, statistically signif-
icant associations with type 2 diabetes were observed in
Chinese and Malays. These two ethnic groups represent a
large proportion of the population living in Southeast Asia,
a region wherein a dramatic increase in the burden of
diabetes is anticipated over the next several decades (25).
Our findings make it unlikely that differences in allele
frequency or genetic architecture underlie the lack of
association reported between these variants and obesity-
related traits in Chinese Hans (8). However, it is still
possible that varied linkage disequilibrium structures and
lower MAFs could reduce power to detect associations in
other populations. Given these findings, it seems impor-
tant to explore interactions between these genetic variants
with lifestyle factors (e.g., physical activity) to better
elucidate possible gene-environmental interactions that
may underlie population differences.
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Paper III 
Genetic Variation in KCNQ1 Associates With Fasting
Glucose and -Cell Function
A Study of 3,734 Subjects Comprising Three Ethnicities
Living in Singapore
Jonathan T. Tan,1 Siti Nurbaya,2 Daphne Gardner,1 Sandra Ye,2 E. Shyong Tai,1 and Daniel P.K. Ng2
OBJECTIVE—The potassium voltage-gated channel, KQT-like
subfamily, member 1 (KCNQ1) has been found through a ge-
nome-wide association study to be a strong candidate for con-
ferring susceptibility to type 2 diabetes in East Asian and
European populations. Our objective was to describe the asso-
ciation between polymorphisms at the KCNQ1 locus with insulin
resistance, -cell function, and other type 2 diabetes–related
traits in a sample of Chinese, Malays, and Asian Indians living in
Singapore.
RESEARCH DESIGN AND METHODS—We examined the
associations between four previously reported KCNQ1 single-
nucleotide polymorphisms (SNPs) with type 2 diabetes–related
traits in 3,734 participants from the population-based 1998 Sin-
gapore National Health Survey cohort (2,520 Chinese, 693 Malay,
and 521 Asian Indians). Insulin resistance was calculated from
fasting insulin and glucose using the homeostasis model assess-
ment method, whereas pancreatic -cell function was assessed
using the corrected insulin response at 120 min (CIR120).
RESULTS—SNPs rs2237897, rs2237892, and rs2283228 were
significantly associated with type 2 diabetes (odds ratio [OR]
1.48, P  3  104; OR 1.38, P  0.002; OR 1.31, P  0.012,
respectively). Within the Chinese population, the risk alleles for
rs2237897, rs2237892, and rs2283228 were significantly associ-
ated with higher fasting glucose levels (P  0.014, 0.011, and
0.034, respectively) and reduced CIR120 (P  0.007, 0.013, and
0.014, respectively). A similar trend was observed among the
Malay and Asian Indian minority groups, although this did not
reach statistical significance because of limited sample sizes.
CONCLUSIONS—The increased risk for type 2 diabetes asso-
ciated with KCNQ1 is likely to be caused by a reduction in insulin
secretion. Further studies will be useful to replicate these
findings and to fully delineate the role of KCNQ1 and its related
pathways in disease pathogenesis. Diabetes 58:1445–1449,
2009
The prevalence of type 2 diabetes has increaseddramatically over the last 2 decades and ispredicted to double in a generation from 150million in 2000 to 300 million by 2025 (1). The
majority of this increase is taking place in developing
countries undergoing nutritional transition and has a ma-
jor impact on morbidity and health care resources (2,3).
Although the precise pathophysiology of type 2 diabetes
remains unclear, it is largely thought to be caused by a
combination of the interaction between multiple genes
and environmental factors (4).
Single-nucleotide polymorphism (SNP) analysis of ge-
nome variation in large cohorts have led to the identifica-
tion of several genes being implicated in the pathogenesis
of type 2 diabetes, of which TCF7L2 has been considered
to be the most important to date (5). More recently, the
first genome-wide association study using 207,097 SNP
markers in Asian (Japanese) patients with type 2 diabetes
and unrelated control subjects was conducted. This led to
the finding that polymorphisms (rs2237895, rs2237897, and
rs2283228) within a novel diabetes susceptibility gene,
KCNQ1, were strongly associated with type 2 diabetes in
the Japanese population (6,7). Importantly, both studies
corroborated these novel findings in populations of Euro-
pean and East Asian ancestry, including Chinese subjects
living in Singapore (6). Notwithstanding these promising
findings, it is unclear whether these polymorphisms are
associated with quantitative traits relevant to the patho-
genesis of type 2 diabetes, primarily impaired -cell func-
tion and insulin resistance (8). Unoki et al. (6) did not
report any association with -cell function or insulin
resistance, whereas only Yasuda et al. (7) found an asso-
ciation with -cell function in Japanese (P  0.021) and
Finnish subjects (P  0.024). To fill this knowledge gap,
we aimed to investigate the association of these polymor-
phisms with 1) insulin resistance and -cell function and
2) other quantitative metabolic risk phenotypes associated
with type 2 diabetes within three different ethnicities
(Chinese, Malay, and Asian Indian) living in Singapore.
RESEARCH DESIGN AND METHODS
The study used data from the cross-sectional population-based 1998 Singapore
National Health Survey (NHS98; n  4,723). Genotype data were available for
3,734 subjects comprising 2,520 Chinese, 693 Malay, and 521 Asian Indians. A
total of 1,881 Chinese subjects with normal glucose tolerance (NGT) had
previously served as the control subjects for the Singapore replication arm in
our original report (6), whereas type 2 diabetes case subjects were from a
separate study (the Singapore Diabetes Cohort Study). In this present study,
all subjects (including subjects with NGT, impaired fasting glucose, impaired
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glucose tolerance [IGT], and type 2 diabetes) were derived from the NHS98
study. Details of the NHS98 survey have been previously described in greater
detail (9). Briefly, this was a population-based, cross-sectional survey con-
ducted between September and November in 1998. The reference population
was 2.16 million Chinese, Malay, and Asian Indian Singapore residents aged
between 18 and 69 years. The survey was based on the World Health
Organization (WHO)-recommended model for field surveys of diabetes and
other noncommunicable diseases and the WHO MONICA protocol for popu-
lation surveys. The research protocol for NHS98 was approved by the
Singapore General Hospital Institutional Review Board (#54/2001).
Biological measures. Fasting blood samples were collected for glucose and
insulin after an overnight fast of 10 h. All subjects underwent a 75-g oral
glucose tolerance test except those taking oral hypoglycemic agents or
insulin. Subjects were classified as having diabetes if they gave a history of
diabetes or if their fasting glucose was 7 mmol/l or 2-h post-challenge
glucose11.1 mmol/l. Impaired fasting glycemia was defined as fasting glucose of
6–7 mmol/l and impaired glucose tolerance as 2-h post-challenge glucose of
7.8–11.1 mmol/l. Other measurements included the following: BMI and waist and
hip circumference. Insulin resistance was estimated using the homeostasis model
assessment method (HOMA-IR) (10). -Cell function was assessed using the
corrected insulin response at 120 min (CIR120) (11).
SNP genotyping. Genotyping of four SNPs in intron 15 of KCNQ1 rs2237897
(cT), rs2237895 (AC), rs2237892 (CT), and rs2283228 (AC) was per-
formed using the TaqMan SNP genotyping assay (Applied Biosystems, Foster
City, CA). Genotyping success rate for rs2237897, rs2237895, rs2237892, and
rs2283228 was 92, 99, 92, and 87%, respectively. To assess reproducibility, 1%
of samples were analyzed in duplicate; genotyping was 100% concordant for
these samples.
Statistical analysis. Minor allele frequency, Hardy-Weinberg equilibrium,
and linkage disequilibrium (LD; reported using r 2) were estimated using
Haploview (12). The distribution of glucose and insulin measures were
skewed and therefore normalized by natural logarithmic transformation.
Means were subsequently back transformed for presentation. Quantitative
traits are presented as means and SDs. Linear regression analyses were
performed to study the associations between diabetes-related traits with
genotypic groups. Individuals were as assigned as 0/1/2 according to their
number of minor alleles under an additive model of inheritance. There was no
significant heterogeneity between the sexes (P  0.05), and subsequent
analyses were performed with the sexes combined and adjusted for sex.
Linear regression with adjustment for ethnicity was used to estimate the
summary effect size of the SNPs in the combined sample from the three ethnic
groups. Logistic regression was used to estimate the association between
KCNQ1 SNPs and type 2 diabetes. All analyses were stratified by ethnic group
and adjusted for age, sex, and BMI (where appropriate). Analysis of associa-
tion with -cell function was further adjusted for insulin resistance (13).
Analyses were performed using STATA (version 9.1 for Windows) (14).
RESULTS
The anthropometric and biochemical characteristics of the
participants are detailed in Table 1. Among these individ-
uals, there was a higher prevalence of type 2 diabetes
among the Malay and Asian Indian populations and a
lower mean BMI and fasting glucose level among the
Chinese population.
Allele frequency for rs2237897, rs2237895, rs2237892,
and rs2283228 were similar between the Chinese and
Malays but different in Asian Indians (Table 2). rs2237895
was in weak LD with rs2237897, rs2237892, and rs2283228
(r2  0.25), whereas moderate LD was observed between
rs2237897, rs2237892, and rs2283228 (Chinese: r2  0.56–
0.79 Malay: r2  0.74–0.86, Asian Indian: r2  0.39–0.62)
(Supplemental Fig. 1, found in an online-only appendix
at http://diabetes.diabetesjournals.org/cgi/content/full/db08-
1138/DC1). All SNPs in the Chinese and Malays were in
Hardy-Weinberg equilibrium (P 0.05). In the Asian Indians,
TABLE 1
Clinical characteristics of the NHS98 study population by ethnicity
Chinese Malay Asian Indian
n 2,520 693 521
Age 37.9  12.2 38.8  12.7 40.5  12
% male 54.5 52.4 52.5
BMI (kg/m2) 22.7  3.7 25.6  5 25.2  4.8
Waist-to-hip ratio 0.82  0.07 0.83  0.08 0.86  0.08
Waist circumference (cm) 78.1  10.6 82.6  12 85.2  11.8
Fasting glucose (mmol/l)*† 5.53 (0–17.9) 5.89 (3.5–30) 6.01 (4.1–21.5)
Fasting insulin (mmol/l)*† 6.13 (0.2–576) 7.38 (0.7–83.4) 8.81 (1–119)
HOMA-IR*† 1.47 (0.05–19.68) 1.86 (0.11–22.24) 2.2 (0.23–31.2)
CIR120*† 0.79 (0.001–9.2) 0.76 (0.002–10.9) 0.84 (0.003–11.1)
Glucose tolerance (%)
NGT 75.2 60 60.7
IFG/IGT 17.2 25.6 19.9
Type 2 diabetes 7.6 14.4 19.4
Data are means  SD unless otherwise stated. CIR120: 100  I120/G120  (G120  70)	. Units for insulin120 (I
120) are given in mmol/l and for
glucose120 (G120) in mg/dl. *Geometric mean (range) shown, due to skewed nature of data. †Subjects taking diabetes medication were
excluded (59 Chinese, 35 Malays, and 44 Asian Indians).
TABLE 2
Association of KCNQ1 genetic variants with type 2 diabetes in
the Chinese, Malay, and Asian Indian population in Singapore
Risk allele
frequency OR (95% CI) P *
rs2237897 (CT)
Chinese 0.65 1.50 (1.15–1.96) 0.003
Malay 0.67 1.32 (0.88–1.98) 0.183
Asian Indians 0.95 2.61 (1.01–6.74) 0.047
Combined 1.48 (1.20–1.83) 3  104
rs2237895 (AC)
Chinese 0.35 1.09 (0.85–1.39) 0.496
Malay 0.32 1.39 (0.90–2.14) 0.14
Asian Indians 0.39 1.17 (0.81–1.70) 0.394
Combined 1.16 (0.97–1.4) 0.111
rs2237892 (CT)
Chinese 0.67 1.39 (1.08–1.79) 0.011
Malay 0.68 1.28 (0.85–1.93) 0.245
Asian Indians 0.95 2.32 (0.87–6.22) 0.094
Combined 1.38 (1.12–1.70) 0.002
rs2283228 (AC)
Chinese 0.63 1.22 (0.94–1.58) 0.135
Malay 0.66 1.39 (0.91–2.11) 0.124
Asian Indians 0.92 2.16 (0.98–4.74) 0.055
Combined 1.31 (1.06–1.61) 0.012
Risk allele denoted in bold. *P values adjusted for age, sex, BMI, and
ethnicity (for combined analysis).
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three of the SNPs that had low minor allele frequency
(rs2237897, rs2237892, and rs2283228) were not in the Hardy-
Weinberg equilibrium. Consequently, the results for the Asian
Indians should be interpreted with caution.
Table 2 shows the association between KCNQ1 SNPs
with type 2 diabetes in the Chinese, Malay, and Asian
Indian population in Singapore. Significant associations
were observed in the Chinese, with rs2237897 showing the
strongest effect: odds ratio (OR) 1.50 (1.15–1.96), P 
0.003. In the combined sample of the three ethnic groups,
the risk alleles of rs2237897 (C), rs2237892 (C), and
rs2283228 (A) were also associated with type 2 diabetes in
our study, consistent with previous reports (6,7). Of these,
rs2237897 showed the strongest association (OR 1.48
[1.20–1.83], P  0.0003). In the combined sample of only
Chinese and Malays subjects, the association with
rs2237897 remained significant (OR 1.45 [1.16–1.81], P 
0.001).
Table 3 shows the association between KCNQ1 SNPs
with diabetes-related traits. The risk alleles for rs2237897,
rs2237892, and rs2283228 showed statistically significant
association with higher fasting glucose levels (P  0.014,
0.011, and 0.034, respectively) and reduced CIR120 (P 
0.007, 0.013, and 0.014, respectively) in the Chinese popu-
lation. After restricting to subjects without diabetes, the
association remained significant with CIR120 (P  0.011,
0.020, and 0.015, respectively; online appendix Table 1). A
similar trend was observed among the Malays and Asian
Indians, although the associations did not reach statistical
significance, possibly because of the limited sample sizes
for these minority ethnic groups. In the combined analysis,
rs2237897 and rs2237892 were significantly associated
with fasting glucose levels (P  0.029 and P  0.021,
respectively), whereas rs2237897, rs2237892, and rs2283228
were significantly associated with lower -cell function
(CIR120) (P  0.013, 0.021, and 0.020, respectively). These
SNPs also showed associations with BMI in the Malay
population and waist-to-hip ratio in Asian Indians. How-
ever, these associations were no longer statistically signif-
icant in the combined analysis. Based on a risk allele
frequency of between 0.3 and 0.6, power calculations
estimate that the combined sample provided 90% power to
detect a 10% change in the examined traits.
DISCUSSION
Polymorphisms within KCNQ1 have recently been shown
to be strongly associated with an increased risk of type 2
diabetes in the East Asian and European populations (6,7).
Of the three polymorphisms within KCNQ1 previously
described, rs2237897 appeared to have the strongest asso-
ciation with type 2 diabetes (6), whereas another study
reported the strongest association with rs2237892 (7).
Consistent with these findings, we found that both these
SNPs were significantly associated with type 2 diabetes in
the combined analysis of three ethnic groups. In addition,
the presence of the risk allele for KCNQ1 variants
rs2237897, rs2237892, and rs2283228 were associated with
increased fasting glucose level and decreased -cell func-
tion in the Chinese population and combined sample. This
is in agreement with the study by Yasuda et al. (7), which
reported an association of these KCNQ1 variants with
-cell function. Together, these findings corroborate the
hypothesis that the role of this protein in the pathogenesis
of type 2 diabetes is likely mediated through its effects on
the pancreatic -cell, although there is still a possibility
that these polymorphisms may increase the risk of type 2
diabetes through regulation of nearby genes. In contrast,
there was no association between rs2237895 with any
diabetes-related traits, specifically highlighting the impor-
tance of the polymorphisms rs2237897, rs2237892, and
rs2283228 (which are in moderate LD) in increasing the
risk of developing type 2 diabetes. Further fine mapping of
SNPs in KCNQ1, especially within the LD block containing
rs2237897 and rs2237892, may allow the identification of
the causal variant.
KCNQ1 is located on 11p15.5, which encodes the pore-
forming 
-subunit of the IKSK
 channel, which is ex-
pressed mainly in the heart and, to a lesser extent, the
inner ear, stomach, small and large intestine, liver, and
kidney. KCNQ1 is also expressed in the pancreas, where it
is coexpressed with products of other regulators such as
KCNE1, which may alter its biophysical characteristics
and role (15). As such, it is plausible that polymorphisms
within the KCNQ1 gene alter the properties and role of
the IKSK
 channel, causing decreased pancreatic -cell
function and insulin production, leading eventually to
hyperglycemia.
Whereas we do appreciate that the associations ob-
served in the Chinese do not represent an independent
replication, since the controls used are largely the same as
those in the study by Unoki et al. (6), we have provided
data on Malays and Indians and, in our opinion, it was
reassuring that similar trends for an effect of these three
polymorphisms on association with type 2 diabetes, fast-
ing glucose, and -cell function were also observed in the
Malay and Asian Indian subjects, even though their limited
numbers certainly resulted in a reduction of study power.
Although associations with BMI in Malays and waist-to-hip
ratio in Asian Indians were found, the smaller sample sizes
for these ethnic groups, together with the fact that these
observations were not found in other ethnic groups,
inevitably led us to be cautious in interpreting these
findings. One caveat of this study is that we only examined
the SNPs, which showed the strongest association, identi-
fied by Unoki et al. (6) and Yasuda et al. (7). Although the
Chinese show strong and consistent associations with
these SNPs, the association among Malays and Asian
Indians is less clear. Further fine mapping of the KCNQ1
locus, for instance, through deep DNA resequencing may
allow the identification of population-specific causative
variants.
The use of CIR120 represented a limitation of our study,
since it only served as an approximate measure of -cell
function, which may be better assessed using the CIR30.
Thus, if CIR30 measurements were available, the positive
associations that had been observed in our study may be
further strengthened. It has also been suggested that
CIR120 could inadvertently capture information on addi-
tional aspects of glucose intolerance instead of insulin
secretion alone. The previous finding of the association
between CIR30 with KCNQ1 SNPs, in nondiabetic Euro-
pean subjects of the Botnia prospective study during their
follow-up visit (P  0.024) (7), however, appeared to
corroborate our hypothesis that these SNPs may exert
their effect on type 2 diabetes through an effect on insulin
secretion.
In conclusion, the risk alleles of rs2237897, rs2237892,
and rs2283228 within the KCNQ1 gene are associated with
decreased pancreatic -cell function and fasting glucose
levels, suggesting that the impact of these polymorphisms
on the risk of type 2 diabetes may be mediated through an
J.T. TAN AND ASSOCIATES
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 Paper IV 
Polymorphisms Identified through Genome-Wide
Association Studies and Their Associations with Type
2 Diabetes in Chinese, Malays, and Asian-Indians in
Singapore
Jonathan T. Tan, Daniel P. K. Ng, Siti Nurbaya, Sandra Ye, Xiu Li Lim,
Helen Leong, Lin Tze Seet, Wei Fong Siew, Winston Kon, Tien Yin Wong,
Seang Mei Saw, Tin Aung, Kee Seng Chia, Jeannette Lee, Suok Kai Chew,
Mark Seielstad,* and E. Shyong Tai*
Department of Epidemiology and Public Health (J.T.T., D.P.K.N., S.N., S.Y., X.L.L., S.M.S., K.S.C., J.L.);
Centre for Molecular Epidemiology (K.S.C.); and Singapore Eye Research Institute (T.Y.W., S.M.S., T.A.)
and Department of Medicine (E.S.T.), Yong Loo Lin School of Medicine; National University of Singapore,
Singapore 117597; Clinical Services (H.L., L.T.S., W.F.S.), National Healthcare Group Polyclinics,
Singapore 149157; Department of Endocrinology (W.K.), Tan Tock Seng Hospital, Singapore 308433;
Ministry of Health (S.K.C.), Singapore 169854; and Genome Institute of Singapore (M.S.), Agency for
Science, Technology and Research, Singapore 138672
Context:Novel type2diabetesmellitus (T2DM) susceptibility loci, identified throughgenome-wide
association studies (GWAS), have been replicated in many European and Japanese populations.
However, the association in other East Asian populations is less well characterized.
Objective: To examine the effects of SNPs in CDKAL1, CDKN2A/B, IGF2BP2,HHEX, SLC30A8, PKN2,
LOC387761, and KCNQ1 on risk of T2DM in Chinese, Malays, and Asian-Indians in Singapore.
Design: We genotyped these candidate single-nucleotide polymorphisms (SNPs) in subjects from
threemajor ethnic groups inAsia, namely, theChinese (2196 controls and1541 cases),Malays (2257
controls and 1076 cases), and Asian-Indians (364 controls and 246 cases). We also performed a
metaanalysis of our results with published studies in East Asians.
Results: In Chinese, SNPs in CDKAL1 [odds ratio (OR) 1.19; P 2 104], HHEX (OR 1.15; P
0.013), and KCNQ1 (OR  1.21; P  3  104) were significantly associated with T2DM. Among
Malays, SNPs inCDKN2A/B (OR 1.22; P 3.7 104),HHEX (OR 1.12; P 0.044), SLC30A8 (OR
1.12; P 0.037), andKCNQ1 (OR 1.19–1.25; P 0.003–2.5 104) showed significant association
with T2DM. The combined analysis of the three ethnic groups revealed significant associations
between SNPs in CDKAL1 (OR  1.13; P  3  104), CDKN2A/B (OR  1.16; P  9  105), HHEX
(OR  1.14; P  6  104), and KCNQ1 (OR  1.16–1.20; P  3  104 to 3  106) with T2DM.
SLC30A8 (OR1.06;P0.039) showedassociationonlyafteradjustment forgenderandbodymass
index. Metaanalysis with data from other East Asian populations showed similar effect sizes to
those observed in populations of European ancestry.
Conclusions: SNPs at T2DMsusceptibility loci identified throughGWAS inpopulations of European
ancestry show similar effects in Asian populations. Failure to detect these effects across different
populations may be due to issues of power owing to limited sample size, lower minor allele
frequency, or differences in genetic effect sizes. (J Clin Endocrinol Metab 95: 390–397, 2010)
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Genome-wide association studies (GWAS) have iden-tified several type 2 diabetes mellitus (T2DM) sus-
ceptibility loci includingCDKAL1,CDKN2B, IGF2BP2,
HHEX, SLC30A8, PKN2, LOC387761 (1–5), and
KCNQ1, which was recently identified by similar GWAS
approach in two independent Japanese samples (6, 7). Al-
though these associations have beenwell replicated in Jap-
anese populations (8), the role of these loci in other East
Asian populations remains less clear. For example, a study
in China by Wu et al. (9) did not find significant associ-
ations between single-nucleotide polymorphisms (SNPs)
in IGF2BP2 and SLC30A8 with T2DM, whereas an asso-
ciation between SNPs at the HHEX locus and T2DM was
reported among Chinese living in Shanghai, but not among
Chinese in Beijing. Another study in Hong Kong Chinese
(10) also did not find an association with SNPs at the
IGF2BP2 locus; however, they reported an association be-
tween T2DMwith SNPs at theHHEX and SLC30A8 loci.
Singapore has a multiethnic population including Chi-
nese, Malays, and Asian-Indians. These three ethnic
groups represent a predominant portion of the population
resident in Asia, where a doubling in the prevalence of
T2DM is expected in the next 20 yr as a result of the rapid
urbanization occurring in this region (11). TheMalay eth-
nicity alone is the third largest ethnic group in Asia with a
total population of over 200 million in Indonesia, Malay-
sia, Singapore, and other Southeast Asian countries. This
ethnic group certainly represents a population with the
propensity to develop T2DM and have a prevalence of
T2DMof 8.5% inmen and 10.1% inwomen in Singapore
(12). However, to date, the effects of these T2DM suscep-
tibility loci in Malays has not been examined.
The aims of this study are to 1) ascertain the association
and contribution of nine SNPs in recently identified
T2DM susceptibility loci (CDKAL1, CDKN2A/B,
IGF2BP2, HHEX, SLC30A8, PKN2, LOC387761, and
KCNQ1) with the risk of T2DM in Chinese, Malays, and
Asian-Indians and 2) to perform ametaanalysis of similar
studies in East Asians.
Subjects and Methods
We used a case-control approach using subjects from two cross-
sectional studies, the 1998 SingaporeNational Health Survey (n
4323), theSingaporeMalayEyeStudy (n2997), andacase-series
study, the Singapore Diabetes Cohort Study (n 1703).
1998 Singapore National Health Survey (NHS98)
NHS98 is a population-based, cross-sectional study compris-
ing Chinese,Malays, andAsian-Indians aged between 18 and 69
yr. The survey methods have been described previously (13) and
were based on the World Health Organization (WHO)-recom-
mended model for field surveys of diabetes and other noncom-
municable diseases, and the WHOMONICA protocol for pop-
ulation surveys. Fasting blood samples were drawn for
measurement of serum glucose (Boehringer Manheim, Mann-
heim, Germany) and insulin (immunoassay using an Abbott
AxSYM; Abbott Laboratories, Chicago, IL) in all subjects after
a 10-h overnight fast. All participants who were not taking oral
hypoglycemic agents or insulin were subjected to a 75-g oral
glucose tolerance test. Subjects were considered to have T2DM
if they gave a history of type 2 diabetes or if their fasting
glucose was 7.0 mmol/liter or higher or if their 2-h postchal-
lenge glucose (2HPG)was 11.1mmol/liter or higher. Impaired
fasting glucose (IFG) was defined as fasting glucose higher than
6.0 mmol/liter and lower than 7.0 mmol/liter and 2HPG lower
than 7.8 mmol/liter, and impaired glucose tolerance (IGT) was
defined as fasting glucose higher than 7.0 mmol/liter and 2HPG
higher than 7.8 mmol/liter and less than 11.1 mmol/liter.
DNA was isolated from blood samples using DNA blood
Midi kits (QIAGEN, Hilden, Germany) following the manufac-
turer’s recommended protocol. At the time of this study, DNA
samples from 2937 Chinese, 788 Malay, and 598 Asian-Indian
subjects were available for analysis. Height, weight, and blood
pressure were measured for all subjects. Body mass index (BMI)
was calculated as weight (in kilograms) divided by the square of
height (in meters).
Singapore Diabetes Cohort Study (SDCS)
SDCS comprises Chinese, Malay, and Asian-Indian individ-
uals with T2DM (http://www.med.nus.edu.sg/cof/resch_sdcs.
html). Since 2004, all individuals treated for T2DM at primary
care facilities of the Singapore National Healthcare Group Poly-
clinics have been invited to participate in the SDCS (14). An
excellent response rateof91%wasachieved, and this formedour
SDCS case group. At the time of this study, DNA samples from
1317 Chinese, 256 Malay, and 130 Asian-Indian subjects were
available for analysis. Blood specimens were obtained for DNA
extraction and analysis at the Disease Genetics Laboratory, De-
partment of Epidemiology and Public Health, National Univer-
sity of Singapore. BMI was measured in all subjects in the same
way as in NHS98.
A total of 1881 Chinese subjects had previously served as the
controls for the Singapore replication arm in the original report
byUnoki et al. (6) identifyingKCNQ1asadiabetes susceptibility
loci. In the original paper, only normal glucose-tolerant controls
were derived fromNHS98, whereas T2DM cases were from the
SDCS. In thepresent study, allChinese,Malay, andAsian-Indian
subjects from the NHS98 study (inclusive subjects with normal
glucose tolerance and T2DM) were included.
Singapore Malay Eye Study (SiMES)
SiMES is a population-based, cross-sectional epidemiological
study ofMalay adults residing in Singapore. Details of the study
design, samplingplan, andmethodologyhavebeen reportedelse-
where (15–18). In brief, age-stratified random sampling of all
Malay adults aged from 40–80 yr residing in 15 residential dis-
tricts in the southwestern part of Singapore was performed. A
40-ml sample of nonfasting venous blood was collected, and
levels of serumglucose, glycatedhemoglobin (HbA1c),and lipids
were measured on the same day using enzymatic methods im-
plemented in the Advia 2400 Chemistry System (Siemens Med-
ical Solutions Diagnostics, Deerfield, IL). T2DMwas diagnosed
if the subject reported a history of type 2 diabetes or if the non-
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fasting plasma glucose was 11.1 mmol/liter or higher. DNAwas
extracted from serum using an automatedDNA extraction tech-
nique at the Singapore Tissue Network. DNA samples for 2997
subjects were available for analysis. BMI was measured in all
subjects in the same way as in NHS98.
Selection of cases and controls
Controls fromNHS98 included subjects with normal glucose
tolerance based on the fasting glucose and the 2HPG (2196 Chi-
nese, 472Malays, and364 Indians).Cases included subjectswith
the diagnosis of T2DM fromNHS98 (224Chinese, 113Malays,
and 116 Indians) as well as all subjects from the SDCS (1317
Chinese, 256 Malays, and 130 Indians). NHS98 Subjects with
IFG/IGT (n 838) were excluded from analysis. In SiMES, con-
trols (n 1785)were selected on the basis of having a nonfasting
bloodglucose level lower than11.1mmol/liter andHbA1c lower
than 6.1% (2 SD above themean for the nondiabetic population),
whereas cases (n  707) were as described in the preceding
paragraph.
Genotyping
We genotyped SNPs in nine diabetes susceptibility loci iden-
tified by recent GWAS studies. These include rs7756992 in
CDKAL1, rs10811661 inCDKN2A/B, rs4402960 in IGF2BP2,
rs1111875 inHHEX, rs13266634 in SLC30A8, and rs2237897
and rs2237892 in KCNQ1. We also examined rs6698181 in
PKN2 because it did show some association in the GWAS by
Diabetes Genetics Initiative (DGI) (1) and Finland-United States
Investigation of Non-insulin Diabetes Genetics (FUSION) (2)
(P103–105) and rs7480010 inLOC387761,which showed
an association in the GWAS by Sladek et al. (5) (P  105).
Because there have been fewer reports examining these loci, we
felt it might be of interest to examine this in our multiethnic
population. Although polymorphisms at the TCF7L2 locus have
the largest effects on the risk ofT2DMinmost studies carriedout
in populations of European ancestry, we did not include these in
this study because the low allele frequency in Asian populations
limits the power of our study to detect any effects, even if they
were present. Furthermore, strictly speaking, these polymor-
phisms were not identified through GWAS.
Genotyping of the SNPs (except rs2237892) was carried out
using the Sequenom MassARRAY platform (Sequenom, San
Diego, CA). Genotyping of rs2237892 was performed using the
TaqMan SNP genotyping assay (Applied Biosystems, Foster
City, CA). All SNPs passed the genotyping call rate threshold
(90%). Thirty samples were analyzed in duplicate; genotyping
was 100% concordant for these samples. Genotyping details of
the SNPs are listed in supplemental Table 1 (published as sup-
plemental data on The Endocrine Society’s Journals Online web
site at http://jcem.endojournals.org).Minor allele frequency and
deviation from Hardy-Weinberg Equilibrium (HWE) were esti-
mated using Haploview (19).
Statistical analysis
Ageneral inheritancemodelwas fitted, and anadditivemodel
was used based on observed effects. Allele-specific odds ratios
(ORs) were calculated under the assumption of an additive risk
model by assigning subjects as 0, 1, or 2 according to the number
of risk alleles (not necessarily the minor alleles at the polymor-
phic site). Logistic regression was performed to study the asso-
ciation between the SNPswith T2DM.We stratified the analysis
by the three ethnic groups (with adjustment for study). The pri-
mary analysis considered only the genetic variants in the model.
These analyses were subsequently adjusted for gender and BMI
by adding these variables to the model.
As a supplementary analysis, we also assessed the joint effect
of the SNPs using logistic regression to calculate the OR with
respect to the number of risk alleles carried (under an additive
model). We grouped individuals into categories based on the
number of risk alleles, with each category treated as an indepen-
dent variable in the logistic regression model. Adjacent catego-
ries were combined if they had a frequency of less than 5%.
For the metaanalysis, Cochran’s Q test and I2 were used to
assess heterogeneity between the studies. Based on the range of
I2 valuesobserved (17–65%),metaanalysiswasperformedusing
a random effects model. A comparison between the estimates
derived from a random-effects model vs. a fixed-effects model is
listed in supplemental Table 2. The statistical analyses were per-
formed using STATA (version 9.2; College Station, TX).
Results
Table 1 shows the clinical characteristics of the three study
populations. InNHS98, theprevalenceofT2DMisobserved
to be highest among Asian-Indians (19.9%), followed by
Malays (14.4%) and Chinese (7.6%). Correspondingly,
theChinese had lower levels for diabetes-related traits (i.e.
obesity measures, blood glucose levels, and insulin resis-
tance) comparedwith theMalays andAsian-Indians. Sim-
ilarly, in SDCS, HbA1c levels were highest among Asian-
Indians, followed byMalays and the Chinese (P 0.001).
Although SiMES participants were older compared with
the NHS98 Malays, they had comparable levels of BMI
(P  0.303). SDCS participants also tended to be older
compared with NHS98 participants; however, there was
no significant difference in the mean BMI between SDCS
participants and NHS98 participants with T2DM (P 
0.26). Allele frequencies for the nine genotyped SNPs, test
for HWE deviation, and genotype call rates are listed in
supplemental Table 1. Significant deviation from HWE
(P 0.01) was observed for rs2237892 and rs2237897 in
the Asian-Indians and for rs7480010 in the SiMES Ma-
lays; consequently, these were excluded from subsequent
analysis.
Table 2 shows the association between the SNPs at
the nine loci with risk of T2DM. In Chinese, SNPs in
CDKAL1 (OR  1.19; P  2  104), HHEX (OR 
1.15;P0.013), andKCNQ1 (OR1.21;P3104)
were significantly associated with T2DM. Among Ma-
lays, SNPs in CDKN2A/B (OR 1.22; P 3.7 104),
HHEX (OR 1.12; P 0.044), SLC30A8 (OR 1.12;
P 0.037), and KCNQ1 (OR 1.19–1.25; P 0.003–
2.5  104) showed significant association with T2DM.
InAsian-Indians, SNPs at theCDKAL1 locus (OR1.39;
P  0.015) and KCNQ1 locus (OR  2.48–2.50; P 
0.012–0.022) were significantly associated with T2DM.
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However, theSNPs inKCNQ1amongAsian-Indianswere
not in HWE; together with their smaller sample size, the
results for the Asian-Indians should be interpreted with
caution. The combined analysis of the three ethnic groups
revealed significant associations between SNPs inCDKAL1
(OR1.13;P3104),CDKN2A/B (OR1.16;P
9  105), HHEX (OR  1.14; P  6  104) and
KCNQ1 (OR1.16–1.20;P3104–3106)with
T2DM. Subsequent adjustment for gender and BMI
largely recapitulated the findings of the unadjusted anal-
ysis, with the exception of SLC30A8 (OR  1.06; P 
0.039), which showed association only after adjustment
for gender and BMI in the combined analysis. No statis-
tically significant associations were observed for SNPs at
the PKN2 and the LOC387761 loci.
The joint-effect analysis of the six SNPs showed a sig-
nificant increase in the risk of T2DM with an increase in
the number of risk alleles for the combined sample of Chi-
nese, Malay, and Asian-Indian subjects from Singapore.
Compared with subjects carrying zero to three risk alleles
(8.3% of study population), each additional risk allele on
average conferred a 14% increase in the odds of T2DM
(supplemental Fig. 1).
Figure 1 illustrates the metaanalysis of risk estimates
for six of the loci (CDKAL1, CDKN2A/B, HHEX,
IGF2BP2, SLC30A8, andKCNQ1), usingdata frompub-
lished studies in East Asia, including Chinese populations
from China (9, 20–23) and Hong Kong (10) as well as
Korean (7, 10, 24) and Japanese (6, 7, 25, 26) populations.
In essence, themetaanalysis showed that these six diabetes
susceptibility loci identified throughGWASare associated
with T2DM in populations across Asia.
Discussion
This study reports on the contribution and importance of
diabetes-susceptibility loci, identified through GWAS, in
the three major ethnic groups in Asia and is the first study
among ethnic Malays. We had previously reported that
variants in the FTO gene were associated with BMI and
contributed toward risk of T2DM in the Singapore pop-
ulation (18). To expand on this, in the present study, we
have examined nine diabetes-susceptibility loci in Chi-
nese, Malays, and Asian-Indians living in Singapore. In
the combined analysis of the three ethnic groups, we
found statistically significant associations with SNPs at
five loci (CDKAL1,CDKN2A/B,HHEX, SLC30A8, and
KCNQ1), demonstrating that these SNPs are also relevant
in Asian populations, despite their allele frequencies dif-
fering from those observed in populations of European
ancestry. In addition, the effects of these diabetes suscep-
tibility loci appear additive, with subjects who carry nine
or more risk alleles having 2.45 times the risk of T2DM
compared with subjects with zero to three risk alleles
(supplemental Fig. 1).
We also found that the effect estimates for IGF2BP2
were in the same direction as previously reported in other
populations (1, 2, 4, 10). Although the association did not
reach statistical significance in the present study, when
metaanalysis was performed with other East Asian pop-
ulations, the effect was as observed in populations of Eu-
ropean ancestry and statistically significant. The failure to
replicate the association with T2DM for all the suscepti-
bility SNPs examined seems tobe commonplacewhen rep-
lication studies are carriedout indifferentpopulations and
TABLE 1. Clinical characteristics of study populations
NHS98 SDCS SiMES,
MalaysChinese Malays Asian-Indians Chinese Malays Asian-Indians
n 2937 788 598 1317 256 130 2997
Age (yr) 37.9  12.2 38.8  12.7 40.5  12 63.9  9.7 60.5  9.5 60  10.5 58.7  11
% male 0.46 0.48 0.48 0.49 0.47 0.51 0.48
BMI (kg/m2) 22.7  3.7 25.6  5 25.2  4.8 25.3  3.9 28.5  5 26.9  4.6 26.4  5.1
Fasting glucose
(mmol/liter)
5.6  1.3 6.1  2.2 6.3  2.2 6.8  3.7a
2-h glucose
(mmol/liter)
6.6  2.8 7.4  3.6 7.6  4
Fasting insulin
(U/ml)
7.4  11.1 9.0  7.1 10.7  8.2
Glucose tolerance,
n (%)
Normal 2196 (74.8) 472 (59.9) 364 (60.9) 2290 (76.4)b
IGT/IFG 517 (17.6) 203 (25.7) 118 (19.7)
T2DM 224 (7.6) 113 (14.3) 116 (19.4) 1317 (100) 256 (100) 130 (100) 707 (23.6)
Data are means  SD unless indicated otherwise.
a Nonfasting blood glucose in SiMES subjects.
b SiMES subjects with HbA1c higher than 6.1% (n  505) were not included as controls in case-control analysis.
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ethnic groups. It has been suggested that differences in the
patternsof linkagedisequilibriumbetween theseSNPsand
functional variants at these loci could underlie these dis-
parate findings. Alternatively, gene-environment interac-
tions may operate in the pathogenesis of T2DM and that
differences in the level of environmental risk factors in
differentpopulationsmayalter the impactof susceptibility
loci on the risk of T2DM. For example, Andreasen et al.
(27) reported that physical activity attenuated the effects
of the FTO variants on obesity. However, when we com-
binedour datawith those in otherAsianpopulations, add-
ing 4817 controls and 2863 cases to the existing literature,
our metaanalysis suggests that the effects of the polymor-
phisms are similar to those in populations of European




95% CI P value P valueaControl Case
CDKAL1 (rs7756992 A3G)
Chinese 0.45 0.50 1.19 (1.09–1.31) 2  104 8  105
Malay 0.44 0.44 1.03 (0.93–1.14) 0.612 0.24
Indian 0.22 0.28 1.39 (1.06–1.81) 0.015 0.011
Combinedb 1.13 (1.06–1.21) 3  104 1  105
CDKN2A/B (rs10811661 T3C)
Chinese 0.58 0.61 1.10 (0.99–1.23) 0.074 0.304
Malay 0.60 0.64 1.22 (1.09–1.36) 3.7  104 4.4  105
Indian 0.81 0.83 1.19 (0.87–1.63) 0.282 0.482
Combinedb 1.16 (1.08–1.25) 9  105 3  105
HHEX (rs1111875 T3C)
Chinese 0.29 0.33 1.15 (1.03–1.29) 0.013 0.028
Malay 0.31 0.33 1.12 (0.99–1.26) 0.044 0.013
Indian 0.33 0.37 1.20 (0.93–1.57) 0.167 0.248
Combinedb 1.14 (1.06–1.24) 6  104 2  104
IGF2BP2 (rs4402960 G3T)
Chinese 0.23 0.25 1.11 (0.98–1.26) 0.103 0.263
Malay 0.31 0.31 1.00 (0.89–1.12) 0.97 0.741
Indian 0.44 0.45 1.02 (0.81–1.3) 0.849 0.941
Combinedb 1.05 (0.97–1.13) 0.26 0.226
SLC30A8 (rs13266634 C3T)
Chinese 0.53 0.53 0.98 (0.88–1.09) 0.734 0.512
Malay 0.57 0.59 1.12 (1.01–1.25) 0.037 0.023
Indian 0.74 0.77 1.18 (0.88–1.58) 0.269 0.316
Combinedb 1.06 (0.98–1.13) 0.145 0.039
KCNQ1 (rs2237982 C3T)
Chinese 0.67 0.69 1.08 (0.96–1.22) 0.183 0.075
Malay 0.68 0.72 1.25 (1.11–1.42) 2.5  104 3.7  105
Indianc 0.94 0.98 2.50 (1.14–5.46) 0.022 0.023
Combinedb 1.16 (1.07–1.27) 4.1  104 2  105
KCNQ1 (rs2237987 C3T)
Chinese 0.65 0.69 1.21 (1.09–1.34) 3  104 2  104
Malay 0.68 0.71 1.19 (1.06–1.34) 0.003 3.9  104
Indianc 0.94 0.98 2.48 (1.22–5.04) 0.012 0.019
Combinedb 1.20 (1.11–1.30) 3  106 1  107
PKN2 (rs6698181 C3T)
Chinese 0.34 0.35 1.06 (0.96–1.17) 0.221 0.387
Malay 0.21 0.22 1.04 (0.92–1.18) 0.552 0.900
Indian 0.18 0.18 1.02 (0.76–1.38) 0.873 0.815
Combinedb 1.05 (0.98–1.13) 0.183 0.535
LOC387761 (rs7480010 A3G)
Chinese 0.22 0.21 0.94 (0.84–1.05) 0.266 0.224
Malay 0.28 0.27 0.98 (0.88–1.10) 0.763 0.455
Indian 0.44 0.45 1.04 (0.83–1.30) 0.734 0.995
Combinedb 0.97 (0.90–1.04) 0.405 0.186
Number of subjects (control/case) were as follows: Chinese (2196/1541), Malay (2257/1076), and Asian-Indian (364/246). CI, Confidence interval.
a Adjusted for gender and BMI.
b Combined odds-ratio adjusted for ethnicity.
c SNP not in HWE (P  0.01), excluded from combined and metaanalysis.
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FIG. 1. Metaanalysis of recently identified type 2 diabetes susceptibility loci in Asian populations. Cochran’sQ test and I2 were used to assess heterogeneity
between the studies. Based on the range of I2 observed (31.3–76.4%), metaanalysis was performed using a random-effects model. The reference studies used in
the metaanalysis were 1) Chinese A (Beijing plus Shanghai; 424 cases and 1908 controls) (9, 23); 2) Chinese B (1912 cases and 2041 controls) (21, 22); 3)
Chinese C (1769 cases and 1734 controls) (20); 4) Chinese D (1577 cases and 1416 controls) (7); 5) Hong Kong (1481 cases and 1530 controls), Korea SNUH
(761 cases and 632 controls), and Korea KHGS (799 cases and 1516 controls) (10); 6) Korean A (908 cases and 502 controls) (24); 7) Korean B (758 cases and
632 controls) (7); 8) Japanese A (1630 cases and 1064 controls) (26); 9) Japanese B (864 cases and 864 controls) (25); and 10) Japanese C (3522 cases and 1320
controls), with only the effect estimate for the Japanese population in this study included in our metaanalysis (6); and 11) Japanese D (4412 cases and 4378
controls) (7).
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descent, in linewith findings from a recent Japanesemeta-
analysis (8). These findings demonstrate that the impor-
tance of these polymorphisms is similar in Asians as it is in
populations of European descent and that limitation in
statistical power, to detect variants which confer amodest
risk for T2DM, may underlie previous failure of replica-
tion studies. This is not to say that heterogeneity of effect
does not exist between populations. In fact, significant
heterogeneity of effect was observed between populations
with I2 of up to 76%. However, our findings suggest that
this heterogeneity, whether due to differences in the pat-
tern of linkage disequilibrium or to gene-environment in-
teractions, may be subtle compared with the main effects
of these loci that have been observed thus far.
One caveat of this study is the smaller sample sizes for
theAsian-Indians,which certainly decreased studypower.
Based on a risk allele frequency of 0.3, power calculations
estimate that the Asian-Indian samples provided only 35–
45% power to detect an OR of 1.2. In contrast, the larger
sample sizes available in theChinese andMalays provided
85–90%power.However, despite the Chinese andMalay
samples being sufficiently powered to detect the effect es-
timates previously reported (1, 2, 5), we did not detect
significant association between SNPs at PKN2 and
LOC387761 with T2DM. With the exception of some of
the initial GWAS, the association with these SNPs have
largely been negative (4, 28, 29); taken together with our
findings, this could suggest that the effects at these loci
may be population specific or possibly false positives. An-
other limitation of this study is that we were not able to
examine and correct for population stratification. One
way to determine the presence of population stratification
is to examine for differences between cases and controls
through principal-components analyses of a large number
of SNPs neutral to the disease of interest as is typically
performed in GWAS. Unfortunately these data are not
available for the samples in this paper. Nevertheless, we
suggest that the consistency between our findings and
other studies argues against population stratification as a
source of confounding.
In conclusion, by studying populations of Chinese,
Malays, andAsian-Indians in Singapore and performing a
metaanalysis with other East Asian populations, we have
found that commonvariants associatedwithT2DM, iden-
tified in populations of European ancestry, are also asso-
ciated in East Asians. Thus, failure to detect these effects
across different populationsmay be due to issues of power
owing to limited sample size, lowerminorallele frequency,
or differences in genetic effect sizes. Several groupsworld-
wide are currently undertaking resequencing studies to
identify causative variants at these loci. Our findings sug-
gest that examination ofmultiple ethnic groupsmay allow
us to exploit differences in the patterns of linkage disequi-
librium between ethnic groups to refine the genomic re-
gion of interest and aid in this effort.
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impact on -cell function rather than insulin resistance.
Further studies will be useful to replicate these promising
findings and to fully delineate the role of KCNQ1 and its
related pathways in the pathogenesis of type 2 diabetes.
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